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ABSTRACT

POLYMERIC MICROFLUIDIC DEVICES FOR BIOANALYSIS

Xuefei Sun
Department of Chemistry and Biochemistry
Doctor of Philosophy

Polymeric microchips have received increasing attention in chemical analysis
because polymers have attractive properties, such as low cost, ease of fabrication,
biocompatibility and high flexibility. However, commercial polymers usually exhibit
analyte adsorption on their surfaces, which can interfere with microfluidic transport in,
for example, chemical separations such as chromatography or electrophoresis. Usually,
surface modification is required to eliminate this problem. To perform stable and
durable surface modification, a new polymer, poly(methyl methacrylate-co-glycidyl
methacrylate) (PGMAMMA) was prepared for microchip fabrication, which provides
epoxy groups on the surface. Whole surface atom transfer radical polymerization
(ATRP) and in-channel ATRP approaches were employed to create uniform and dense
poly(ethylene glycol) (PEG)-functionalized polymer brush channel surfaces for
capillary electrophoresis (CE) separation of biomolecules, such as peptides and
proteins. In addition, a novel microchip material was developed for bioanalysis,

which does not require surface modification, made from a PEG-functionalized
copolymer. The fabrication is easy and fast, and the bonding is strong. Microchips
fabricated from this material have been applied for CE separation of small molecules,
peptides, proteins and enantiomers.
Electric field gradient focusing (EFGF) is an attractive technique, which
depends on an electric field gradient and a counter-flow to focus, concentrate and
separate charged analytes, such as peptides and proteins. I used the
PEG-functionalized copolymer to fabricate EFGF substrates. The separation channel
was formed in an ionically conductive and protein resistant PEG-functionalized
hydrogel, which was cast in a changing cross-sectional cavity in the plastic substrate.
The hydrogel shape was designed to create linear or non-linear gradients. These
EFGF devices were successfully used for protein focusing, and their performance was
optimized. Use of buffers containing small electrolyte ions promoted rapid ion
transport in the hydrogel for achieving the designed gradients. A PEG-functionalized
monolith was incorporated in the EFGF separation channel to reduce dispersion and
improve focusing performance. Improvement in peak capacity was proposed using a
bilinear EFGF device. Protein concentration exceeding 10,000-fold was demonstrated
using such devices.
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INTRODUCTION

1.1

Micro-Total-Analysis Systems

1.1.1 Introduction
Although the first analytical miniaturized device, a gas chromatographic
analyzer fabricated on a silicon wafer, was reported almost 30 years ago,1 the concept
of micro-total-analysis systems (µTAS) was first proposed by Manz et al. in 1990.2
µTAS, also called “lab on a chip” devices, are miniaturized analysis systems, which
integrate many components together, including sample preparation, injection,
separation, and detection. Recently, the development of µTAS has become one of the
hottest research fields in analytical chemistry.3-7
Both inorganic materials and organic polymers are used for microfabrication
of µTAS. Various components of microfluidic devices, such as micropumps,
micromixers, microvalves, microreactors, microcolumns, and micro-detectors have
been explored. µTAS have many advantages, such as fast and high throughput
analysis, comparable performance to conventional methods, small sample and reagent
consumption, and easy integration of components in a single device.8,9 Currently,
µTAS are widely used in applications covering chemistry, biochemistry,
environmental science, forensics, medicine, and clinical diagnostics.10 For example,
µTAS are employed for cell culture and cell handling,11 proteins and DNA separation
and analysis, particle synthesis and separation, and polymerase chain reaction.12
1.1.2

Fabrication of Microdevices Using Inorganic Materials
Inorganic materials used for microfabrication. In the early years of µTAS,
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the dominant materials applicable for microfluidic device fabrication were inorganic
materials, such as silicon,1,13,14 glass,15-19 and quartz.20-22 All of these materials are
widely used in the microelectronics industry and standard microfabrication techniques
have already been well developed. Among these materials, silicon is seldom used for
microfluidic devices because it is not transparent to visible and UV light for optical
detection. Moreover, its breakdown voltage is relatively low (~500 V).23 In
comparison, glass has been the major inorganic material used in microfluidic device
fabrication because it has good optical, mechanical, electrically insulating and thermal
properties. In addition, glass surfaces are easy to modify because surface chemistries
have been well established. Even though quartz, a pure form of silicon dioxide, has
superior physical properties over other inorganic materials for microfabrication, it is
not widely used in microfluidic device fabrication due to its high cost and difficult
fabrication requirements. Recently, Pan et al.24 fabricated microfluidic capillary
electrophoresis devices using calcium fluoride (CaF2), which has good optical
properties and is suitable for various optical detection methods, such as UV, IR,
Raman, and fluorescence. However, difficult fabrication and bonding procedures limit
its general use.
Fabrication of inorganic microfluidic devices. One of the conventional
fabrication techniques for inorganic materials is photolithography. In photolithography,
the desired microstructures are fabricated onto inorganic substrates with the help of a
photoresist, which is a light-sensitive polymer material. The fabrication procedure
usually consists of substrate pretreatment, photolithography, etching and bonding.
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Figure 1.1 outlines a typical photolithographic process.
First, a substrate is cleaned using boiling Piranha (H2SO4/H2O2) or NH4F/HF
solution (step 1, Figure 1.1). Then, an etch mask or sacrificial material (such as
Cr/Au,17,20 amorphous Si,25 or SiO226-29) is attached to the substrate surface to protect
some areas of the substrate during etching (step 2, Figure 1.1). Following, a layer of
photoresist is spin-coated on the top of the etch mask (step 3, Figure 1.1). After soft
baking, a photomask, which is a glass plate or transparent polymer sheet containing a
high-resolution pattern, is placed on top of the photoresist-coated substrate. UV
radiation is employed to transfer the pattern from the photomask to the photoresist
layer (step 4, Figure 1.1). To allow the pattern to appear on the surface, a developing
solution is used to remove some areas of the photoresist. The final feature on the
substrate depends on the photoresist that is used.
There are two types of photoresist: positive and negative.30 For a positive
photoresist, the UV-exposed portion is dissolved during the development process (step
5A, Figure 1.1). The unexposed portion, which is identical to the photomask remains
on the surface. In comparison, the UV-exposed portion remains on the substrate when
a negative photoresist is used (step 5B, Figure 1.1) and a reversed pattern is obtained
on the substrate. After photoresist development, the unprotected etch mask is removed
using an etchant (step 6, Figure 1.1), and the bare substrate is further etched (step 7,
Figure 1.1). Finally, all of the remnant photoresist and etch mask is removed to
complete the desired microstructure on the substrate. When a positive photoresist is
used, the final structure is recessed (step 8A, Figure 1.1), however, a negative
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Figure 1.1. Typical photolithographic procedures for microfabrication.
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photoresist gives a protruding structure (step 8B, Figure 1.1).
Currently, there are two approaches used to etch inorganic materials: wet
etching and dry etching.30 Wet etching employs liquid chemicals to dissolve the
inorganic material. For example, concentrated potassium hydroxide (KOH) solution is
a typical anisotropic etchant for silicon,26-29 which preferentially attacks the <1 0 0>
plane of silicon and results in the sidewalls forming an angle of 54.74o with the top
surface.30 HNA solution, a mixture of HF, HNO3 and CH3COOH, is an isotropic
etchant which generates rounded sidewalls and corners on a silicon surface.
HF-containing solutions, such as HF/HNO3,17 HF/NH4F,18,20 HF/HCl,31 and
concentrated HF,25 can be used to isotropically etch glass and quartz. The wet etching
approach only produces low-aspect-ratio microstructures. Dry etching, such as deep
reactive ion etching (DRIE), can create microstructures with high aspect ratios and
complex patterns on the surfaces of inorganic substrates.32,33
In typical microfluidic device fabrication, a bonding process is needed to
enclose the microchannels. Thermal bonding is the most popular technique to bond
inorganic substrates. Typically, glass substrates are pretreated in hot Piranha solution
to produce silanol groups on the surfaces. Then the substrates are clamped together
and heated at an elevated temperature for a period of time to form siloxane bonds
between silanol groups on the contacted surfaces.30 Most glass bonding is carried out
in a temperature range from 500 to 700 oC.17,18,25 Sometimes, a temperature program
is necessary for optimal bonding. The bonding of quartz substrates is usually
performed at very high temperature (~ 1100 oC).20,22 To bond silicon to silicon or glass,
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electric-field-assisted thermal bonding or anodic bonding is used, which is performed
at temperatures of 180 – 500 oC with assistance of an applied voltage from 200 to
1000 V.13,33-35 Adhesive bonding is an alternative method to bond inorganic
microfluidic devices.24,36,37 This method is usually performed at relatively low
temperature. However, the adhesives will impact the microchannel surface properties
and, thus, affect the performance of the microfluidic device.
Thin-film fabrication. Recently, a new technique, called thin-film fabrication,
was developed to fabricate inorganic microfluidic devices.38 The procedure is briefly
illustrated in Figure 1.2. First, a clean substrate, such as quartz, is coated with a
composite sacrificial layer, which contains an aluminum layer and a photoresist layer
(Figure 1.2 A). Then standard photolithography using a photomask is employed to
pattern the sacrificial layer (Figure 1.2 B). Then, a silicon dioxide (SiO2) layer is
deposited on the patterned surface to enclose the features using plasma-enhanced
chemical vapor deposition (PECVD) (Figure 1.2 C). Finally, the enclosed sacrificial
layer is removed using etchants to form hollow tubular microfluidic channels.
Compared with conventional microfabrication approaches, thin-film fabrication has
many advantages. The most attractive advantage is elimination of the bonding
procedure. Moreover, it is convenient to produce complex structures, such as
multi-layer crossover microfluidic channels. This approach is also applicable to a
wide range of inorganic materials for microfabrication. However, the time-consuming
etching process is a major disadvantage of this approach.
Although microfabrication using inorganic materials has played an important
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Figure 1.2. Thin-film technique for microfabrication.
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role in the origin and development of TAS, some disadvantages limit its widespread
use. The fabrication process must be performed in a clean room with expensive
equipment. In addition, hazardous chemicals are involved in the wet etching process.
1.1.3

Fabrication of Microdevices Using Polymeric Materials
Polymer materials used for microfabrication. The disadvantages of

inorganic microfluidic devices have driven researchers and producers to seek
alternative materials. Recent efforts have led to increasing use of polymeric materials
in microfabrication.39,40 Polymeric materials offer attractive mechanical and chemical
properties, low cost, ease of fabrication, biocompatibility, and higher flexibility.41 To
date, many polymers have been explored for fabrication of microfluidic devices,
including polydimethylsiloxane (PDMS),42-45 poly(methyl methacrylate)
(PMMA),26-28,46,47 polystyrene (PS),48,49 polycarbonate (PC),50,51 polyethylene
terephthalate (PET/PETG),52,53 polyimide (PI),54,55 cycloolefin copolymer (COC),56-58
and polyester.59-61 Such polymers differ in their properties; therefore, various
techniques have been developed for the fabrication of microfluidic devices. Currently,
two types of methods are used for microfabrication: replication technologies (such as
hot embossing, injection molding and casting) and direct techniques (such as laser
ablation).62
Template fabrication. In replication technologies, the patterns on the
templates or molds are transferred to polymer substrates. First-generation microfluidic
devices were fabricated using simple metal wires as templates to directly create
straight channels.46 Second-generation microfluidic devices were fabricated using
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planar templates with three-dimensional features on the surfaces, which were
produced using various techniques and rigid materials, including silicon,26-28,46
metals32,47 and polymers.47,63-65 For silicon templates, the fabrication methods are the
same as for fabrication of inorganic microfluidic devices demonstrated in Figure 1.1.
Micromachining technologies (e.g., sawing, cutting, milling, and turning) are capable
of producing metal templates.47 However, these micromachining methods cannot
produce complex and high aspect ratio structures. The most commonly used methods
for metal template fabrication are electroplating techniques, by which a thick metal
layer (nickel or nickel alloy) is grown on a silicon substrate which is patterned using
standard photolithographic methods. The substrates are removed to obtain the final
metal templates.32 The LIGA technique, which is a German acronym for lithographie
(lithography), galvanoformung (electroplating), and abformung (molding), is a
complicated method to produce high-quality templates.30
Some polymers with high mechanical strength, such as polyetheretherketone
(PEEK), SU-8, and polyetherimide (PEI), can also be used to produce templates. For
example, SU-8 templates were fabricated on silicon or glass substrates using
photolithography.63 PEI templates were produced using a hot embossing method.47
PMMA templates were created from an original negative glass master using a thermal
imprinting technique.64 Recently, a rapid and non-photolithographic approach was
presented to generate microfluidic patterns with deep and rounded channels, which
leverages the inherent shrinkage properties of polystyrene thermoplastic sheets
(Shrinky Dinks).65

9

Hot embossing. Currently the most widely used replication method to
fabricate polymeric microfluidic devices is hot embossing.26-28,46 This method is
suitable for thermoplastic polymers, such as PMMA, PC, PET, PS and COC.
Generally, a template and a planar polymer substrate are mounted together (Figure 1.3
A). Then the temperature is elevated above the polymer glass transition temperature
(Tg) to soften it, and the pattern on the template is embossed into the polymer
substrate with assistance of high pressure (Figure 1.3 B). Finally, the assembly is
cooled to release the patterned substrate from the template (Figure 1.3 C). During hot
embossing, vacuum conditions are usually necessary to prevent the generation of air
bubbles between the template and substrate. Also, thermally induced stresses should
be minimized to eliminate replication defects.
Injection molding. Injection molding is another commonly used method for
fabrication of thermoplastic polymer microdevices.66 This process starts with raw
polymer resins. The resins are melted in a chamber at an elevated temperature and
injected into a mold cavity under a high pressure. The cavity is then cooled to allow
ejection of the replica. Compared with hot embossing, injection embossing is easier
for mass production. Moreover, the cycle time for injection molding is shorter, and it
is convenient to integrate other components, such as optical fibers, into the
microdevices. One challenge of this method is that the process temperature and
pressure should be well controlled to prevent deviations in the replica structure.
Casting. Casting or soft lithography is a simple and flexible replication
method for microfabrication.67 This method does not need special facilities, but can
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Figure 1.3. Fabrication of polymeric microfluidic devices using hot embossing.
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fabricate complex three-dimensional microstructures.68-70
The earliest miniaturized PDMS separation device was fabricated using a
casting method.43 PDMS is the most commonly used elastomer for microfabrication.
In the casting process, the PDMS monomer is thoroughly mixed with a curing agent
and the generated bubbles are removed with vacuum. Then the viscous liquid is
poured into a cartridge containing a template. After it is cured, the PDMS slab with
desired pattern is peeled off the template. Usually, casting is done under mild
conditions, therefore, various materials such as metal, silicon and polymer can serve
as templates.
Besides PDMS, many other polymers can also be used in casting, such as
solvent-resistant photocurable perfluoropolyether (PFPE),71 thermoset polyester
(TPE)59 and poly(ethylene glycol) functionalized acrylic copolymers.72,73
Solvent imprinting. Recently, a new approach called solvent imprinting was
developed to rapidly fabricate microstructures on hard polymer substrates.74 First, a
good solvent for the polyme is spread on the planar polymeric substrate surface
(Figure 1.4 A). After a while, a template is pressed into the solvent-coated surface
(Figure 1.4 B). When the pattern is transferred to the polymer surface, the substrate is
detached from the template (Figure 1.4 C). This procedure is similar to hot embossing,
however, solvent imprinting is performed at room temperature and its cycle time is
shorter. Furthermore, this method is easily combined with solvent bonding to enclose
the microchannels.
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Figure 1.4. Fabrication of microfluidic devices using solvent imprinting.
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Laser ablation. In contrast to replication technologies, direct techniques do
not depend on templates, which fabricate microdevices individually. Laser ablation or
laser micromachining is such a method.75-78 In this process, the energy of a laser, such
as a UV excimer laser or CO2 infrared laser, is used to break the polymeric bonds and
remove the decomposed polymer fragments from the ablation region to form channels.
Complex patterns can be fabricated by moving a computer-controlled stage on which
the polymer substrate is positioned.
With this technique, a wide range of polymer materials, including PC,75 PS,75
PET,76 PMMA,77,78 and PETG,52,75 have been structured. During laser ablation,
channel surfaces are simultaneously modified due to photochemical reactions.79
However, the channel surfaces are rougher than those fabricated using replication
methods. Another consideration is that generated polymer fragments may deposit onto
the surface to change the local surface properties.
Microfluidic tectonics. Microfluidic tectonics (FT) is the fabrication and
assembly of microfluidic components into a universal platform, in which the
microchannels and other components are formed using liquid-phase
photopolymerization or laminar flow.80-83 Typically, a monomer solution containing
photoinitiator is filled into a cartridge assembled with microfluidic connections and
posts (Figure 1.5 A). Then the cartridge is exposed to UV light with a photomask
placed on the top (Figure 1.5 B). The unblocked areas are polymerized (Figure 1.5 C),
and the solution under the masked area is finally flushed out to form the channels
(Figure 1.5 D).
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Figure 1.5. Diagram of microfluidic tectonics process.
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In this procedure, templates and bonding are not required, and the fabrication
consumes only a short period of time. Moreover, some complicated structures, such as
valves, pumps and sensors, can be integrated easily by using different photomasks,
UV exposure steps and monomers. Membranes or metal wire can be directly
fabricated in the microchannels using laminar flow. However, the FT technique
cannot be used to fabricate features smaller than 100 m due to the lower resolution
in fabrication than traditional techniques. During photopolymerization, diffraction of
UV light at the edge of the photomask may initiate partial polymerization in regions
close to the pattern edge. In addition, free radicals may diffuse to regions under the
photomask to cause undesired polymerization. Therefore, monomers that are used
should induce polymerization with low shrinkage and fast reaction rate.
SU-8 photolithography. SU-8 is successfully used to fabricate microchannels
by applying UV-patterning of SU-8 and adhesive bonding.84 First, a layer of SU-8 is
spin-coated on a wafer and reservoirs are exposed on this layer. Then a second SU-8
layer is coated on top of the first SU-8 layer, followed by patterning using a standard
photolithographic approach. The thickness of the second layer defines the depth of the
microchannels. Post-exposure bake and development are performed for both SU-8
layers. Finally, a layer of SU-8 spin-coated on a bottom plate wafer is used as an
adhesive layer to enclose the microchannels. SU-8 has high thermal stability and
optical transparency, good mechanical strength and chemical resistance. However, the
electroosmotic flow (EOF) of SU-8 microchannels is large and pH-dependent.
Thermal bonding. Thermal bonding is a broadly used approach to enclose
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microfluidic channels.26,27,46,48-51 Typically, a patterned plate and a cover plate are
clamped together. Appropriate pressure is applied to the assembly at elevated
temperature around the Tg of the polymer. After a while, the temperature is lowered
and the bonded microfluidic device is released from the clamp.
Although thermal bonding is simple and easy to perform, the bonding is often
not strong enough, and delamination occurs. Moreover, since the bonding is
performed around the Tg of the polymer, channel deformation usually happens, which
limits the application of this method to fabrication of high aspect ratio or large
dimension structures.
Solvent bonding. Solvent bonding is an alternative bonding method for
polymer microfluidic devices.28,32,47,85 In this method, good solvents for the polymer
are employed to dissolve a thin layer of one polymer substrate, which can adhere to
the other substrate strongly because the flexible polymer chains at the interface
infiltrate into each other and entangle together. Currently, three solvent bonding
approaches as shown in Figure 1.6 have been developed. In approach A,85 a thin layer
of solvent is spin-coated on the cover plate (Figure 1.6 A1). Then the patterned
substrate is brought into contact with the cover plate (Figure 1.6 A2). After a while,
the two substrates are bonded together and enclosed microchannels are formed
(Figure 1.6 A3). In approach B,32 a thin layer of solvent is spin-coated on a glass or
silicon wafer, and a patterned substrate stamp is placed on the coated surface (Figure
1.6 B1) to wet all except the recessed areas (Figure 1.6 B2). Then, the solvent-coated
substrate and a blank substrate are placed together (Figure 1.6 B3) for a while to bond
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Figure 1.6. Solvent bonding of polymeric microdevices.
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them to each other (Figure 1.6 B4).
Solvent bonding is performed at room temperature and can give high bonding
strength. However, sometimes the solvent flows into the channels to deform and even
block the channels. To avoid these problems, a phase-changing sacrificial layer was
reported to protect the channels (Figure 1.6 C).28 After the channels are temporarily
enclosed using a PDMS slab (Figure 1.6 C1), a sacrificial material is introduced into
the channels in a fluidic state, and then changed to the solid phase by decreasing the
temperature (Figure 1.6 C2). Similar to approach A, a cover plate spin-coated with a
thin layer of solvent is pressed onto the patterned substrate after detaching the PDMS
slab (Figure 1.6 C3). When the two substrates are bonded together tightly, the
sacrificial material is removed by changing it back to the fluidic state from the
microchannels. Wax28 and water47 have been used as sacrificial materials to fabricate
PMMA microfluidic devices.
Adhesive bonding. Adhesive bonding is an approach similar to solvent
bonding, however, the adhesive works as a glue and does not dissolve the polymer
substrate.86-88 One consideration is that the residual adhesive on the channel surface
may alter the surface properties, leading to sample adsorption and electroosmotic flow
(EOF).
Resin-gas injection bonding. Recently, a new technique, resin-gas injection,
has been explored for bonding of polymer microfluidic devices (Figure 1.7).89 Initially,
a patterned substrate and a cover plate are assembled together (Figure 1.7 A). A
monomer solution containing photoinitiator is introduced into the microchannels
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Figure 1.7. Resin-gas injection bonding.
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through a reservoir. The solution fills all of the channels, reservoirs and gaps between
the patterned substrate and cover plate (Figure 1.7 B). Then nitrogen gas or vacuum is
employed to remove the solution in the channels (Figure 1.7 C), and the residual
monomer solution in the gaps and on the surfaces is cured using UV radiation (Figure
1.7 D). In this way, the microfluidic devices are bonded together and the channel
surfaces are modified simultaneously.
Lamination. Lamination is a simple and rapid method to seal microchannels
using thin polymer films. For example, photoablated polymer devices were sealed by
thermal lamination with a PET/PE film at 125 oC using a standard industrial
lamination instrument.75
Chemical bonding. Chemical bonding depends on a suitable reaction to form
chemical bonds between two contact surfaces. This approach provides strong and
permanent bonding, however, specific methods must be developed for specific
polymers.
To ensure that PDMS is covalently bonded with substrates, such as glass,
silicon or PDMS itself, a low power O2 plasma has been used to treat their surfaces.
During O2 plasma treatment, the surfaces are activated by cleaving siloxane bonds on
the surfaces into silanol groups. After plasma treatment, the PDMS substrate is
quickly brought into contact with the other complementary substrate to form covalent
bonds at the interface.43,45 Commercial PDMS kits employ a different chemical
bonding mechanism. One part of the kit contains a PDMS polymer with vinyl groups
and a platinum catalyst, while the other part contains a cross-linker with silicon
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hydride groups. When these two PDMS polymers contact, the vinyl groups react with
the silicon hydride groups in the presence of the catalyst at an elevated temperature to
form covalent bonds.90,91
Thermoset polyester (TPE) microchannels are also enclosed using chemical
bonding.59 TPE substrates are fabricated using a casting approach by UV exposure of
TPE resin solution containing both photoinitiator and thermal initiator. Then the
patterned substrate and cover plate are assembled, exposed to UV radiation, and
heated to initiate polymerization between the unsaturated polyester backbones.
Recently, a poly(ethylene glycol)-functionalized acrylic copolymer was used
to fabricate microfluidic devices with UV-assisted chemical bonding.72,73 Partially
polymerized planar substrates of this material were given various features after UV
exposure of the cast monomer solution. Since polymerization was not taken to
completion, active species or groups were left on the prepolymer surfaces. When the
two substrates were assembled together and further exposed to UV light, reactions at
the interface ensued for bonding. The obtained devices were applied for bioanalysis
without further surface modification.

1.2

Microchip Electrophoresis Separation

1.2.1 Introduction
The electrophoretic separation technique is based on the principle that, under
an applied potential field, analytes migrate at different velocities due to their net
charges and sizes.92 Historically, electrophoresis has been performed in various
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support media, such as paper, cellulose acetate and slab gels. In the early 1980s,
capillary electrophoresis (CE) emerged as a high resolution form of
electrophoresis.93,94 Since then, CE has experienced rapid development to become a
popular separation method. Several operation modes of CE have been developed,
including capillary zone electrophoresis (CZE), capillary gel electrophoresis (CGE),
capillary isoelectric focusing (CIEF), capillary isotachophoresis (CITP), and micellar
electrokinetic capillary chromatography (MEKC). CE has been successfully used for
separation of nucleic acids, proteins, peptides, saccharides, inorganic ions, and small
organic molecules.
After the introduction of TAS, CE separation was successfully combined
with TAS. To date, although microchip liquid chromatography (LC) has also shown
excellent performance,55 microchip CE has been the dominant separation technique in
TAS,95 including CZE,96,97 CGE,98,99 CITP,100 CIEF,101,102 MEKC,103 and 2-D
microchip CE.32,104-106 The most mature application of microchip CE is DNA
analysis.19,107 Recently, protein separation using microchips has received increasing
attention.27,101,108-111
1.2.2

Fundamental Theory of Capillary Electrophoresis
Electrophoretic mobility. The fundamental theory of modern CE was first

described by Jorgenson and Lukacs.93,94 When a voltage ( V ) is applied over a
capillary with length L , an electric field ( E ) is established, which drives an analyte
to the electrode of opposite charge. The analyte migration velocity ( uep ) is expressed
as
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uep  ep E  ep

V
L

(1.1)

where ep is the electrophoretic mobility of the analyte. Therefore, analytes are
separated in CE according to their different electrophoretic mobilities. Generally,
electrophoretic mobility depends on the analyte and on the local environment, as
expressed in equation 1.2.

ep 

q
6 r

(1.2)

where q is the charge of the analyte,  is the buffer viscosity, and r is the
hydrodynamic radius of the analyte. Because different analytes have distinct q and
r , their electrophoretic mobilities are also different. It should be mentioned that

electrophoretic mobility also relies on the buffer conditions, such as pH value and
temperature.
Practically, electrophoretic mobility of an analyte is determined in experiment
by measuring the migration time ( t m ) through a distance ( Lm ) when a voltage ( V ) is
applied over a capillary with total length L

 Lm   L 
 
 tm   V 

ep  

(1.3)

Electroosmotic flow. Electroosmotic flow (EOF) is used to describe the
movement of a liquid in contact with a solid surface when an electric field is
applied.92 EOF occurs in fused silica capillaries where acidic silanol groups on the
surface dissociate to form a negatively charged layer when in contact with an
electrolyte solution (Figure 1.8). Hydrated cations in the solution are attracted to this
layer and arranged into two layers. As illustrated in Figure 1.8, one layer is tightly
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Figure 1.8. Electric double layer on a silica capillary surface and creation of EOF.

25

attracted (compact layer), the other is more loosely attracted (diffuse layer). The
boundary between these two electrical layers is the shear plane. When an electric field
is applied, the diffuse layer breaks away at the shear plane and moves toward the
cathode, dragging with it the bulk buffer solution, thereby resulting in EOF.
The EOF velocity ( u EOF ) is given by
uEOF   EOF E

(1.4)

where E is the electric field intensity, and  EOF is the EOF mobility, which is
defined by

 EOF 




(1.5)

where  is the permittivity of the buffer solution and  (zeta potential) is the
electrical potential at the shear plane. The zeta potential depends upon the surface
properties and the pH value of the buffer solution. In addition to fused silica,
polymeric channel surfaces also generate EOF due to the presence of charged
functional groups.112
If EOF is considered in CE, the total or effective migration velocity of an
analyte ( uTotal ) is the vector sum of both the electrophoretic and EOF velocities, as
expressed in equation 1.6,
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where Total is the effective mobility of the analyte.
Separation efficiency and resolution. When an analyte migrates from the
injection point to the detection point, its migration time is given by
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During this time, diffusion occurs. According to Einstein’s equation, the spatial
variance of the analyte band (  2 ) is defined by

 2  2Dtm

(1.8)

where D is the effective diffusivity of the analyte. The separation efficiency of CE
may be expressed in terms of the number of theoretical plates ( N ) as given in
equation 1.9.92
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where the migration distance, Lm , equals the total length of the column, L .
Experimentally, the efficiency may be determined using92
 t 
N  5.54  m 
 w1/ 2 

2

(1.10)

where w1/ 2 is the width of the peak at half height.
The resolution ( Rs ) of two analytes in CE is defined as92

Rs 

2  t2  t1  t2  t1

w1  w2
4

(1.11)

where t is the migration time, w is the baseline width in time, and  is the
standard deviation. A better description of resolution was derived by Jorgenson and
Lukacs as follows: 92
1/ 2
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(1.12)

where ep is the average mobility of the two analytes for which the resolution is
being calculated.
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From equations 1.7, 1.9 and 1.12, a high applied voltage results in fast
separation, high efficiency and high resolution. But too high voltage will generate
Joule heating and compromise the separation performance. High effective mobility
can contribute to high efficiency. Usually, efficiency is also affected by injection
length, diffusion and dispersion. When the EOF velocity decreases or moves in the
opposite direction from the electrophoretic velocity, the resolution increases.
1.2.3 Sample Injection and Separation in Microchip Electrophoresis
Figure 1.9 shows a typical design of a microchip CE system, where a sample
plug formed at the intersection of the channel cross is injected into the long channel
for separation. Due to the scale of the channel dimensions, a very small amount of
sample can be injected in order to obtain efficient separation. Currently,
electrokinectic injection is broadly used in microchip CE and various operation modes
have been demonstrated.
Cross injection. The first method introduced in microchip CE is cross
injection.15 A voltage is applied across reservoirs 1 and 2 to form a sample stream as
illustrated in Figure 1.10 A. After sample fills the intersection volume, the injection
voltage is turned off and a separation voltage is applied across reservoirs 3 and 4 to
direct the plug at the intersection region into the downstream channel for separation. It
is somewhat difficult to control the injected sample size reproducibly using this
technique.
Single T injection. The simplest injection mode is single T injection.113 As
shown in Figure 1.11, a voltage is applied over reservoirs 1 and 3 to drive the sample
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Figure 1.9. Schematic of a typical microchip design.
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Figure 1.10. Cross injection. (A) Loading and (B) injection and separation.
30

Figure 1.11. Single T injection. (A) Loading and (B) injection and separation.
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flow into the separation channel. After a short period, the voltage is switched across
reservoirs 2 and 3, and the voltage on reservoir 1 is left floating. In this way, a sample
plug is injected and then separated. This technique leads to “injection bias”, in which
analytes with high mobilities are injected in higher relative concentration than in the
original sample.
Double T injection. To avoid injection bias and obtain reproducible sample
size, double T injection was introduced (Figure 1.12).16,114 During sample loading, a
voltage is applied across reservoirs 1 and 2 to produce a sample stream through the
intersection volume while reservoirs 3 and 4 are allowed to float. After a short period
of time, voltage across reservoirs 3 and 4 is applied. At the same time, reservoirs 1
and 2 are allowed to float. By this procedure, a sample plug is injected into the
separation channel for analysis. A serious problem with this technique is leaking of
the sample from the injection channel to the separation channel during operation
because of convection and diffusion.
Pinched injection. To minimize sample leakage, an approach called pinched
injection was developed (Figure 1.13).18,115 In typical operation, a potential is applied
from reservoirs 1, 3 and 4 to reservoir 2 to create a stream of sample ions migrating
from reservoir 1 to reservoir 2 (Figure 1.13 A). After a well-defined sample stream is
formed, an identical and relatively low potential is applied on reservoirs 1 and 2 to
drive sample back toward the reservoirs. Simultaneously, a high voltage is applied
across reservoirs 3 and 4 to inject a sample plug into the separation channel (Figure
1.13 B). This technique not only avoids sample leakage, but also gives good
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Figure 1.12. Double T injection. (A) Loading and (B) injection and separation.
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Figure 1.13. Pinched injection. (A) Loading and (B) injection and separation.
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reproducibility.
Double L injection. Double L injection is another low leakage injection
technique.116 This method uses “L” shape voltage application twice to control the
sample movement as shown in Figure 1.14. The first “L” shape voltage is applied
across reservoirs 1 and 3 to form an ion stream (Figure 1.14 A). Then the first voltage
is turned off and the second “L” shape voltage is applied across reservoirs 2 and 4 to
drive the sample plug formed at the intersection into the separation channel (Figure
1.14 B).
Gated injection. Gated injection is a repetitive injection technique.117 As
illustrated in Figure 1.15, there are three steps involved. First, two “L” shape voltages
are applied. One is across reservoirs 2 and 3 to form a sample ion stream while the
other is across reservoirs 1 and 4 to form a buffer stream to prevent leakage (Figure
1.15 A). Next, the voltage across 1 and 4 is turned off for a short time to allow a small
amount of the sample to enter the separation channel (Figure 1.15 B). Then, the
voltage across 1 and 4 is applied again and a sample plug is injected into the
separation channel (Figure 1.15 C). Using this method, various sample amounts can
be injected by controlling the injection time.
1.2.4 Detection Approaches in Microchip Electrophoresis
Optical detection. UV-absorbance detection is the most commonly used
optical detection method for conventional CE and HPLC. Even though this detection
method has been used in inorganic microchip CE, it has not been successfully applied
to polymeric microchips because of strong UV adsorption by commodity polymeric
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Figure 1.14. Double L injection. (A) Loading and (B) injection and separation.
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Figure 1.15. Gated injection. (A) Loading, (B) injection, and (C) separation.
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substrates.
So far, laser induced fluorescence (LIF) detection is the most popular method
for polymeric microchip CE.26-28,74,113,118 Typically, this method uses a laser with
visible wavelength, such as 488 nm, to excite and then emit another visible
wavelength. Common polymer substrates are transparent to these wavelengths, which
provides high sensitivity and low detection limits. Unfortunately, most analytes
including proteins and peptides do not exhibit native fluorescence when excited using
a visible laser. Analytes should be tagged with fluorescent dyes for microchip CE
detection. Several fluorescent dyes have been used for labeling, such as fluorescein
isothiocyanate (FITC).
In addition to UV and LIF, two-photon excited fluorescence (TPEF) detection
has been used for quartz microchip CE to detect native fluorescence of analytes.119 In
a typical TPEF process, a fluorophore absorbs two photons sequentially within an
extremely short period (~ 1 fs), which are produced by a tightly focused laser beam.
After excited to a high energy state, the fluorophore emits fluorescence with a shorter
wavelength than the excitation light, which makes it easy to discriminate between the
excitation light (visible) and the fluorescence signal. TPEF has potential application in
polymer microchip CE detection.
Electrochemical detection. Electrochemical detection is another widely used
detection method for microchip CE.120 Compared with optical methods,
electrochemical detection is simple and less expensive. Most importantly, electrodes
can be integrated in the microchips using standard photolithography to obtain high
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sensitivity and fast response time (~300 ms). Presently, electrochemical detection has
been used in both inorganic and polymeric microchips for detection of DNA, proteins,
peptides, amino acids, and other samples. There are several operation modes for
electrochemical detection, including conductometry, amperometry, and voltammetry.
Mass spectrometry. Mass spectrometry (MS) is a very powerful technique in
analytical chemistry. It provides high sensitivity, fast analysis, and small sample
consumption. Another advantage of MS is the capability to identity analytes, which is
very useful for bioanalysis. A major challenge is the interface for coupling the
microchip with MS.121,122 To date, the most commonly used interface is electrospray
ionization (ESI).102

1.3

Surface Modification of Polymeric Microfluidic Devices

1.3.1 Introduction
In microfluidic devices, the surface characteristics are important to consider
due to the high surface-to-volume ratio. Especially in microchip CE, the channel
surface has a significant impact on separation performance. Normally, the polymer
surface is charged when in contact with buffer solutions, resulting in EOF in the
presence of an electric field. Furthermore, most polymeric surfaces tend to adsorb
biomolecules through hydrophobic, electrostatic or other interactions, which
compromises separation power and reproducibility. Therefore, it is necessary to
modify the microdevice surface as part of the fabrication protocol.123 Two methods
have been commonly used for modification: dynamic adsorption and permanent
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surface modification.124-127
1.3.2 Dynamic Adsorption Methods
Dynamic adsorption is a simple and rapid surface modification technique that
has been used widely to control analyte adsorption and to manipulate EOF for
separation of proteins, DNA, or oligosaccharides with polymeric microdevices. Using
this approach, surface modifiers are introduced into the separation buffer, which are
then physically adsorbed to the channel surface. Many species can serve as surface
modifiers, including neutral polymers, charged compounds, surfactants, and
nanoparticles.
Among the candidate additives, neutral hydrophilic polymers are the most
effective surface modifiers. It was reported that certain neutral polymers with
hydroxyl groups, such as poly(ethylene glycol) (PEG), hydroxyethylcellulose (HEC),
hydroxypropyl methylcellulose (HPMC), and methylcellulose (MC), could be used to
suppress adsorption and improve separation of oligosaccharides in PMMA
microchips.128 Hybrid dynamic adsorption using n-dodecyl -D-maltoside (DDM)
and MC in PMMA microchannels was developed for analysis of carbohydrates.129
Fast protein separation was performed in PMMA microchips dynamically coated with
polydimethylacrylamide.130 Some native fluorescent proteins were isolated in an MC
coated PDMS microchip using isoelectric focusing.131 Hydroxypropyl cellulose (HPC)
was employed to dynamically coat PMMA microchannels for separation of amino
acids and peptides.28 To reduce DNA adsorption, poly(ethylene
glycol)-poly(propylene glycol)-poly(ethylene glycol) (PEG-PPG-PEG) triblock
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copolymer and a mixture containing HPMC, mannitol, glucose and glycerol were
used to dynamically coat PMMA microchip surfaces.132,133
Charged compounds used for dynamic coating include polymers, such as
polybrene (PB), dextran sulfate (DS),134 poly(styrene sulfonate) (PSS) and
poly(allylamine hydrochloride) (PAH),49 quaternary ammonium derivatized starch,135
proteins136 and low-molecular weight species, such as various amines.128 These have
been adsorbed on the channel surface to manipulate the EOF. Polyelectrolyte
multilayers (PEMs) have been reported for microchip surface modification. For
example, negatively charged PSS and positively charged PAH can be alternately
coated on PMMA, PS and PETG surfaces to form PEMs.48,49 Makamba et al.137
exposed hydrophobic PDMS to hydrolyze poly(styrene-alt-maleic anhydride)
(h-PSMA). The h-PSMA strongly interacted with the hydrophobic PDMS surface
through the benzene rings while the carboxylic groups extended away from the
surface. Subsequently, polyethyleneimine (PEI) and poly(acrylic acid) (PAA) were
alternately adsorbed on the surface to form PEMs. The PEMs were then cross-linked
by carbodiimide coupling to form amide bonds between the PEI and PAA layers.
Finally, a PEG layer was immobilized on the PEMs surface to form a stable
permanently hydrophilic, protein-resistant, thin-film coating on the PDMS surface.
Proteins, such as albumin and lysozyme, were used for modification of PDMS
microchips to enhance separation of neurotransmitters and environmental
pollutants.136
Other commonly used species for dynamic coating are various surfactants, in

41

which the hydrophobic segments attach to the polymer surface and the hydrophilic
segments extend outward to alter the surface properties. Reported surfactants used for
dynamic coating include sodium dodecyl sulfate (SDS), dodecyltrimethylammonium
chloride, tetrabutylammonium chloride, cetyltrimethylammonium bromide, Brij 35,
Brij 76, and Brij 78.128,132,138-140
Recently, nanoparticles have also been used for dynamic adsorption on
polymer microchip surfaces. Usually, nanoparticles are employed together with
neutral polymers or charged polymers. For example, a coating containing gold
nanoparticles (GNPs), poly(ethylene oxide) (PEO), and poly(vinyl pyrrolidone) (PVP)
was applied to PMMA microchip for analysis of DNA.141 PDMS microchannel
surfaces have been modified by successive coating with chitosan, GNPs, and
albumin.136
Although dynamic adsorption is convenient, surface modifiers can influence
separation and detection. Sometimes they are detrimental in applications that require
coupling to mass spectrometry or to miniaturized chemical reactors. Therefore,
permanent surface modification is preferred.
1.3.3

Permanent Surface Modification Methods
Permanent surface modification involves specific chemical reactions to change

the surface composition, for instance, attaching protein resistant polymer layers on the
surface. Many efforts have been devoted to permanent surface modification of
polymeric materials to improve the performance of microdevices.127
Plasma-assisted modification. An oxygen plasma is a simple and fast tool to
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modify polymeric surfaces. Plasma treatment renders the PDMS surfaces hydrophilic
through surface oxidation reactions to form a layer of silanol groups.67 However, the
hydrophilicity disappears after a short time (~3 h) due to hydrophobic recovery.43
Recently, a new method called two-step extraction/oxidation was developed to
generate relatively stable hydrophilicity.142 First, PDMS was extracted using a series
of solvents to remove unreacted oligomers in the bulk. Then, the oligomer-free PDMS
was oxidized in an air plasma to generate a layer of hydrophilic SiO2 on the surface,
which was stable for at least 7 days. This method improved the performance of PDMS
microchip electrophoresis and also increased the EOF.
The silanols produced by oxygen plasma treatment can be employed for
further modification to generate stable hydrophilic layers. Papra et al.143 grafted
PEG-functionalized silanes on an oxygen plasma-treated PDMS microchip surface to
resist TRITC-labeled IgG adsorption. Wang et al.108 treated an oxygen plasma
activated PDMS microchip surface with (3-methacryloxypropyl)trimethoxysilane to
introduce methacrylic groups, and then polyacrylamide was attached on the surface
through reaction with the immobilized methacrylic double bonds. These microchips
were used for two-dimensional protein separation after further coating with
methylcellulose. Wu et al.144 introduced amino groups on the plasma pretreated
PDMS surface by reaction with 3-aminopropyl-triethoxysilane (APTES). Then some
epoxy-containing hydrophilic copolymers, such as poly(AAM-co-GMA) and
PVA-g-GMA, were grafted on the surface by reaction between the amino groups and
epoxy groups. The surface obtained was hydrophilic and protein-adsorption resistant.
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Besides PDMS, an oxygen plasma has been used to treat other polymeric microdevice
surfaces, such as PMMA,27 COC145 and TPE59.
UV-light assisted modification. UV radiation is another widely used tool to
activate and treat polymer surfaces. UV light assisted graft polymerization is
attractive for surface modification of microfluidic devices since it requires few steps
and low light penetration into the bulk polymer substrate. For instance, a PDMS
surface was exposed to UV light to generate radicals that initiated polymerization
from the surface. Several hydrophilic polymers, including polyacrylic acid,
polyacrylamide, polydimethylacrylamide, poly(2-hydroxylethyl acrylate) and
poly(poly(ethylene glycol)monomethoxyl acylate), were grafted on PDMS
microdevice surfaces to improve the separation performance.109,110,146 The one-step
UV light photografting process required a relatively long exposure time, and the
microchannels were prone to clog with the polymers generated in the solution.
Moreover, it was difficult to achieve reproducible surface modification using this
method. To overcome these problems, Hu et al.111 proposed an alternative strategy
called surface-directed graft polymerization. In this two-step process, a photoinitiator
was first absorbed onto the PDMS surface. Then, a monomer solution without
initiator was introduced into the channel. A polymer layer was formed on the surface
when exposed to UV radiation. No clogging was observed in the channel because
polymerization on the surface was enhanced by the trapped initiators and, therefore,
was faster than in the bulk solution. The resultant microfluidic device exhibited stable
EOF and improved separation performance.
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PMMA and PC microchips were treated with UV light and ozone to generate
hydroxyl and carboxyl groups on their surfaces, which were further used to introduce
methacrylate functionality by reacting with 3-methacryloxypropyltrimethoxysilane.
Polyacrylamide was then UV light grafted onto the chemically modified surfaces.147
The carboxyl groups could also be used to attach amine groups to the surface for
further modification.148 Polyacrylamide was UV grafted onto the inner wall of COC
microchips for isoelectric focusing of proteins.101 UV-initiated photografting was also
performed on polybutylmethacrylate (PBMA), PS, hydrogenated polystyrene (PS-H),
polypropylene (PP), and other polymeric substrates.149A pulsed UV excimer laser
(KrF, 248 nm) below the ablation threshold was also employed to produce carboxyl
groups on the PMMA surface without changing the physical surface morphology. The
UV laser-treated PMMA microchip exhibited an increase in EOF and a decrease in
band broadening during electrokinetic flow.150 An ArF excimer laser (193 nm) was
used to modify PET microchannels for EOF control.76
Modification using other energy sources. In addition to plasma and UV
radiation, other energy sources have also been employed to oxidize PDMS surfaces.
For example, a Tesla coil was used to generate sufficient ozone to oxidize PDMS
surfaces.151 The Si-OH and/or COOH groups formed by oxidation resulted in an
increase in the EOF. An amine-terminated surface was produced by exposing the
oxidized PDMS substrate to a solution of 3-aminopropyl triethoxysilane (APTES). A
cross-linked amine-terminated layer was formed on the surface, which resulted in a
decrease in EOF compared with the native PDMS surface.
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Sol-gel modification. A unique sol gel method was reported to modify PDMS
microchips, in which nanometer SiO2 particles were uniformly distributed in the
matrix.152 The first step was to swell a sealed PDMS microchip in tetraethyl
orthosilicate (TEOS), which became trapped in the expanded matrix. Then the
swelled microchip was immersed in an aqueous solution containing ethylamine to
catalyze the formation of SiO2 particles and shrink the microchip back to its original
form. After removal from the ethylamine solution, the PDMS microchip was dried in
an oven. Compared with the original PDMS microchip, the modified chip exhibited
increased and stable EOF. Moreover, both the hydrophobicity and adsorption
proterties of the surface were reduced.
Chemical modification. PDMS microchips have been modified using cerium
(IV)-catalyzed polymerization.153,154 The silanol groups on the PDMS surface were
activated using cerium (IV) to form radicals, which initiated polymerization from the
surface. Poly(vinylsulfonic acid), poly(acrylic acid), poly(2-acrylamido-2methylpropanesulfonic acid), poly(4-styrenesulfonic acid), and poly(stearyl
methacrylate) were successfully coated on microfabricated collocated monolith
support microchip structures for capillary electrochromatography of peptides.
In addition to oxygen plasma and UV radiation treatment, the PDMS surface
can be oxidized in acidic H2O2 solution to produce silanol groups. The hydrophilic
silanol-covered PDMS surface can be further modified by reaction with silanes. Using
this approach, functional groups such as PEG and amine can be introduced onto
PDMS surfaces for minimization of nonspecific protein adsorption and attachment of
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biomolecules, respectively. Surface-grafted amino groups can be converted to
isothiocyanate groups for further attachment of peptides, DNA and proteins. The
biomolecule-grafted PDMS microchannels can be used for cell immobilization and
incubation, DNA hybridization and immunoassay.155
Henry et al. chemically modified PMMA surfaces using aminolysis.156 The
ester groups on the PMMA surface reacted with N-lithiodiaminoethane or
N-lithiodiaminopropane to yield an amine-terminated surface. The EOF in the
aminated PMMA microchannels was reversed compared to the original PMMA. The
terminal amine groups could be used for further treatment, such as reaction with
n-octadecane-1-isocyanate to achieve a C18H37-modified PMMA microchannel
surface, which was used for CEC separation of oligonucleotides.157 Waddell et al.158
and Wang et al.159 reacted the amine groups with glutaric dialdehyde, and then reacted
the resulting aldehyde groups with amino-modified oligonucleotides to immobilize
them on the surface.
PETG microchips were treated with NaOH solution, which hydrolyzed the
ester groups in PETG backbone chains to produce carboxylic groups. These
carboxylate moieties were then used as a means for further modification, such as
reaction with amine group-containing reagents.52
Bulk modification. Wang et al.160 reported a bulk modification approach to
control surface chemistry and performance of PMMA microchips during the
fabrication process. Some alkylmethacrylate modifiers, such as methacrylic acid
(MAA), 2-sulfoethyl methacrylate (2-SEMA), and 2-aminoethyl methacrylate
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(2-AEMA), were added to MMA monomer solutions to produce copolymers with
different surface properties and charges. This resulted in significant enhancement
and/or modulation of the EOF. For example, an MAA-modified PMMA microchip
showed an increase in EOF and a 2-AEMA-modified microchip exhibited a reversal
of EOF compared with untreated PMMA microchips. This simple one-step method
that couples the fabrication and modification processes could be easily extended to
other polymers to achieve diverse surface chemistries for specific applications. Liu et
al. prepared a surface reactive polymer (PGMAMMA) by copolymerization of GMA
and MMA. The epoxy groups present on this copolymer surface could be used for
further modification, such as photografting of polyacrylamide and aminolysis.29 Xu et
al. used a similar process to bulk modify polyester microchips. Olefinic alcohols were
incorporated into an unsaturated polyester matrix, which was then cured with addition
of curing agent to initiate cross-linking.161 Zhou et al. blended PMMA with
acrylonitrile-butadiene-styrene (ABS) to fabricate microchips using
injection-molding.162
Luo et al. doped 0.5 wt % undecylenic acid (UDA) into a PDMS prepolymer
to fabricate microchips.163 This modification did not change the hydrophobicity of the
PDMS surface, but increased the EOF. The UDA-doped PDMS microchip was then
hydrodynamically coated with n-dodecyl--D-maltoside (DDM) to minimize protein
adsorption on the surface. These microchips could then be used for electrophoretic
separation of immunocomplexes.
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1.3.4 Atom Transfer Radical Polymerization
Atom transfer radical polymerization. Unfortunately, among the methods
reported to permanently modify the microchip inner surface, few were effective for
high-efficiency separations of proteins, indicating that more uniform polymer layers
with higher surface coverage are needed. Recently, atom transfer radical
polymerization (ATRP) has been used to grow polymers on planar surfaces or
spherical particles, which appears to provide the desired higher surface coverage.
Different from traditional radical polymerization, ATRP is a transition metal
catalyzed free radical living polymerization method, which produces well-defined
polymers of low polydispersity.164,165 A general mechanism for ATRP is shown in
Figure 1.16.164 A free radical (R.) is generated from an organic halide (R-X, where X
is a halogen atom) through a one-electron oxidation with concomitant abstraction of X
from R-X, which is a reversible redox process catalyzed by a transition metal complex
(Mtn-Y/Ligand, where Y is another ligand or a counter ion). The generated radicals
react with monomers to propagate the polymer chains in a manner similar to
traditional radical polymerization. Termination reactions also occur through radical
coupling and disproportionation. Typically, few growing polymer chains undergo
termination and other side reactions because of fast initiation and rapid reversible
deactivation. The radicals react rapidly with the oxidized metal complexes
(X-Mtn+1-Y/Ligand) to reduce the stationary concentration of radicals and thereby
minimize the contribution of termination. Therefore, ATRP is a living polymerization
method. In ATRP, one polymer chain forms per molecule of organic halide and the
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Figure 1.16. Atom transfer radical polymerization.
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generated polymer chains are uniform and well controlled by the reaction conditions.
Surface-initiated ATRP for microchip surface modification.
Surface-initiated ATRP (SI-ATRP) is a well-controlled “grafting from”
polymerization technique that produces uniform and dense polymer brushes on
various surfaces. Huang et al. grafted a polyacrylamide film on nanoporous
silicasurfaces using SI-ATRP to separate proteins by size exclusion.166 They also used
SI-ATRP to graft linear or cross-linked polyacrylamide films on fused silica capillary
inner walls without clogging for capillary electrophoresis of proteins.167 Leinweber et
al. used a similar method to graft poly(2-hydroxyethyl methacrylate) (PHEMA) on a
capillary surface to lower the EOF and to separate proteins with high efficiency.168
Miller et al. further derivatized the grafted PHEMA layer with ethylenediamine or
octanoyl chloride to afford better resolution of phenols and anilines.169 Unsal et al.
used SI-ATRP to graft poly(3-sulfopropyl methacrylate) (PSPM) onto hydrolyzed
porous poly(glycidyl methacrylate-co-ethylene dimethacrylate)
(poly(GMA-co-EDMA)) particles for use as an ion-exchange chromatographic
stationary phase.170
SI-ATRP has also been applied to modify microchip surfaces. Xiao et al.171
carried out microchannel confined SI-ATRP to graft a thin polyacrylamide layer
inside a PDMS microchannel. The patterned PDMS surface was oxidized using a
UV/ozone plasma and then bonded with the ATRP initiator. Finally, an aqueous
solution containing acrylamide, catalyst and ligand was introduced into the enclosed
microchannel to perform ATRP. The resultant microchip was successfully used for
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electrophoretic separation of proteins.
Liu et al.27 employed an oxygen plasma to oxidize PMMA and generate
hydroxyl groups on the surface. Following plasma treatment, an ATRP initiator was
anchored by reaction of 2-bromoisobutyryl bromide with the hydroxyl groups. Then a
PEG-functionalized monomer, poly(ethylene glycol) methyl ether methacrylate
(PEGMEMA), was polymerized from the surface through SI-ATRP. The coupled
PEG-containing layer resisted protein adsorption and reduced EOF. Efficient and
reproducible CE of proteins was obtained using the resultant PMMA microchips.
Recently, Pan et al.118 developed a new technique called in-channel ATRP to
modify TPE microdevices, which were fabricated using a casting method. An ATRP
initiator was first immobilized on the channel surface through the existing hydroxyl
groups. Then a dilute PEG-functionalized monomer solution containing catalyst and
ligand was introduced into the microchannel to perform ATRP. The resultant
PEG-grafted TPE microchannel exhibited low, pH-stable EOF, low protein adsorption,
and efficient separation of amino acids and peptides. This microdevice was also used
to separate phosducin-like protein and phosphorylated phosducin-like protein to
evaluate the efficiency of phosphorylation.

1.4

Electric Field Gradient Focusing

1.4.1 Introduction
With completion of the sequencing of the human genome, scientists have
turned their attention to proteomics, which involves the study of proteins in organisms
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including identification of amino acid sequences, tertiary structures and functions in
biological systems.172,173 Identification of a target protein or biomarker of a disease,
such as cancer, can significantly help to develop an efficient drug to treat the disease.
However, protein analysis is a major challenge because of the vast number of proteins
in biological systems and their dynamic nature. It has been estimated that 500,000 to 1
million proteins are expressed in humans.174 They have different molecular weights,
isoelectric points (pI) and other properties. Most importantly, the dynamic range of
protein abundance ranges from >> mg/mL to << pg/mL, exceeding approximately ten
orders of magnitude.175 Moreover, proteins interact with each other or with other
ligands, and they are frequently modified by post-translational reactions, such as
phosphorylation, carbamylation, glycosylation, deamidation, etc.176 All of these
challenges make complete characterization of a proteome nearly impossible with
current analytical techniques. Therefore, sophisticated analytical techniques are
needed to analyze such complex mixtures. For the first step of protein analysis,
protein isolation, the techniques must offer fast and high throughput separations with
high peak capacity, large dynamic detection range, low detection limits, and reliable
resolution.
Currently, the most widely used approach for large-scale separation of protein
mixtures is two-dimensional (2-D) gel electrophoresis.177-179 Although this technique
can provide over 1,000 discrete bands per gel, it has a number of limitations. This
method is time-consuming and labor-intensive. It cannot provide sufficient resolution
and reproducibility. It cannot analyze proteins with extreme pI values and
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hydrophobicity. Moreover, the detection limits of this technique are not sufficient to
analyze lower-abundance proteins, which have potential value for clinical diagnosis.
Because of this, researchers have been developing alternative techniques such as 2-D
liquid chromatography (LC) and mass spectrometry (MS) for peak identification.180
Most of the newer techniques are combinations of liquid chromatography (LC) and
electrophoresis. Both LC and electrophoresis are linear techniques widely used in
separation science. However, they have some inherent limitations. For example, the
injected sample plugs broaden as the separation continues, which impacts the
separation efficiency and resolution. Another problem is that samples are diluted
during the separation, which complicates the determination of trace analytes.181 To
circumvent these limitations, a nonlinear technique, termed equilibrium gradient
focusing, was introduced by Giddings and Dahlgren.182 In this method, the net force
applied on an analyte, as a result of an external gradient field and an opposing force,
changes monotonically along the channel and reverses its direction at an equilibrium
point where the net force is zero. All analyte molecules of the same kind are drawn to
the equilibrium point and are focused and concentrated. A good example of such a
technique used for separation of proteins is isoelectric focusing (IEF), which is based
on the establishment of a pH gradient in a separation column.
1.4.2

Principles of Electric Field Gradient Focusing
Electric field gradient focusing (EFGF), another member of the family of

equilibrium gradient focusing techniques, depends on an electric field gradient and a
counter-flow to focus, concentrate and separate charged analytes, such as peptides and
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proteins.181,183-188 The constant counter flow is opposite to the electrophoretic force
that drives the analytes. When the electrophoretic velocity of a particular analyte is
equal and opposite to the velocity of the counter flow, the analyte is focused in a
narrow band because at this position the net force on it is zero (Figure 1.17). Since
analytes with different electrophoretic mobilities have unique equilibrium positions,
EFGF separates analytes according to their electrophoretic mobilities, similar to the
way IEF separates analytes according to isoelectric points. However, EFGF avoids
protein precipitation that often occurs in IEF when proteins reach their isoelectric
points and, therefore, can be applied to a broad range of proteins.
The basic theory of EFGF developed by Tolley et al.186,187 was derived starting
from the general transport equation

J   u   E ( x)  c( x)  DT

c( x)
x

(1.13)

where J is the flux density of the analyte, u is the velocity of the counter
hydrodynamic flow,  is the electrophoretic mobility of the analyte, E( x) is the
electric field intensity at point x , c( x) is the concentration of the analyte at point
x , and DT is the dispersion coefficient that represents the sum of all contributions to

effective diffusion.
The electric field gradient at point x is expressed as

q ( x)  

E ( x)
x

(1.14)

When the analyte is focused at point x0 (i.e., its equilibrium point), the flux is set
equal to zero

J 0

(1.15)
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Figure 1.17. Schematic representation of an EFGF separation.
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and
u   E ( x0 )  0

(1.16)

From equations 1.13 to 1.16, the standard deviation (  ) of the focused band is
obtained as
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The resolution ( Rs ) can be expressed as
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and the peak capacity ( n ) can be expressed as
n
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L

4 4

 q  x0 

(1.19)

DT

where  is the mobility difference between two analytes,  is the average
mobility of the two analytes, and L is the length of the separation channel.
Equations 1.17 and 1.18 indicate that both the width of the focused band and
resolution are inversely proportional to

q( x0 ) , which indicates that a steeper

gradient will generate a narrower band and lower resolution, while a shallower
gradient will produce higher resolution and broader bands. From equation 1.19, for a
fixed separation channel length, the peak capacity is high when the electric field
gradient is steep. At first glance, it appears that the peak capacity and resolution
cannot be improved simultaneously. To solve this problem, Tolley et al. proposed a
nonlinear electric field gradient, in which the first section of the gradient is relatively
steep and the second section is rather shallow.186,187 Thus, analytes will be tightly
stacked with narrow bandwidths in the first segment to achieve high peak capacity
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and then moved sequentially to the second segment where they are resolved. A
bilinear gradient profile shown in Figure 1.18 illustrates this design. Based on such a
profile, computer simulation demonstrates dynamic improvement of peak capacity.186
However, long separation time is required. The alternative is to use parallel EFGF
arrays which can achieve high peak capacity within relatively short separation time.
1.4.3 Approaches to Establish the Electric Field Gradient
A major challenge in EFGF is establishment of the desired electric field
gradient along the separation channel. When a voltage is applied across the channel
ends, the electric field strength along the channel, E( x) , depends on the current, I,
buffer conductivity,  ( x) , and cross-sectional area normal to the field, A( x) , by

E ( x) 

I
 ( x) A( x)

(1.20)

According to this equation,184 it is possible to obtain an electric field gradient when
the buffer conductivity,  ( x) or cross-sectional area, A( x) is gradually changed
because the current is constant in the channel. Currently, several methods have been
reported to create an electric field gradient, including the use of a conductive
changing cross-sectional area around a separation channel, a buffer conductivity
gradient in a column, a temperature gradient along a column filled with a buffer that
has a temperature-dependent conductivity, and electrodes along a channel for digital
field gradient focusing.181
Changing cross-sectional area. Koegler and Ivory183,184 first reported a
preparative scale EFGF device, in which a size exclusion resin-packed dialysis tube
was mounted in the center of a poly(methyl methacrylate) (PMMA) cylinder (Figure
58

Figure 1.18. Bilinear electric field gradient profile.
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1.19). The inner surface of the cylinder was conically shaped to generate the electric
field gradient along the dialysis tube. Proteins were focused in the dialysis tube when a
counter flow was pumped through the tube and a voltage was applied along the shaped
chamber. This system was cumbersome to set up and gave mediocre results. Humble et
al.189 improved this design and made capillary-based planar devices for analytical scale
EFGF (Figure 1.20). The separation channel was created using a small diameter wire as
template to form a channel surrounded by an ionically conductive acrylic copolymer
that freely allowed passage of small ions but restricted migration of biomacromolecules
into the gel. This nanoporous copolymer was shaped to form a linear electric field
gradient by changing the cross-sectional area. With the use of these devices, a
10,000-fold concentration factor was obtained for green fluorescent protein (GFP), and
several proteins were separated. Although the fabrication of these devices was easy and
reproducible, limitations included low peak capacity and low resolution, primarily due
to flow dispersion in the channel. Recently, Kelly et al.190 miniaturized this
capillary-based EFGF device into a PMMA microchip format, in which a microchannel
was imprinted on the bottom plate and a shaped cavity of changing cross-sectional area
was cut into the top plate. The same ionically conductive copolymer was polymerized
in the shaped cavity using phase-changing sacrificial layers to protect the
microchannel. This microchip EFGF device was used to separate various proteins and
peptides. Compared with the capillary-based system, the microchip EFGF device
offered 3-fold improved resolution of proteins.
Liu et al.88 used a different approach to fabricate a micro electric field gradient
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Figure 1.19. EFGF device of Koegler and Ivory.184
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Figure 1.20. EFGF device of Humble at al.189
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focusing (EFGF) device out of poly(glycidyl methacrylate-co-methyl methacrylate).
A weir structure was fabricated between the separation channel and changing
cross-section electric field gradient generating channel (Figure 1.21). A buffer
ion-permeable membrane made from a poly(ethylene glycol) (PEG)-functionalized
copolymer was positioned on the weir to separate the two microchannels. GFP was
concentrated 4,000-fold using this EFGF device. Separation and selective elution of
one component from a mixture containing three proteins was also investigated.
Unfortunately, the fabrication procedure and chemistry were complex and the
membrane strongly influenced the behavior of the EFGF device.
Conductivity gradient. Greenlee and Ivory191 proposed another EFGF form,
termed conductivity gradient focusing, which used a dialysis membrane to divide the
electrolyte chamber into two regions: separation channel and purge channel (Figure
1.22). A high conductivity electrolyte was introduced into the separation channel with
a low velocity, which also acted as the counter flow for focusing. Simultaneously, a
low conductivity buffer was introduced into the adjacent purge channel with a high
velocity. Thus, an axial conductivity gradient was created along the separation
channel as the buffer ions diffused from the higher conductivity buffer through the
membrane to the lower conductivity buffer. An electric field gradient could be
established by applying a voltage along the channel. In the free solution experiments,
the proteins formed contiguous bands. When focusing in a packed channel, the
resolution was improved. Following this idea, an analytical scale EFGF device based
on a dialysis hollow fiber was fabricated by Wang et al.192 An online UV absorbance
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Figure 1.21. Diagram of the EFGF device of Liu at al.88
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Figure 1.22. Diagram of the EFGF device of Greenlee.191
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detector was used to detect protein focusing and voltage-controlled elution. Later, this
system was applied for protein analysis, including protein concentration, desalting,
and purification of protein samples.193 This EFGF system provided a concentration
factor as high as 15,000 for bovine serum albumin (BSA). Recently, this hollow fiber
based system was coupled to the capillary-based EFGF device to form a tandem
EFGF system, which can trap and concentrate specific proteins of interest based on
their mobilities while desalting and removing unwanted components.194
Temperature gradient focusing. Temperature gradient focusing (TGF) is a
third form of EFGF, which was recently reported (Figure 1.23).195-197 In TGF, a
temperature gradient is employed to produce an electric field gradient due to the
dependence of the buffer conductivity on temperature. The temperature gradient could
be induced by external heating or internal Joule heating.198 One advantage of TGF is
that a membrane is not required. Therefore, TGF can be applied to focus and separate
various analytes, including proteins,195 DNA,199 enantiomers,200 small dye
molecules195,201 and amino acids,202 in both capillaries and microchannels. However,
the short channel used in TGF limits the peak capacity, and only a few buffer
solutions can be used to generate the temperate gradient. Also the temperature
gradient is constrained by the buffer and analytes.
Digital field gradient focusing. Digital field gradient focusing is the fourth
form of EFGF, in which an array of electrodes is used to generate the electric field
gradient.203-206 The electrode voltages were individually controlled by a computer, and
a dialysis membrane is used to isolate the electrodes and separation channel. In this
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Figure 1.23. Diagram of TGF.
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design, the field gradient profile can be dynamically adjusted using the computer. It is
possible to manipulate the field during separation to achieve better resolution and
narrower bands. However, this system is fairly complicated and the number of
electrodes affects the resolving power. Recently, this multielectrode design was
miniaturized on a poly(dimethylsiloxane) (PDMS) microchip.207 Two side channels
separated from the main fluidic channel with a dialysis fiber were used to replace the
metal electrodes and create the field gradient. A constant electroosmotic flow was
used as the counter flow to balance the electrophoresis. Myers and Bartle208 fabricated
a miniaturized dynamic field gradient focusing device for protein separation and
focusing. The separation channel was in contact with a parallel electric field channel
with five individual electrodes through a porous glass membrane. A porous monolith
was filled in the separation channel to reduce diffusional band broadening caused by
hydrodynamic flow.

1.5

Dissertation Overview
My research focused on polymeric microchips for CE and EFGF. Chapter 2

describes surface modification of PGMAMMA microchips using SI-ATRP. A
PEG-functionalized polymer layer was grafted on the polymer surface using three
different surface activation methods. Chapter 3 demonstrates in-channel ATRP surface
modification of PGMAMMA microchips. Chapter 4 focuses on a new polymeric
microchip for CE separation that does not require surface modification. In Chapter 5,
an EFGF device made of PEG-functionalized polymers is introduced for protein
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focusing and separation. Chapter 6 describes the performance optimization of this
EFGF device. Chapter 7 describes work done to construct and evaluate EFGF devices
with non-linear electric field gradients. Finally, Chapter 8 summarizes the conclusions
of this dissertation and gives suggestions of future work that could be pursued.
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2

SURFACE MODIFICATION OF GLYCIDYL-CONTAINING
POLY(METHYL METHACRYLATE) MICROCHIPS USING
SURFACE-INITIATED ATOM TRANSFER RADICAL
POLYMERIZATION *

2.1

Introduction
As reviewed in Chapter 1, among all of the reported methods for permanent

modification of the polymeric microchip inner surface, the ATRP technique gives the
best protein separation results, indicating that ATRP provides uniform polymer layers
with high surface coverage. Unfortunately, for most commercially available polymers,
surface modification is usually preceded by activating the inert polymer surface by
harsh conditions or using high-energy radiation or plasma sources. Recently, a novel
surface-reactive acrylic copolymer, poly(glycidyl methacrylate-co-methyl
methacrylate) (PGMAMMA) (Figure 2.1), was synthesized in our laboratory, which
introduced epoxy functionalities on the surface.1 Several surface reactions were
performed using this material, including aminolysis and photografting of
polyacrylamide. The thermal properties, solvent resistance, and transparency of this
material are suitable for microfabrication.
In this study, three methods were employed to activate the PGMAMMA
surface, including plasma treatment, hydrolysis and aminolysis. The latter two
methods were easiest to perform in the laboratory without specialized equipment.
Following surface activation, an ATRP initiator was immobilized and a
*

This chapter (except Figures 2.1 and 2.2) is reproduced with permission from Anal. Chem. 2008, 80, 856-863.

Copyright 2008 American Chemical Society.
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Figure 2.1. Structure of PGMAMMA.
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PEG-functionalized layer was grown on the surface. Surface modified PGMAMMA
microchips were used to separate peptides and proteins.

2.2

Experimental Section

2.2.1 Materials
Glycidyl methacrylate (GMA, 97%), methyl methacrylate (MMA),
poly(ethylene glycol) methyl ether methacrylate (PEGMEMA, MW ~475),
2-bromoisobutyryl bromide (98%), 2,2’-azobisisobutyronitrile (AIBN, 98%),
2,2’-dipyridyl (99+%), copper(I) chloride (CuCl, 98+%), and copper(II) bromide
(CuBr2, 99%) were purchased from Aldrich (Milwaukee, WI) and used without
further purification. Pyridine (reagent grade), heptane (reagent grade), tetrahydrofuran
(THF, reagent grade), anhydrous ethylenediamine (reagent grade) and sodium silicate
solution (40-42o, Bé) were obtained from Fisher Scientific (Fair Lawn, NJ). Hydrogen
peroxide (ACS grade, 30%) was purchased from Columbus Chemical Industries
(Columbus, WI). Sodium carbonate, sodium bicarbonate, and sulfuric acid (96.4%)
were purchased from Mallinckrodt Specialty Chemicals (Paris, KY). Isopropyl
alcohol (IPA, USP grade) was obtained from AAPER Alcohol and Chemical
(Shelbyville, KY). Ethylenediaminetetraacetic acid disodium salt dihydrate
(Na2EDTA·2H2O, 99+%) was obtained from Invitrogen Life Technologies (Carlsbad,
CA). (Heptadecafluoro-1,1,2,2-tetrahydrodecyl)trichlorosilane was ordered from
Gelest (Morrisville, PA). Fluorescein isothiocyanate (FITC), dimethyl sulfoxide
(DMSO, 99.5%), tris(hydroxymethyl)aminomethane (TRIZMA, Tris),
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Phe-Leu-Glu-Glu-Ile (FLEEI), Phe-Ala (FA), Phe-Gly-Gly-Phe (FGGF),
Phe-Phe-Tyr-Arg (FFYR), leu enkephalin, angiotensin II fragment 3-8, angiotensin II,
myoglobin, porcine thyroglobulin, -lactoglobulin A, and FITC conjugated human
serum albumin (FITC-HSA) were purchased from Sigma-Aldrich (St. Louis, MO).
Deionized water (18.2 MΩ·cm) was prepared using a Milli-Q UF Plus water
purification system (Millipore, Billerica, MA). All buffers used in FITC labeling,
EOF measurement and µCE separation were filtered using 0.2 m syringe filters (Pall
Gelman Laboratory, Ann Arbor, MI) before experiments. PMMA sheet (Acrylite FF)
was purchased from Cyro (West Paterson, NJ). Precleaned microscope slides with
dimensions of 75 × 50 × 1 mm3 and 75 × 25 × 1 mm3 were obtained from Fisher
Scientific (Pittsburgh, PA) and Hardy Diagnostics (Santa Maria, CA), respectively.
2.2.2 Synthesis of PGMAMMA
PGMAMMA is a novel polymeric material with reactive epoxy functionalities
on the surface, which has been successfully used to prepare microfluidic devices.1,2
PGMAMMA plates were synthesized by copolymerizing MMA and GMA in glass
forms (75 × 50 × 1.5 mm3) using thermally-initiated free-radical polymerization. To
prevent the polymer from sticking to the glass, the glass slides were cleaned by
submersion in a boiling Piranha solution (70:30 H2SO4/30% aqueous H2O2) for 30
min and then treated with (heptadecafluoro-1,1,2,2-tetrahydrodecyl)trichlorosilane
vapor. After assembling the form using sodium silicate solution as cement, an
ultrasonically degassed monomer solution [(1:1 mol/mol) MMA/GMA and 0.1 %
(w/w) AIBN] was introduced into the form. After sealing a glass cover over the form
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using sodium silicate solution, it was placed in an oven and held at 65°C for 24 h.
After the reaction was complete, the form was immersed in a water bath to dissolve
the sodium silicate glue, and the glass form was disassembled to release the polymer
plate. The resulting polymer plates were rinsed with IPA and deionized water, and
then dried with nitrogen gas.
2.2.3 Microchip Fabrication
The procedures for fabrication of the silicon template and microchips were the
same as previously reported.1,3 Briefly, the pattern as shown in Figure 2.2A on the
silicon template was embossed into the bottom PGMAMMA plate at 92 oC. The
resulting plate possessed crossed microchannels; the short one was used for injection
and the long one was used for separation. The top plate with four access holes was
prepared using a C-200 CO2 laser engraving system (Universal Laser Systems,
Scottsdale, AZ). The top and bottom plates were then bonded together at 65oC after
surface modification described below. The hot embossing and bonding processes were
carried out using an HP 5890 gas chromatograph oven.
2.2.4 Surface Activation of PGMAMMA
For plasma activation, the polymer substrates (PGMAMMA and PMMA) were
treated with an air plasma produced in a PDC-32G plasma cleaner (Harrick Plasma,
Ithaca, NY) for 3-5 min (~10.5 W and 400 mTorr), followed by immobilizing the
ATRP initiator immediately. To hydrolyze the epoxy groups on the polymer surface,
the substrates were placed in 0.5 M sulfuric acid solution at 40 oC for 12 h.4 After
reaction was complete, the substrates were rinsed with DI water until neutral and
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dried with nitrogen gas. For aminolysis, the PGMAMMA substrates were immersed
in a solution containing 20% (w/w) ethylenediamine, 40% (w/w) IPA and 40% (w/w)
ethyl alcohol at room temperature for 24 h, followed by rinsing with deionized water
again until neutral and dried with nitrogen gas.1
2.2.5

Attachment of ATRP Initiator on the PGMAMMA Surface
Immobilization of a typical ATRP initiator, 2-bromoisobutyryl bromide, on

PGMAMMA and PMMA surfaces has been previously reported.1,3 After air plasma
activation, substrates were immediately immersed in a 5:1 (v/v) heptane/THF solution
containing 25 mM initiator and 27.5 mM pyridine and placed on a MaxQ 2000 shaker
(Barnstead International, IA) at room temperature for 6 h. For hydrolyzed and
aminolyzed substrates, after cleaning and drying, the substrates were also placed in
the initiator solution for 6 h. Then, the substrates were removed, rinsed thoroughly
with IPA and deionized water, and dried with nitrogen gas.
2.2.6 Surface-Initiated Atom Transfer Radial Polymerization (SI-ATRP)
To avoid the negative effects of oxygen in the reaction, the ATRP process was
carried out in a nitrogen-filled glove box. The initiator-anchored substrate plates were
immersed in an aqueous solution containing 20% PEGMEMA 475 (v/v), 18 mM
CuCl, 5.4 mM CuBr2, and 46.8 mM 2,2’-dipyridyl. After reaction at room temperature
for 12 h, the substrates were removed and immersed in saturated aqueous Na2EDTA
solution to quench the reaction and remove residual copper ions. All polymer plates
were thoroughly rinsed with deionized water and dried with nitrogen gas before
characterization and thermal bonding.
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2.2.7 Electroosmotic Flow Measurement
The current monitoring approach was employed to measure the electroosmotic
flow (EOF) in the PEG grafted PGMAMMA microchannel.5 The measurement
procedure and instrument were the same as used before.1 In brief, the separation
microchannel and one of the reservoirs were filled with 20 mM Tris-HCl buffer (pH
8.5), and the other reservoir was emptied using a pipette and then filled with 10 mM
Tris-HCl buffer (pH 8.5). The solution levels for both reservoirs were carefully
maintained the same. A voltage of 1000 V was applied over the microchannel and the
current was recorded. The sampling rate for data collection was 50 Hz.
2.2.8 X-ray Photoelectron Spectroscopy (XPS)
X-ray photoelectron spectroscopy (XPS) was used to determine the elemental
composition of various treated surfaces, including the initial PGMAMMA surface,
initiator-bonded PGMAMMA and PMMA plates, and PEG grafted PGMAMMA
surface. Before XPS experiments, all polymer samples were thoroughly rinsed with
deionized water, purged with nitrogen gas, and dried under vacuum. XPS was
performed using an SSX-100 X-ray photoelectron spectrometer with a
monochromatic Al K source and a hemispherical analyzer. An electron flood gun
was employed because the samples were insulating polymers. Survey scans as well as
narrow scans were recorded with an 800×800 m2 spot size. Data acquisition and
processing were implemented with the instrument software (ESCA NT 3.0).
2.2.9 Contact Angle Measurement
An NRL-100 goniometer (Ramé-hart, Mountain Lakes, NJ) was employed to
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measure contact angles of activated PGMAMMA and PMMA surfaces, and
initiator-bonded and PEG grafted PGMAMMA surfaces. The contact angle was
determined immediately after 4 μL deionized water was dropped on the surface,
reported as the mean of the left and right contact angles of the water drop.
2.2.10 FITC Labeling of Peptides and Proteins
Each peptide and protein sample was dissolved in 10 mM carbonate solution
(pH 9.2), and diluted to 2 mM and 1 mg/mL, respectively. The solutions were passed
through 0.2 m syringe filters prior to use. FITC was diluted in absolute DMSO to
prepare a 6 mM solution. For peptides, a 200 L solution of each sample was
combined with 50 L of FITC solution. For proteins, 600 L of each protein solution
was thoroughly mixed with 40 L of FITC solution. All sample-FITC solutions were
allowed to react in the dark for at least 24 h at room temperature. Each sample was
diluted with 10 mM Tris-HCl buffer (pH 8.5) before use.
2.2.11 CE Separation of Peptides and Proteins
The setup for CE separation, including laser induced fluorescence (LIF)
detection and data acquisition, was the same as reported before.1,3 The sampling rate
for data collection was 100 Hz. Pinched injection was used for sample injection and
the voltages applied to the reservoirs for both injection and separation are shown in
Figures 2.2 B and C.
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Figure 2.2. (A) Schematic diagram of microchip design used in this work, (B) voltage
scheme for sample injection, (C) voltage scheme for CE separation. (1) Sample
reservoir, (2) sample waste reservoir, (3) buffer reservoir, (4) buffer waste reservoir.
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2.3

Results and Discussion

2.3.1 Synthesis of PGMAMMA
PGMAMMA is a novel plastic that has physical properties similar to PMMA,
such as good thermal stability and UV transparency above 300 nm. These
characteristics make it suitable for fabrication of microfluidic devices.1 Most
importantly, it is easy to modify this plastic surface due to the presence of epoxy
functionalities on the surface. Thus, it is feasible to obtain biocompatible surfaces
using this polymer and various traditional chemical reactions.
PGMAMMA plates were first prepared in glass forms assembled with
unmodified glass slides.1 However, sometimes it was hard to remove the plastic plates
out of the forms because the copolymer stuck to the glass. Occasionally, Si peaks
were seen in the XPS spectra of the plastic surfaces, which indicated that the glass
sometimes adhered strongly to the polymer surface. This may have resulted from
interactions between the epoxy groups in the plastic and silanol groups on the glass.
The presence of Si changed the polymer surface properties, affecting surface
modification, microfabrication and thermal bonding. To prevent this problem, the
glass slides were reacted with a perfluorinated silane vapor to produce a monolayer
which was crosslinked at high temperature. These modified glass slides were then
assembled into forms as before using sodium silicate solution. The monomer solution
was then poured into the forms, followed by sealing them with cover plates and
placing them in a GC oven at 65 oC for 24 h. After polymerization, the plastic plates
were easily removed from the forms when they were immersed in a water bath. With
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this treatment, no permanent adhesion or adsorption of glass or perfluorinated silane
was observed on the polymer surface, as indicated by the absence of fluorine and
silica peaks in the XPS spectrum of the surface (Figure 2.6 F). The contact angle of
the PGMAMMA surface was 67.3o±0.5 (calculated from 3 measurements at 95% CL),
which is close to that of PMMA.
2.3.2 Surface Activation of PGMAMMA
Various plasmas can be used to activate inert polymer surfaces, such as PDMS
and PMMA.3,6,7 Ionized oxygen or oxygen radicals in an oxygen plasma attack the
polymer chains to introduce oxygen-containing functionalities onto the surface, such
as hydroxyl and carboxyl groups. Such plasma treated surfaces are hydrophilic and
the new generated functionalities can participate in further chemical reactions. In this
work, I first used an air plasma to activate the PGMAMMA surface. Compared with
PMMA, it was much easier to activate a PGMAMMA surface due to the presence of
reactive epoxy functionalities. The epoxy rings opened easily to generate hydroxyl or
carboxyl groups. To oxidize a PMMA surface using an oxygen plasma, pure oxygen
gas should be introduced and the plasma should be maintained at 80 W.3 For
PGMAMMA, an air plasma with lower power (~10.5 W) was sufficient to activate the
surface.1 The plasma treatment time was approximately 3-5 min. If the treatment time
was too long, the plastic plate deformed under the generated heat because its glass
transition temperature is only 82 oC. Figure 2.3 shows that the contact angles of
PGMAMMA and PMMA surfaces change with exposure time in air after 5 min air
plasma treatment. The contact angles increase with exposure time, which is consistent
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Figure 2.3. Plots of contact angle of PMMA and PGMAMMA surfaces as a function
of time after 5 min plasma treatment.
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with results from PDMS.8 The recovery of hydrophobicity occurs because the
hydrophilic groups or segments migrate into the bulk polymer by rotational or
translational motion in order to minimize the interfacial free energy between the
polymer surface and its air environment.9 After similar treatment, the PGMAMMA
surface wettability changed more than PMMA. After exposure to air for 10 min, the
contact angle of the PGMAMMA surface was 22.5o (Table 2.1), which was smaller
than PMMA (~45o). This indicates that the plasma produces more hydrophilic groups
on the PGMAMMA surface than PMMA. After 7 h, the contact angle of the PMMA
surface was ~55o, which again was larger than PGMAMMA (~45o).
In addition to plasma oxidation, the PGMAMMA surface can be activated by
other means. For example, ring-opening of the epoxy groups occurs with
ethylenediamine to introduce amino groups on the surface.1 Another simple reaction is
to hydrolyze the epoxy groups under acidic conditions to produce diol groups on the
surface.4 This hydrolysis reaction, which has been widely used to modify GMA
copolymers, is shown in Figure 2.4. Even though surface activation by chemical
treatment takes considerably longer than plasma treatment, it is much less expensive
than using a plasma source, and batch processing eliminates most concerns about
lengthy treatment time. After hydrolysis and aminolysis, PGMAMMA surfaces have
similar contact angles (Table 2.1). Compared with plasma activation, hydrolysis and
aminolysis can be carried out in most laboratories without any special equipment, and
these methods generate more stable activated surfaces, which have been stored for up
to 6 months without any noticeable change in reactivity.
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Table 2.1. Contact angles of PGMAMMA surfaces after activation, initiator bonding,
and PEG grafting. a, b
Treatment

Activated
oc

Plasma

22.5±1.2

Hydrolysis

48.7±2.6

Aminolysis

48.8±3.7

o

o

Initiator bonded
56.5±0.7
54.5±3.1
56.6±0.9

o

o

o

a

Data were calculated from four consecutive measurements.

b

CL% = 95%.

c

Contact angle was measured ~10 min after 5 min plasma treatment.

PEG grafted
39.6±0.2
39.4±0.7
39.3±0.1

o

o

o
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Figure 2.4. Hydrolysis of PGMAMMA under acidic conditions.
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2.3.3 Surface-Initiated Atom Transfer Radical Polymerization
To generate a covalently attached polymer “brush” on a surface, two strategies
have been employed: “grafting from” and “grafting to.” Surface-initiated
polymerization is a “grafting from” technique in which polymer chains are grown
directly from initiator sites on the surface. This method achieves much higher grafting
density than a “grafting to” technique. ATRP has been implemented in various
surface-initiated polymerization studies to date.10-14 This technique produces
well-controlled polymer brush growth under mild conditions. In this work, I took
advantage of surface-initiated atom transfer radical polymerization (SI-ATRP) to
generate a protein-adsorption resistant polymer brush on the PGMAMMA surface.
To perform SI-ATRP, I first covered the polymeric substrate surface with
ATRP initiator. The three surface activation methods described above introduce either
hydroxyl or amino groups on the PGMAMMA surface, which are used to anchor the
ATRP initiator.10 The reactions are shown in Figure 2.5. After reaction, a transferable
halogen (bromine) is attached on the surface, which acts as the ATRP initiator. The
contact angles of initiator-bound surfaces (~56o) increased in comparison to activated
surfaces (Table 2.1) because more hydrophobic groups replaced the hydroxyl or
amino groups. Figures 2.6 A-C show XPS spectra of initiator-anchored PGMAMMA
surfaces, which were activated using different methods. Figure 2.6 D is the XPS
spectrum of an initiator-bound PMMA surface that was first treated with an air plasma;
no evidence of bromine can be found. In contrast, three bromine peaks (Br 3s, Br 3p
and Br 3d) are easily recognized for treated PGMAMMA surfaces. From XPS narrow
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Figure 2.5. Bonding of ATRP initiator on PGMAMMA surface.
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A

B

C

D

E

F

Figure 2.6. XPS survey spectra of (A) air plasma treated PGMAMMA with bonded
ATRP initiator, (B) hydrolyzed PGMAMMA with bonded initiator, (C) aminolyzed
PGMAMMA with bonded initiator, (D) air plasma treated PMMA with bonded
initiator, (E) PEG grafted PGMAMMA using ATRP, and (F) untreated PGMAMMA.
The binding energies of O 1s, N 1s, C 1s, Br 3s, Br 3p and Br 3d are 526.5 eV, 394.6
eV, 279.7 eV, 250.7 eV, 177.8 eV, and 64.9 eV, respectively.
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scans, the bromine content (atom percentage) on each initiator-anchored surface was
obtained (see Table 2.2). The bromine content was very small (0.19%) on the PMMA
surface compared to the PGMAMMA surfaces (> 4.5%), although these surfaces were
activated by different means. The hydrolyzed polymer surface had a bromine content
similar to the aminolyzed surface. However, both were higher than the air plasma
treated surface. This is because hydrolyzed and aminolyzed surfaces have relatively
stable reactive groups, i.e., hydroxyl and amino groups. The reactive groups on the air
plasma treated surface disappeared gradually due to hydrophobic recovery. For the
PMMA surface, only a few reactive groups were generated after air plasma treatment.
An aminolyzed PGMAMMA surface showed a nitrogen content of 3.03±0.26% based
on three measurements at 95% confidence level.
After surface initiator bonding, ATRP was carried out to attach the polymer
film to the surface. To render the microchip suitable for biomolecule separations, the
microchannel surface should be resistant to biomolecule adsorption. PEG is useful for
resisting adsorption of proteins and adhesion of platelets and other cells.15 Recently,
PEG has been used to passivate various surfaces, including metal, silicon and polymer
surfaces.3,16,17 In this work, I used PEGMEMA (MW ~475) as the ATRP monomer.
Although the backbone of the grafted polymer is based on methacrylate, PEG side
chains surround the backbone to provide a hydrophilic and neutral environment,
which is nonadsorptive to biomolecules, such as proteins and peptides. Figure 2.7
shows the ATRP reaction. The thickness of the grafted layer can be adjusted by simply
varying the polymerization time and monomer concentration. Compared with
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Table 2.2. Atom percentages of Br on various polymer surfaces after bonding of the
initiator as determined by XPS narrow scans.

Br %

Plasma treated
PGMAMMA

Hydrolyzed
PGMAMMA

Aminolyzed
PGMAMMA

Plasma treated
PMMA

4.51±0.33 a, b

5.77±0.69 a, b

5.23±0.64 a, b

0.19

a

Data were calculated from three measurements.

b

CL% = 95%.
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Figure 2.7. Surface-initiated atom transfer radical polymerization of PEGMEMA on a
PGMAMMA surface.
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modification of the PMMA surface, not only is the monomer concentration lower, but
the polymerization time is also shorter. This is because of the greater density of
initiator anchored on the PGMAMMA surface. In SI-ATRP, the polymerization rate is
proportional to monomer and initiator concentrations.11 When the initiator density is
high, the monomer concentration should be reduced in order to carefully control the
polymerization. In addition, the polymer graft density depends on the surface density
of the initiator. It was observed, however, that the plate became opaque when the
polymer density was too high, which not only destroyed the transparency of the plate,
but also interfered with thermal bonding. To obtain suitably modified plates, I reduced
the polymerization time to control the polymer molecular weight and the polymer
graft density.
The contact angles of the PEG grafted surfaces are listed in Table 2.1. For the
three activation methods, the final polymer surfaces have similar wettabilities. Their
contact angles were approximately 39.4o, which is in agreement with the results
obtained from PEG films grafted on silicon (~41o)16 and PMMA surfaces (~38.6o).3
Figure 2.6 E shows an XPS spectrum of a PEG grafted PGMAMMA surface, which
was first hydrolyzed. Only carbon and oxygen peaks (C 1s and O 1s) appear in the
spectrum. No bromine peak was found on the surface. Most likely, most of the chains
were terminated and, therefore, no living chain-ends were left on the surface.11
2.3.4 Micro-CE of Biomolecules in Modified PGMAMMA Microchips
Electroosmotic flow. The electroosmotic (EO) mobility of an untreated
PGMAMMA microchannel is (3.5±0.6)×10-4 cm2/V·s (Table 2.3), and its direction is
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from the anode to the cathode, which is opposite to the movement of negative
analytes when a high voltage is applied. This EO mobility is larger than for a PMMA
microchannel (~1.6×10-4 cm2/V·s) because of the presence of epoxy groups on the
PGMAMMA surface. When a PEG film is generated on the polymer surface, the EO
mobility reduces by one order of magnitude (Table 2.3). The EO mobility was
approximately 3×10-5 cm2/V·s when the polymer surface was activated using any of
the three methods. This is because the EO mobility only depends on the surface
characteristics.
CE separation of peptides. Figure 2.8 shows the CE separation of seven
FITC labeled peptides using a PEG-grafted PGMAMMA microchip, which was first
activated using an air plasma and then grafted with a PEG layer using the ATRP
method. Seven peptides were completely separated in 30 s when the electric field
strength was 500 V/cm (Figure 2.8 A). To achieve a faster separation, I applied a
higher electric field strength (750 V/cm), and all peptides were totally separated in 18
s (Figure 2.8 B). The column efficiencies for each peak in Figure 2.8 are listed in
Table 2.4. The efficiencies are all higher than 1.8×104 plates for a 3.5 cm separation
channel.
CE separation of proteins. All PEG grafted PGMAMMA microchips gave
good protein separations. Figure 2.9 A shows complete separation of four FITC
labeled proteins in 20 s using a hydrolyzed and then grafted device. In addition to the
main component (peak 4), HSA had three other minor components. The first two were
located between peaks 1 and 2, and the third small peak was overlapped with peak 3
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Table 2.3. Electroosmotic mobilities of untreated and PEG modified PGMAMMA
microchips.a,b

EOF (cm2/V·s)

Untreated

Plasma treated

Hydrolyzed

Aminolyzed

(3.5±0.6)×10-4

(3.4±0.1)×10-5

(2.6±0.1)×10-5

(3.0±0.4)×10-5

a

Data were calculated from three consecutive measurements.

b

CL% = 95%.
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A

B

Figure 2.8. CE separations of seven FITC-labeled peptides using a PEG grafted
PGMAMMA microchip, which was first treated by an air plasma. Injection voltage
was 600 V, and separation voltage was (A) 2000 V and (B) 3000 V. Peak
identifications: (1) FLEEI; (2) FA; (3) FGGF; (4) leu enkephalin; (5) angiotensin II,
fragment 3-8; (6) angiotensin II and (7) FFYR.
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Table 2.4. Column efficiencies for peaks separated in Figures 2.8 and 2.9.

1

2

3

Peak No.
4

Figure 2.8 A

3.6×104

3.1×104

2.8×104

2.7×104

2.3×104

1.9×104

1.8×104

Figure 2.8 B

3.5×104

3.2×104

2.7×104

2.3×104

2.1×104

2.0×104

1.8×104

Figure 2.9 A

4.4×104

3.4×104

3.5×104

3.6×104

--

--

--

Figure 2.9 B

1.5×104

--

--

--

--

--

--

Figure

5

6

7
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A

B

Figure 2.9. CE separations of FITC-labeled proteins using PEG grafted PGMAMMA
microchips. (A) Hydrolyzed microchip. Peak identifications: (1) -lactoglobulin A; (2)
thyroglobulin; (3) myoglobin; and (4) human serum albumin (HSA). (B) Aminolyzed
microchip. Peak identifications: same as for Figure 2.9 A. Injection voltage was 800 V
and separation voltage was 3000 V.
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(see Figure 2.10). The separation efficiencies are listed in Table 2.4;
FITC--lactoglobulin A gave an efficiency of 4.4×104 plates. The other three peaks
gave similar efficiencies. Figure 2.9 B shows the separation of three proteins using a
PEG grafted PGMAMMA microdevice, which was first activated by aminolysis.
Compared with Figure 2.9 A, this separation is not very good. The unlabeled small
peaks belonging to HSA are not resolved, and peaks 2 and 3 are not completely
separated. The column efficiency for the first peak was 1.5×104 plates, which was
only one third of that achieved in Figure 2.9 A. The poor separation is most likely due
to damage of the microchannel surface by ethylenediamine when performing the
aminolysis treatment.
Reproducibility. A good microchip should provide good separation
reproducibility. I used FITC-labeled HSA to examine the reproducibility of
PEG-bound microchips. Figure 2.10 shows four independent electropherograms of
HSA using a hydrolyzed and then PEG-grafted PGMAMMA microchip. One major
peak and three minor peaks were resolved. The migration times and efficiencies of the
major peak in the HSA sample are listed in Table 2.5. The relative standard deviations
(RSD) for migration time and column efficiency were 1.3 and 2.7%, respectively.
These results demonstrate that the PEG film grafted on the PGMAMMA surface using
SI-ATRP is uniform and stable and, therefore, the resultant microchip demonstrates
good reducibility for CE separation of biomolecules.
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A

B

C

D

Figure 2.10. CE separations of FITC-HSA using PEG grafted PGMAMMA
microchips, which were first hydrolyzed. Electropherograms were recorded for four
different microchips. Injection voltage was 800 V and separation voltage was 3000 V.
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Table 2.5. Migration time and column efficiency reproducibilities for the major HSA
peak shown in Figure 2.10.
Run

Mean

RSD (%)

18.57

18.81

1.3

3.4×104

3.4×104

2.7

A

B

C

D

tm (s)

18.74

19.16

18.76

Total plates

3.4×104

3.5×104

3.3×104
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2.4

Conclusions
The presence of epoxy functionalities on the PGMAMMA surface renders

plastic plates made of this material easy to activate and modify. I successfully used
three methods to activate this polymer surface. An air plasma oxidizes the polymer
surface and, therefore, introduces oxygen-containing functionalities on the surface,
such as hydroxyl groups. Compared with a PMMA surface, for which pure oxygen
gas is required for plasma treatment, an air plasma at low power is sufficient to treat
the PGMAMMA surface. In addition, the epoxy groups can be directly hydrolyzed
under acidic conditions to generate diol groups on the surface. Also the epoxy rings
can be opened when attacked by amine reagents. After surface activation, ATRP
initiator groups can be anchored on the surface through reaction of the surface
hydroxyl or amino groups with 2-bromoisobutyryl bromide. Plasma treated surfaces
must be treated quickly in order to avoid hydrophobic recovery of the surface.
Reagent activated surfaces are more stable. In the last step of surface modification,
SI-ATRP was carried out to graft PEG groups on the surface. This grafted polymer
film was uniform, hydrophilic, stable and resistant to protein adsorption. PGMAMMA
microchips treated via this modification strategy showed excellent performance in
separation of peptides and proteins. These devices provided high separation efficiency
and good reproducibility.
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3

SURFACE MODIFICATION OF POLYMER MICROFLUIDIC
DEVICES USING IN-CHANNEL ATOM TRANSFER RADICAL
POLYMERIZATION *

3.1

Introduction
As introduced in Chapter 2, I grafted PEG-functionalized layers on

PGMAMMA microchannel surfaces using the SI-ATRP method.1 During the ATRP
modification process, the complete surfaces of both plates were grafted with a PEG
layer, which affected the thermal bonding strength of the resultant microchips.
Modification of only the microchannel surface would certainly improve the bonding
strength.
Xiao et al.2 carried out microchannel confined SI-ATRP to graft a thin
polyacrylamide layer inside the PDMS microchannel. The patterned PDMS surface
was oxidized using a UV/ozone plasma and then bound with ATRP initiator. Finally,
an aqueous solution containing acrylamide, catalyst and ligand was introduced into
the enclosed microchannel to perform ATRP. The resultant microchip was
successfully used for electrophoretic separation of proteins with an efficiency of
~1.16×103 plates for a 3.5 cm-length microchannel.
Recently, Pan et al.3 developed a new technique called in-channel ATRP to
modify TPE microdevices, which were fabricated using a casting method. An ATRP
initiator was first immobilized on the channel surface through the existing hydroxyl
groups. Then a dilute PEG-functionalized monomer solution containing catalyst and
*

This chapter is reproduced with permission from Electrophoresis 2008, 29, 2760-2767. Copyright 2008

Wiley-VCH.
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ligand was introduced into the microchannel to perform ATRP. The resultant
PEG-grafted TPE microchannel exhibited low, pH-stable EOF and low protein
adsorption. Electrophoresis efficiencies of 4.5×103 plates for amino acids and 1.2×103
plates for peptides were obtained using the surface modified TPE microdevice with a
3.0-cm-long separation channel. This microdevice was used to separate
phosducin-like protein and phosphorylated phosducin-like protein to evaluate the
efficiency of phosphorylation.
In this study, I developed an in-channel ATRP method to graft a
PEG-functionalized layer on a PGMAMMA microchannel surface, following ATRP
initiator coupling and thermal bonding, for electrophoresis of peptides and proteins. I
was hopeful that this approach would produce more stable and robust devices than
previously reported ATRP methods.

3.2

Experimental Section

3.2.1 Materials and Preparation of Test Samples
GMA (97%), MMA, PEGMEMA (MW ~475), 2-bromoisobutyryl bromide
(98%), 2,2’-azobisisobutyronitrile (AIBN, 98%), 2,2’-dipyridyl (99+%), copper(I)
chloride (CuCl, 98+%), and copper(II) bromide (CuBr2, 99%) were purchased from
Aldrich (Milwaukee, WI). Pyridine (reagent grade), heptane (reagent grade),
tetrahydrofuran (THF, reagent grade), sodium silicate solution (40o-42o Bé), urea
(reagent grade), and dithiothreitol (molecular biology grade) were obtained from
Fisher Scientific (Fair Lawn, NJ). Iodoacetamide was purchased from Amersham
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Biosciences (Piscataway, NJ), isopropyl alcohol (IPA, USP grade) was obtained from
AAPER Alcohol and Chemical (Shelbyville, KY),
(heptadecafluoro-1,1,2,2-tetrahydrodecyl) trichlorosilane was from Gelest
(Morrisville, PA), and DL-aspartic acid, DL-glutamic acid, DL-phenylalanine,
DL-asparagine, and glycine were purchased from ICN Biomedicals (Aurora, OH).
Fluorescein isothiocyanate (FITC), dimethyl sulfoxide (DMSO, 99.5%),
tris(hydroxymethyl)aminomethane (TRIZMA, Tris), Gly-Tyr (GY), Phe-Gly-Gly-Phe
(FGGF), Trp-Met-Asp-Phe (WMDG), Phe-Phe-Tyr-Arg (FFYR), angiotensin III
(Ang III), myoglobin, porcine thyroglobulin, -lactoglobulin A, -casein, trypsin,
FITC-conjugated human serum albumin (FITC-HSA), FITC-conjugated insulin, and
FITC-conjugated -casein were purchased from Sigma-Aldrich (St. Louis, MO). All
monomers were directly used without further purification.
Amino acid, peptide and protein test samples were labeled with FITC for
fluorescence detection. The labeling procedure was reported elsewhere.4 In brief, each
sample was dissolved in 10 mM carbonate solution (pH 9.2) to give 3 mM (amino
acids), 2 mM (peptides), or 1 mg/mL (proteins) concentrations, respectively. The test
solutions were filtered through 0.2 m syringe filters (Pall Gelman Laboratory, Ann
Arbor, MI) prior to use. FITC was dissolved in absolute DMSO to prepare a 6 mM
solution. For amino acids, a 600 µL volume of sample solution was mixed with 200
µL of FITC solution; for peptides, a 200 L volume of solution was combined with 50
L of FITC solution; and for proteins, a 600 L volume of solution was thoroughly
mixed with 40 L of FITC solution. All solutions were allowed to react in the dark for
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at least 24 h at room temperature and then stored in a refrigerator (4 oC). Immediately
prior to use, samples were diluted with 10 mM Tris-HCl buffer (pH 8.5).
-Casein was digested using a protocol described in the literature.5 In brief, 1
mg-casein was sequentially treated with 6 M urea, dithiothreitol and iodoacetamide
at 37 oC. Trypsin (20 mg) was then added, and the solution was left overnight at 37 oC
and pH 8.0. The resulting digest was desalted using a cellulose ester dialysis
membrane (MWCO 100, Spectrum Medical Industries, Houston, TX) for 24 h. Before
CE analysis, the digest was diluted with 10 mM Tris-HCl (pH 8.5) buffer.
Deionized water (18.2 MΩ·cm) was prepared using a Milli-Q UF Plus water
purification system (Millipore, Billerica, MA). All buffers used in FITC labeling,
EOF measurements and µCE separations were filtered before use. Precleaned
microscope slides with dimensions of 75 × 50 × 1 and 75 × 25 × 1 mm3 were
purchased from Fisher Scientific (Pittsburgh, PA) and Hardy Diagnostics (Santa
Maria, CA), respectively.
3.2.2 Synthesis of PGMAMMA
PGMAMMA plates were synthesized using thermal-initiated free-radical
polymerization of MMA and GMA in glass forms (75 × 50 × 1.5 mm3) which had
their surfaces passivated using (heptadecafluoro-1,1,2,2-tetrahydrodecyl)
trichlorosilane to prevent polymer-glass adhesion.1 The ingredients in the monomer
solution included 50% (mol concentration) MMA, 50% GMA, and 0.1 % (weight
percentage of total monomers) AIBN. Polymerization was carried out at 65°C for 24 h,
after which the resulting polymer plates were released by immersing the glass forms
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in a water bath. Finally, the plates were cleaned with IPA and deionized water.
3.2.3 Microchip Fabrication
The PGMAMMA plates were trimmed to dimensions of 50 × 20 mm2 using a
C-200 CO2 laser engraving system (Universal Laser Systems, Scottsdale, AZ). The
microfabrication procedure was followed as previously reported.4 Briefly, a simple
crosschannel design as shown in Figure 2.2 A on a silicon template was hot embossed
into the PGMAMMA plates at 92 oC. Top plates containing four holes for reservoirs
were fabricated using the laser engraving system. Top and bottom plates were
assembled together, then clamped tightly and placed in an HP 5890 gas
chromatograph oven to perform thermal bonding at 68 oC after immobilizing the
ATRP initiator on the contacting surfaces as described in the next section.
3.2.4 Immobilization of ATRP Initiator
Before anchoring the ATRP initiator, the surfaces of the top and bottom plates
were activated using an air plasma to produce oxygen-containing functionalities, such
as hydroxyl and carboxyl groups. The activated plates were immediately immersed in
a 5:1 (v/v) heptane/THF solution containing 25 mM 2-bromoisobutyryl bromide and
27.5 mM pyridine. An Erlenmeyer flask storing the reaction mixture was sealed with
a rubber stopper and placed on a MaxQ 2000 shaker (Barnstead International, IA) at
room temperature for 6 h. Then, the plates were removed, washed with IPA and
deionized water, and dried with nitrogen gas.
3.2.5 In-Channel ATRP
After the top and bottom plates of a device were bonded together as described
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in Section 3.2.3, the surface of the microchannel was grafted with a PEG-containing
layer using an in-channel ATRP technique. The complete procedure was carried out in
a nitrogen-filled glove box. Initially, a brown aqueous solution (10 mL) containing
20% PEGMEMA 475 (v/v), 18 mM CuCl, 5.4 mM CuBr2, and 46.8 mM
2,2’-dipyridyl was prepared and mixed thoroughly using a magnetic stirrer. After all
catalyst and ligand were dissolved, the solution was diluted five-fold by adding
nitrogen-purged deionized water and then filtered through a 0.2 m syringe filter.
After the fittings and microchip were assembled, the final 4% PEGMEMA solution
was withdrawn into a 3 mL syringe and pushed into the initiator-bound microchannel
at room temperature from the end reservoir of the separation channel at 0.5 L/min.
Then the microchannel was flushed with deionized water to remove the unreacted
monomer and residual catalyst and ligand.
3.2.6 Electroosmotic Flow Measurement
The current monitoring approach was employed to measure any EOF that
could be generated by the PEG-grafted PGMAMMA microchannel.5 Briefly, the
separation microchannel and one reservoir were filled with 20 mM Tris-HCl buffer
(pH 8.5), and the other reservoir was filled with 10 mM Tris-HCl buffer (pH 8.5) to
the same level. A voltage (1000 V) was then immediately applied across the
microchannel using a PS-350 high-voltage supply unit (Stanford Research Systems,
Sunnyvale, CA). Current variation was recorded using a PCI-1200 data acquisition
system (National Instruments, Austin, TX) and a LabView 6i software program
(National Instruments).
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3.2.7 X-ray Photoelectron Spectroscopy (XPS)
X-ray photoelectron spectroscopy (XPS) was employed to investigate the
ATRP initiator-anchored PGMAMMA surface using an SSX-100 X-ray photoelectron
spectrometer with a monochromatic Al K source and a hemispherical analyzer. An
electron flood gun was utilized to perform a survey scan because the sample was an
insulator. Data were recorded and processed using the instrument software (ESCA NT
3.0).
3.2.8 CE Separation of Amino Acids, Peptides and Proteins
The in-channel ATRP modified polymer microchips were employed to
separate various mixtures of amino acids, peptides and proteins. The voltages applied
to the reservoirs for both injection and separation are shown in Figures 2.2 B and C,
respectively. The laser induced fluorescence (LIF) detection system and data
acquisition system used in this study were described previously.5 The sampling
frequency was 100 Hz. Pinched injection was used for sample injection.

3.3

Results and Discussion

3.3.1 In-channel ATRP Modification
Surface-initiated ATRP has proven to be an effective method to modify
PMMA and PGMAMMA microchannel surfaces.1,5 PEG-functionalized groups were
grafted using this technique to suppress electroosmotic flow and to resist protein
adsorption. The resultant microchips provided highly efficient separations of peptides
and proteins. During the fabrication of these microchips, ATRP grafting was
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performed on the surfaces of top and bottom plates before thermally bonding them
together to form the enclosed microchannels. Unfortunately, some of these bonded
PEG-grafted microchips only survived several hours, delaminating spontaneously
during use. This was due to the weak bonding strength of the PEG-functionalized
surfaces. The grafted layer contained short PEG side chains (~8 ethylene glycol units)
which could not interact or entangle sufficiently during thermal bonding to provide
good adhesion. This problem is magnified by the fact that polymers of relatively low
molecular weight are typically formed in aqueous solution using the ATRP method.6
Furthermore, the underlying substrate surface polymers were prevented from
interacting because of the more hydrophilic PEG-functionalized surface layer. It was
found in this study that the PGMAMMA plates after immobilization of only the ATRP
initiator bonded together strongly, similar to untreated PGMAMMA, producing much
more robust devices than obtained in the previous study.
The modification procedure reported here is notably different from the
reported TPE modification procedure.3 I anchored the initiator on the total surfaces of
both plates before bonding them together to form the enclosed microchannel, instead
of bonding before introducing initiator into the channels. In this way, the reaction was
faster and more efficient, which avoided swelling and deforming of the microchannel.
Furthermore, clogging of the microchannel by precipitate generated in the reagent
solution was avoided. Figure 3.1 shows an XPS spectrum of the initiator anchored
polymer surface, in which the Br peaks are clearly visible. After thermal bonding of
the plates, an aqueous solution containing monomer (PEGMEMA), catalyst and
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Figure 3.1. XPS survey scan spectrum of a PGMAMMA surface bound with ATRP
initiator. The binding energies of O 1s, C 1s, Br 3s, Br 3p and Br 3d are 525.9 eV,
278.7 eV, 250.7 eV, 176.8 eV, and 63.9 eV, respectively.
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ligand, prepared in an oxygen-free environment, was pumped into the microchannels
to perform the in-channel ATRP modification. To avoid blocking of the channel, the
monomer solution was diluted to approximately 4% PEGMEMA. In addition, the
microchips were placed face down in order to drain solution out of the channels to
prevent crystallization of the catalyst or excess polymerization in the microchannels
around the reservoirs.
To evaluate the extent of in-channel ATRP modification, EOF measurements
after modification were made as listed in Table 3.1. The grafted PEG layer not only
resisted protein adsorption, but also reduced the EOF from 3.5×10-4 cm2/V·s for
untreated PGMAMMA microchips1 to 6.6×10-5 cm2/V·s after 24 h reaction time. This
EOF was significantly lower than observed for untreated PMMA (1.6×10-4 cm2/V·s),5
but was higher than measured for in-channel ATRP modified TPE microchannels
(~1.0×10-5 cm2/V·s),3 as well as for PGMAMMA (~2.6×10-5 cm2/V·s),1 and PMMA
(~1.0×10-5 cm2/V·s)5 microchannels modified using the ATRP method before bonding
the cover plates to the microfluidic devices. Even though the EOF is higher, the
in-channel ATRP method is preferred over ATRP reaction before bonding because the
microfluidic chips are more robust.
3.3.2 CE Separations of Amino Acids, Peptides and Proteins
Figure 3.2 shows a CE separation of five FITC-labeled amino acids using an
in-channel ATRP modified PGMAMMA microchip. The column efficiency of the
completely resolved glycine peak was ~1.8×104 plates for the 3.5 cm separation
channel, which was approximately four times that obtained with PEG-grafted TPE
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Table 3.1. Electroosmotic flow measurements for PGMAMMA microchannels
modified by in-channel ATRP for different times. a, b
Modification time (h)

EO mobility (cm2/V·s)

6

(1.9±0.3)×10-4

12

(9.4±0.7)×10-5

24

(6.6±1.7)×10-5

a

Data were calculated from three consecutive measurements.

b

CL% = 95%.
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Figure 3.2. CE separation of five FITC-labeled amino acids. Injection voltage was
600 V and separation voltage was 2000 V. Peak identifications: (1) aspartic acid, (2)
glutamic acid, (3) glycine, (4) asparagine, (5) phenylalanine, and (6) FITC.
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microdevices.3 Figure 3.3 A shows CE separations of four FITC-labeled peptides
using an in-channel PEG-grafted PGMAMMA microchip for different applied electric
field strengths. With an increase in electric field strength from 375 to 1000 V/cm, the
separation time decreased from 75 to 22 s. Figure 3.3 B shows a plot of total
theoretical plates as a function of field strength for each peak in Figure 3.3 A. In
general, column efficiencies increased with an increase in electric field strength.
Approximately 4.0×104 plates for the 3.5 cm separation channel were obtained for GY
at 1000 V/cm electric field. A high electric field resulted in fast separation as well as a
gain in efficiency. Figure 3.4 shows a separation of five FITC-labeled peptides.
Theoretical plate measurements of four of the peaks are listed in Table 3.2, which
were all over 1.4×104 plates for the 3.5 cm separation channel, or one order of
magnitude greater than that obtained with PEG-grafted TPE microdevices.3
Figure 3.5 A is an electropherogram of FITC-labeled HSA using an in-channel
ATRP modified microdevice. In addition to the main component, three other minor
components were resolved, which is consistent with previous results.1 The main peak
gave an efficiency of 1.9×104 plates. An electropherogram of FITC-labeled insulin
(Figure 3.5 B) shows five peaks, which again agrees with a previously reported
separation.5 These peaks most likely result from the FITC labeling reaction,
producing multiple FITC tags or labeled peptide decomposition products. The
theoretical plate measurements of the three major peaks are listed in Table 3.2. The
first two peaks gave efficiencies over 1.0×104 plates. Figure 3.5 C shows a separation
of four standard proteins. A high efficiency of 7.1×104 plates was obtained for
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A

B

Figure 3.3. (A) CE separation of four FITC-labeled peptides at different applied
electric field strengths (given in figure) and (B) theoretical plates versus applied
electric field strength for the peptide separations shown in Figure 3.3 A. Legend: 1.
GY (●), 2. FGGF (■), 3. WMDG (▲), 4. FFYR (◆).
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Figure 3.4. CE separation of five FITC-labeled peptides. Injection voltage was 600 V
and separation voltage was 3000 V. Peak identifications: (1) GY; (2) FGGF; (3)
WMDG; (4) FFYR; (5) Ang III.
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Table 3.2. Theoretical plate measurements of peaks numbered in Figures 3.4, 3.5 B
and 3.5 C.
Peak No.
Figure
1

2

3

4

3.4

1.5×104

2.4×104

1.7×104

1.5×104

3.5 B

1.2×104

1.0×104

5.8×103

--

3.5 C

3.9×104

7.1×104

2.3×104

9.8×103
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A

B

C

Figure 3.5. CE separations of (A) FITC-HSA, (B) FITC-insulin, and (C) FITC-labeled
protein mixture. Injection voltage was 800 V and separation voltage was 3000 V. Peak
identifications in electrophoregram C: (1) -lactoglobulin A; (2) thyroglobulin; (3)
myoglobin; and (4) -casein.
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thyroglobulin. All of these protein separations gave efficiencies approximately one
order of magnitude higher than polyacrylamide grafted PDMS microchips modified
using the ATRP technique.2 Moreover, most of the peaks were symmetrical, which
indicates that there was little protein adsorption on the microchannel surface. Figure
3.6 shows a separation of FITC-labeled -casein tryptic digest.
FITC-labeled -lactoglobulin A was used to evaluate the repeatability and
stability of the PEG grafted microchip devices. Figure 3.7 shows four
electropherograms of -lactoglobulin A chosen randomly from more than 200
sequential CE runs over a 2-wk period using a single PEG-grafted PGMAMMA
microchip. No degradation of performance was observed over this 2-wk period. The
migration times and efficiencies of the peaks are given in Table 3.3. The relative
standard deviations (RSD) for migration time and efficiency were 1.4 and 3.3%,
respectively. These results demonstrate that the PEG layer grafted on the
PGMAMMA microchannel surface using in-channel ATRP is homogeneous and
stable. Furthermore, microchips modified using in-channel ATRP have bonding
strength similar to untreated microchips, and can last for at least several hundred CE
runs and several weeks.

3.4

Conclusions
In-channel ATRP was successfully employed to graft a PEG-functionalized

layer on a PGMAMMA microchannel surface without compromising the bonding
strength. The resultant microchips had low EOF and resisted protein adsorption.
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Figure 3.6. CE separations of FITC-labeled -casein tryptic digest. Injection voltage
was 800 V and separation voltage was 3000 V.
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A

B

C

D

Figure 3.7. CE separation of FITC-labeled -lactoglobulin A. Electropherograms were
recorded for four different runs. Injection and separation voltages were 800 V and
3000 V, respectively.
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Table 3.3. Repeatabilities of migration times and theoretical plate measurements of
-lactoglobulin A from electropherograms in Figure 3.7.
Electropherograms
Mean

RSD (%)

13.83

13.58

1.4

3.3×104

3.4×104

3.3

A

B

C

D

tm (s)

13.57

13.50

13.40

Total plates

3.5×104

3.5×104

3.4×104

137

Rapid CE separations of amino acids, peptides and proteins with good reproducibility
were obtained. Compared with previously reported in-channel ATRP modified TPE
and PDMS microchips, PGMAMMA microchips gave higher efficiencies in CE
separations, indicating that the in-channel grafted PEG-functionalized layer on the
PGMAMMA surface was more dense and uniform. Compared with PGMAMMA
microchips modified using the previously reported ATRP method, microchips
modified using the in-channel ATRP technique showed better long-term stability. This
technique should be applicable to PMMA and other commercial polymer microchips.
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4

INHERENTLY INERT POLY(ETHYLENE GLYCOL)FUNCTIONALIZED POLYMERIC MICROCHIPS FOR CAPILLARY
ELECTROPHORESIS

4.1

Introduction
Among the surface modification techniques, dynamic adsorption is usually not

reproducible or durable. Dynamic surface modifiers can also interfere with mass
spectrometric detection. On the other hand, permanent surface modification often
involves multi-step physical/chemical processing. Obviously, the solution to all
problems encountered in surface modification is to prepare new polymeric materials
with inherent analyte resistance and good physical properties that are desirable for
microfabrication. Microfluidic devices made from such materials could be directly
used for separation without any surface modification.
Recently, Kim et al.1 fabricated PEG micro/nanochannels using UV light
induced photopolymerization of PEG-functionalized crosslinkers. The microfluidic
devices were non-biofouling and irreversibly bonded. Liu et al.2 used a similar
method to fabricate PEG-functionalized polymer microchips. A monomer mixture
containing poly(ethylene glycol) diacrylate (PEGDA), poly(ethylene glycol) methyl
ether methacrylate (PEGMEMA) and MMA was introduced into a microchip form
constructed from a silica template and a glass slide. Exposure to UV light for a
specific period of time initiated polymerization and imprinting of a patterned
prepolymer plate. Another plate with reservoirs was prepared using the same
procedure. The two plates were assembled together and exposed to UV light again to
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complete the polymerization and chemical bonding of the plates together. The
resulting microchips were directly used for separation of peptides and proteins
without surface modification.
In this work, I investigated the effect of monomer composition on microchip
CE performance, including the purity of the PEGDA crosslinker and the addition of
MMA as a co-monomer. CE separations of various small molecules, peptides and
proteins were evaluated using the improved microchips. Chiral separation was also
explored by introducing -cyclodextrin (-CD) into the running buffer as a chiral
selector.

4.2

Experimental Section

4.2.1 Materials
Poly(ethylene glycol) diacrylate (PEGDA, MW~258), poly(ethylene glycol)
methyl ether methacrylate (PEGMEMA, MW~1100), methyl methacrylate (MMA,
99%), 2,2’-dimethoxy-2-phenylacetophenone (DMPA), and-cyclodextrin hydrate
(-CD) were purchased from Aldrich (Milwaukee, WI, USA). Sodium carbonate
(Na2CO3) and anhydrous Na2SO4 were obtained from Fisher Scientific (Fair Lawn, NJ,
USA). Dichloromethane was purchased from Mallinckrodt (Hazelwood, MO),
fluorescein was purchased from Fluka (Buchs, Switzerland), and fluorescein
isothiocyanate (FITC) was purchased from Invitrogen (Carlsbad, CA, USA).
D,L-aspartic acid (D,L-Asp), D,L-glutamic acid (D,L-Glu), D,L-phenylalanine
(D,L-Phe), D,L-asparagine (D,L-Asn), D,L-serine (D,L-Ser), D,L-leucine (D,L-Leu)
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and glycine were purchased from ICN Biomedicals (Aurora, OH). D,L-tryptophan
(D,L-Trp) was obtained from Matheson, Coleman & Bell (Norwood, OH). Dimethyl
sulfoxide (DMSO, 99.5%), phenylmethanesulfonyl fluoride,
tris(hydroxymethyl)aminomethane (TRIZMA, Tris), D-Asp, D-Glu, D-Asn, D-Gln,
D-Phe, D-histidine (D-His), D-arginine (D-Arg), D-proline (D-Pro), L-Asp, L-Glu,
L-Asn, L-Gln, L-Phe, L-His, L-Arg, L-Pro, Glu-Val-Phe, D-Leu-Gly, Phe-Phe,
β-lactoglobulin A, and lysozyme were purchased from Sigma (St. Louis, MO, USA).
A protein mixture was extracted from Escherichia coli (E. coli). The E. coli
DH5  cells were cultivated in Luria-Bertani medium at 37 oC until the optical
density at 600 nm reached 1.0. The cells were harvested by centrifugation at 4000 rpm
and then washed with 50 mL prechilled PBS buffer (10 mM, pH 8.5) twice. After the
cells were suspended in PBS buffer, lysozyme and phenylmethanesulfonyl fluoride
were added to a final concentration of 1 mg/mL and 1 mM, respectively. The cell
suspension was sonicated for 20 min. Then the cell debris was removed by
centrifugation at 12,000 rpm to obtain a cell-free protein mixture. All processes were
conducted at 4 oC. The total protein concentration in the mixture was approximately
1.0 mg/mL as measured by the Bradford assay.
Deionized water (18.2 MΩ·cm) was prepared using a Milli-Q UF Plus water
purification system (Millipore, Billerica, MA, USA). Buffer solutions included 10
mM Tris-HCl (pH 8.3), 10 mM carbonate buffers (pH 9.2, pH 10 and pH 11), and 10
mM Tris-HCl buffer containing 1 mM -CD (pH 8.3), which were filtered using 0.2
m syringe filters (Pall Gelman Laboratory, Ann Arbor, MI, USA) before use.
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Pre-cleaned microscope slides with dimensions of 75 × 50 × 1 mm3 and 75 × 25 × 1
mm3 were obtained from Fisher Scientific (Pittsburgh, PA, USA) and Hardy
Diagnostics (Santa Maria, CA, USA), respectively. Unless specifically noted, all
chemicals were used as purchased without further purification.
4.2.2

FITC Labeling of Amino Acids, Peptides and Proteins
All amino acid, peptide and protein samples were labeled with FITC for laser

induced fluorescence detection (LIF).3 Each sample was dissolved in 10 mM
carbonate buffer solution (pH 9.2) to form 3 mM (amino acids), 2 mM (peptides), or 1
mg/mL (proteins) concentrations. A 6 mM FITC solution was prepared in DMSO. For
amino acids, a 600 µL volume of sample solution was thoroughly mixed with 200 µL
of FITC solution; for peptides, a 200 L volume of solution was mixed with 50 L of
FITC solution; and for proteins, a 600 L volume of solution was mixed with 40 L
of FITC solution. All solutions were allowed to react in the dark for at least 24 h at
room temperature and then stored at 4 oC. All FITC-tagged samples were diluted with
10 mM Tris-HCl buffer (pH 8.3) before use.
4.2.3

Purification of PEGDA 258
Typically, monomers should be purified before polymerization in order to

remove impurities and any inhibitors. In this work, only the crosslinker, PEGDA 258,
was purified before use because it was the major monomer. The purification
procedure was reported previously.2 In brief, PEGDA (50 mL) was washed with
aqueous saturated Na2CO3 solution (30 mL) three times to remove the acidic
impurities and inhibitor. Then the Na2CO3 residue was removed by thoroughly rinsing
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with deionized water (50 mL). Dichloromethane (50 mL) was used to extract PEGDA
258 from the aqueous phase twice. The dichloromethane extracts were combined
together and desiccated with anhydrous Na2SO4. Finally, the dichloromethane solvent
was removed using a rotary evaporator after filtering through a filter paper (0.2-m
pore size).
4.2.4

Fabrication of Microchips
The PEG-functionalized microchips were fabricated by casting as reported

previously.2 In brief, two plate glass forms were assembled. One was used to fabricate
the top plate, for which four PDMS posts served as reservoir molds. The other was
used to fabricate the bottom plate. A silicon wafer containing a typical cross pattern
was used as template to form the microchannels. The thickness of the final polymer
plates depended on the PDMS spacers. Monomer solution was introduced into the
forms and the assemblies were placed under a Dymax 5000AS UV curing lamp
(Torrington, CT) for 10-15 s for photopolymerization. The ingredients in the
monomer solution included PEGDA 258, PEGMEMA 1100 and MMA (Table 4.1).
The resultant incompletely polymerized plates were assembled together and placed
again under the UV light for 5 s to complete the polymerization and covalently bond
the plates together. Careful control of the polymerization times was necessary to avoid
blocking the enclosed microchannels. After bonding, the microchips were
immediately pressed under a weight for 10 min to release stress and heat, and flatten
the microchips.
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Table 4.1. Ingredients of monomer solutions for fabrication of three different
microchips.
Microchip

PEGDA 258

PEGMEMA 1100

MMA

DMPA*

A

85% (purified)

15%

0%

0.1%

B

85% (purified)

12%

3%

0.1%

C

85% (impure)

12%

3%

0.1%

*

DMPA content is given as a weight percentage of the total amount of monomers.
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4.2.5 Scanning Electron Microscopy (SEM)
The microchannel cross sectional shape was observed using SEM. To avoid
damaging the microchannel when exposing it for SEM analysis, a CO2 laser
(Universal Laser Systems, Scottsdale, AZ) was used to cut the polymeric plates on
both sides of the channel, but not into the channel. This was followed by breaking the
microchip by hand to make a smooth cross section. SEM images were taken using an
FEI Philips XL30 ESEM FEG (Hillsboro, OR).
4.2.6 CE Separations
Microchips were used to separate fluorescent dyes, amino acids, peptides and
proteins. Laser induced fluorescence (LIF) detection and data acquisition system were
used as previously reported.4 The voltage scheme for injection and separation is
illustrated in Figure 2.2. During injection (Figure 2.2 B), reservoirs 1, 3, and 4 were
grounded, and +0.6 kV were applied at reservoir 2. During separation (Figure 2.2 C),
reservoirs 1 and 2 were maintained at +0.6 kV, reservoir 3 was grounded, and
reservoir 4 was set at +2.0 kV.

4.3

Results and Discussion

4.3.1

Fabrication of PEG-Functionalized Microchips
The PEG-functionalized microchips were fabricated by casting. The procedure

was simple and easy, and the fabrication was fast. The top and bottom plates were
photopolymerized in two molds.2 The thickness of the plates depended on the mold
dimensions. In this work, approximately 400 m thick plates were fabricated, and
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they possessed excellent mechanical strength. During fabrication, the most important
concern was to control the extent of polymerization. Usually, only 15 s were required
to polymerize a fresh monomer solution to form plates with the desired degree of
polymerization. It was important to stop the initial polymerization step before the
plates were completely polymerized so that they could be covalently bonded together
by subsequent UV light exposure. If the UV exposure time was too long, the plates
over-polymerized and deformed. If the reaction time was too short, the plates were
soft and difficult to handle. In addition, unsolidified monomer solution on the surfaces
could flow into the microchannels during bonding of the plates together, causing
blockage. A major advantage of this method is the ease and strength of covalent
bonding of the plates, which was effected by reaction between the partially
polymerized liquid layers on the top and bottom plate surfaces. Figure 4.1 shows
SEM images of two final microchannel cross-sections. In Figure 4.1 A, the two plates
were bonded together very well and the microchannel had a good shape. However, in
Figure 4.1 B, the partially polymerized top plate was a little too hard, which left a
small groove between the two plates after bonding. Obviously, such a groove would
impact the separation performance. In both cases the plates were seamlessly bonded
together.
PEG-funtionalized acrylates were used as the major components in the
monomer solutions to provide protein adsorption resistant characteristics. In the
previous work,2 a small amount of MMA was added to increase the material
mechanical strength (microchip B listed in Table 4.1). However, it was suspected that
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A

B

Figure 4.1. SEM images of microchannel cross sections. (A) Microchannel with a
good shape, and (B) microchannel with a groove defect.
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the presence of MMA could affect the performance of the microchips. In this study, I
fabricated a microchip without MMA (microchip A), with ingredients as listed in
Table 4.1. Polymerization of this microchip only required ~10 s to achieve the desired
prepolymerized plates. The PEG-functionalized acrylate monomers were more
reactive than MMA. Another microchip made with impure PEGDA (microchip C in
Table 4.1) was also fabricated to study the influence of crosslinker purity on
separation performance.
4.3.2 CE Separation of Fluorescent Dyes
The PEG-functionalized microchips were able to separate both small
molecules and macromolecules. Figure 4.2 shows the separation of fluorescein and
FITC at different pH values using microchip B. With an increase in pH, the migration
times decreased. This is expected since fluorescein and FITC are weak acids.
Fluorescein has a pKa of 6.35 and FITC is a fluorescein derivative (pKa 6.9),6 with an
isothiocyanate group replacing a hydrogen atom on a benzene ring. Therefore, in a
basic environment, both are negatively charged. Separation efficiency measurements
of each peak in Figure 4.2 are listed in Table 4.2. While all efficiency measurements
were higher than 1.0 × 104 plates for the 3.5 cm long microchannel, they were higher
at higher pH values. At pH 11, the efficiency of fluorescein reached 2.6 × 104 plates.
4.3.3 CE Separation of Amino Acids
Figure 4.3 shows separations of 6 amino acids using three different microchips
under the same conditions. With microchip A made from purified PEGDA and
PEGMEMA, all of the amino acids were almost completely resolved (Figure 4.3 A).
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Figure 4.2. CE separations of fluorescein (peak 1) and FITC (peak 2) at different pH
values using microchip B (Table 4.1). Injection voltage was 600 V and separation
voltage was 2000 V.
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Table 4.2. Efficiencies of fluorescein and FITC peaks in Figure 4.2.
pH 8.3

pH 9.2

pH 10

pH 11

Total plates*

1.4 × 104

2.5 × 104

2.6 × 104

2.6 × 104

RSD*

8.3%

0.5%

0.8%

11%

Total plates*

1.1 × 104

1.7 × 104

1.9 × 104

1.9 × 104

RSD*

7.3%

5.8%

4.8%

2.9%

Fluorescein

FITC

*

Data were calculated from three consecutive runs.
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In addition, this microchip provided the highest efficiency. The theoretical plates
measured for each peak in Figure 4.3 A are listed in Table 4.3. The efficiency of
FITC-Asp was 4.2 × 104 plates for the 3.5 cm long microchannel.
Figure 4.3 B shows the separation of amino acids using microchip B, which
was synthesized with 3% MMA. Compared with Figure 4.3 A, the migration times of
the corresponding amino acids are similar, however, all peak widths are broader and
the first 5 peaks are not well resolved. When impure PEGDA is used in the fabrication
of microchips (microchip C in Table 4.1), not only are the efficiency and resolution
lower, but also analytes migrate slower in the microchannel (Figure 4.3 C). The
migration times and efficiencies of the sixth peak (FITC-Arg) for the three microchips
are listed in Table 4.4. The migration times for microchips A and B are almost the
same, however, the efficiency for microchip A is nearly 4 times that of microchip B.
On the other hand, the efficiencies of microchips B and C are similar, but the
migration times for microchip C are longer than microchip B. These results
demonstrate that MMA mainly impacts separation efficiency, while PEGDA purity
affects migration time. Both MMA and impurities in PEGDA change the polymer
surface properties. Addition of a small amount of MMA in the polymer increases
analyte adsorption on the surface and, therefore, decreases separation efficiency and
resolution. Impurities present in the original PEGDA (such as carboxylic acids)
greatly increase electroosmotic flow (EOF), which is in the opposite direction to
electrophoresis migration and, therefore, reduces analyte migration speed in the
channel.
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Figure 4.3. CE separations of 6 amino acids using three different microchips (Table
4.1). Injection voltage was 600 V and separation voltage was 2000 V. Peak
identifications: (1) FITC-Asp, (2) FITC-Glu, (3) FITC-Gly, (4) FITC-Asn, (5)
FITC-Phe, and (6) FITC-Arg.
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Table 4.3. Efficiencies of amino acid peaks in Figure 4.3 A.
1

2

3

Total plates*

4.2 × 104

4.1 × 10

3.5 × 10

3.4 × 10

RSD*

2.5%

4.2%

4.9%

11%

4

4
4

5
4

6
4

3.3 × 10

2.4 × 10

10%

6.2%

4

*

Data were calculated from three consecutive runs.
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Table 4.4. Migration times and efficiencies of peak 6 in Figure 4.3.
Microchip
A

B

C

Mean*

37.8

37.6

55.2

RSD*

3.2%

0.8%

0.8%

Mean*

2.4 × 104

6.3 × 103

5.8 × 103

RSD*

6.2%

4.4%

0.8%

tm (s)

Total plates

*

Data were calculated from three consecutive runs.
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4.3.4 CE Separation of Peptides and Proteins
Peptides were also used to evaluate the separation performance of these
different microchips. Table 4.5 lists the migration times and efficiencies of 3 peptide
peaks separated using the different microchips under the same separation conditions.
Similar to the separation of amino acids, microchip A provided the best separation
efficiency (see Figure 4.4). The analytes migrated in microchip B at similar rates to
those in microchip A, however, the peak efficiencies were lower. For example, the
efficiency of the first peak (FITC-Glu-Val-Phe) for microchip A was approximately 5
times that for microchip B. For microchip C, the peptide samples migrated slower
than in the other two microchips. However, the peak efficiencies were similar to those
measured for microchip B.
Electropherograms of FITC--lactoglobulin A separated using microchips A
and B are illustrated in Figure 4.5. Migration times and theoretical plates for both
peaks are listed in Table 4.6. Although this protein migrates at similar velocities, the
efficiency obtained using microchip A is nearly 4 times that achieved using microchip
B (i.e., 3.2 ×104 plates for a 3.5 cm long channel). When the performance of
microchip C was evaluated for this protein, the peak was very broad and tailing, the
signal was low and the baseline drifted. Figure 4.6 shows a separation of many E. coli
proteins using microchip A.
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Table 4.5. Migration times and efficiencies of 3 peptide peaks separated using three
different microchips (Table 4.1) under the same conditions as described in Figure 4.4.
Microchip
Peak No.
A

B

C

tm (s)

22.4

21.6

29.0

Total plates

3.8 × 104

7.6 × 103

7.9 × 103

tm (s)

24.8

24.6

34.4

Total plates

3.3 × 104

7.6 ×103

7.4 ×103

tm (s)

26.2

26.1

37.1

Total plates

1.7 ×103

7.1 ×103

6.9 ×103

1

2

3
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Figure 4.4. CE separation of 3 peptides using microchip A (Table 4.1). Injection
voltage was 600 V and separation voltage was 2000 V. Peak identifications: (1)
FITC-Glu-Val-Phe, (2) FITC-D-Leu-Gly, (3) FITC-Phe-Phe.

157

Figure 4.5. CE of FITC--lactoglobulin A using two different microchips (Table 4.1).
Injection voltage was 600 V and separation voltage was 2000 V.
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Table 4.6. Migration times and efficiencies of peaks in Figure 4.5.
Peak

Figure 4.5 A

Figure 4.5 B

tm (s)

21.4

21.8

Total plates

3.2 ×104

8.3 ×103
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Figure 4.6. CE separation of FITC labeled E. coli proteins using microchip A (Table
4.1). Injection voltage was 600 V and separation voltage was 2000 V.
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4.3.5 CE Chiral Separation of Amino Acids
During the past decade, microchip CE was studied for enantiomer separations
by addition of a chiral selector in the operating buffer.7-10 Cyclodextrins (CDs) are the
most frequently used chiral selectors in CE.11 CDs are cyclic oligosaccharides, which
contain six (-CD), seven (-CD), or eight (-CD) glucopyranose units. CDs possess
a hydrophilic surface with hydroxyl groups and a truncated cone with a hydrophobic
cavity. Chiral recognition is based on inclusion of the bulky hydrophobic group of an
analyte in the hydrophobic cavity of the CD.
In this study, -CD was added as a chiral selector to the Tris-HCl buffer. First,
I studied the influence of this additive on separation performance. Figure 4.7 shows
CE elution of FITC-D-Asp using microchip A in 10 mM Tris-HCl (pH 8.3) buffer
containing 1 mM -CD (Figure 4.7 A) and buffer without -CD (Figure 4.7 B). The
migration times and efficiencies of the first peaks (FITC-D-Asp) are listed in Table
4.7. The addition of -CD resulted in slow migration in the channel and broad peaks.
When an analyte interacts with -CD, the mobility of the analyte decreases because
-CD is a large neutral molecule. It was reported that -CD is a better selector because
the cavity diameter of -CD is suitable for FITC-tagged amino acids.7 The -CD
cavity is so small that the interaction between the analyte and -CD is weak.
Therefore, the whole -CD-analyte complex is not sufficiently stable, which
definitely leads to broad peaks and low separation efficiency. CE elution performed in
buffer without -CD gave 6 times higher efficiency.
I evaluated the chiral separation performance of 10 different D,L-amino acids.
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Figure 4.7. CE elution of FITC-D-Asp using microchip A (Table 4.1). (A) 10 mM Tris
buffer (pH 8.3) containing 1 mM -CD and (B) 10 mM Tris buffer (pH 8.3). Injection
voltage was 600 V and separation voltage was 2000 V.
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Table 4.7. Migration times and efficiencies of D-Asp peaks in Figure 4.7.
Peak

Figure 4.7 A

Figure 4.7 B

tm (s)

29.21

19.66

Total plates

2.3 ×103

1.4 ×104
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Figure 4.8 shows CE separations of FITC-labeled D,L-Asn (Figure 4.8 A) and Leu
(Figure 4.8 B). The separation selectivities () for Asn and Leu enantiomers were
1.08 and 1.16, respectively, where  is defined as the ratio of electrophoretic
mobilities (). When EOF is negligible (such as in PEG-functionalized microchips), 
approximately equals the ratio of migration times. The resolution values for Asn and
Leu enantiomer peaks were 1.13 and 1.64, respectively. Because the composition ratio
of the enantiomeric mixture was 1:1, both peaks have approximately equal peak areas.
The selectivities and resolution values of the other amino acids are listed in Table 4.8.
Except for proline, all other amino acids had selectivities larger than 1.06, however,
most resolution values were low due to low peak efficiencies. FITC labeled proline
enantiomers were not separated using our system. The large steric hindrance after
FITC labeling inhibited the interaction between the -CD and analyte to form a stable
host-guest complex. When the R groups of amino acids contain a benzene ring, such
as phenylalanine and tryptophan, the resolution of enantiomers is too low to be
precisely measured.
In this work, I aimed only to demonstrate the feasibility of chiral separation of
FITC-tagged amino acids using the PEG-functionalized microchips. The separations
were not optimized. -CD and other CD derivatives may provide better chiral
separation performance as a result of higher selectivity, resolution and efficiency. In
addition, chiral separation depends on other conditions, such as concentration of CD,
type and concentration of operating buffer, addition of surfactant in the buffer solution,
pH, applied voltage, and operating temperature.
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A

B

Figure 4.8. CE chiral separations of (A) D,L-Asn and (B) D,L-Leu using microchip A
(Table 4.1) in 10 mM Tris buffer (pH 8.3) containing 1 mM -CD. Injection voltage
was 600 V and separation voltage was 2000 V.
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Table 4.8. Selectivity () and resolution (Rs) for chiral separation of D,L-amino acids
using PEG-functionalized microchips with addition of 1 mM -CD in 10 mM Tris
buffer (pH 8.3).


Rs

Mean

RSD

Mean

RSD

D,L – Asp

1.11

0.4%

1.05

6.5%

D,L – Glu

1.11

0.2%

0.89

5.4%

D,L – Asn

1.08

0.2%

1.13

3.4%

D,L – Gln

1.10

0.2%

0.87

3.1%

D,L – Leu

1.16

0.3%

1.64

0.8%

D,L – His

1.07

0.1%

0.77

5.0%

D,L – Ser

1.06

0.3%

0.89

4.2%

D,L – Phe

1.06

0.4%

--

--

D,L – Trp

1.06

0.7%

--

--

D,L – Pro

1.00

--

--

--
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4.4

Conclusions
A PEG-functionalized microchip was fabricated to separate small molecules

(fluorescent dyes and amino acids), peptides and proteins without surface
modification. I studied the influence of monomer type and purity on CE separation
performance. Impurities in the PEGDA monomer induced undesirable EOF, which
increased analyte migration time. Addition of a small amount of MMA increased the
analyte adsorption on the surface, which decreased separation efficiency. Chiral
separations of FITC-labeled amino acids were demonstrated by adding -CD to the
running buffer as a chiral selector. Chiral selectivity and enantiomer resolution were
reported. Although most enantiomers studied were separated, the conditions could be
optimized to improve the separation performance, such as using -CD or other CD
derivatives as chiral selectors, optimizing the concentrations of chiral selector and
buffer solution, and utilizing other additives.
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5

POLY(ETHYLENE GLYCOL)-FUNCTIONALIZED DEVICES FOR
ELECTRIC FIELD GRADIENT FOCUSING *

5.1

Introduction
Electric field gradient focusing (EFGF), a member of the family of

equilibrium gradient focusing techniques,1 depends on an electric field gradient and a
counter-flow to focus, concentrate and separate charged analytes, such as peptides and
proteins.2-6 The constant counter flow is opposite to the electrophoretic force that
drives the analytes. When the electrophoretic velocity of a particular analyte is equal
and opposite to the velocity of the counter flow, the analyte is focused in a narrow
band because at this position its net force is zero. This technique avoids protein
precipitation that often occurs in IEF when proteins reach their isoelectric points. A
major challenge in EFGF is establishment of the desired electric field gradient.
Currently, several methods have been reported to create an electric field gradient,
including the use of a conductive changing cross-sectional area around a separation
channel,2,7-10 a buffer conductivity gradient in a column,11-14 electrodes along a
channel for digital field gradient focusing,15-17 and a temperature gradient along a
column filled with a buffer that has a temperature-dependent conductivity.18-23
Humble et al.8 prepared capillary-based planar devices for analytical scale
EFGF based on the changing cross-sectional area design. The separation channel was
created using a small diameter wire as template to form a channel surrounded by an
ionically conductive acrylic copolymer that freely allowed passage of small ions but
*

This chapter is reproduced with permission from Anal. Chem. 2008, 80, 451-460. Copyright 2008 American

Chemical Society.
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restricted migration of biomacromolecules into the gel. This nanoporous copolymer
was shaped to form a linear electric field gradient by changing the cross-sectional area.
Although the fabrication of these devices was easy and reproducible, limitations
included low peak capacity and low resolution, primarily due to flow dispersion in the
open channel, which was due to (a) the parabolic laminar counterflow profile, (b)
variable  potential along the channel in the changing electric field, and (c) protein
adsorption on the channel wall. Furthermore, the hydrogel could not be chemically
bonded to the PMMA substrate surface.
Recently, Kelly et al.9 miniaturized this capillary-based EFGF device into a
PMMA microchip format, in which a microchannel was imprinted on the bottom plate
and a shaped cavity of changing cross-sectional area was cut into the top plate. The
same ionically conductive copolymer was polymerized in the shaped cavity using
phase-changing sacrificial layers to protect the microchannel. Liu et al.10 used a
different approach to fabricate a micro electric field gradient focusing (EFGF)
device out of poly(glycidyl methacrylate-co-methyl methacrylate). A weir structure
was fabricated between the separation channel and changing cross-section electric
field gradient generating channel. A buffer ion-permeable membrane made from a
poly(ethylene glycol) (PEG)-functionalized copolymer was positioned on the weir to
separate the two microchannels.
In this work, I fabricated changing cross-sectional EFGF devices using
PEG-functionalized polymers. These materials were used to resist protein adsorption
and suppress electroosmotic flow. Another considerable advantage of this approach
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was the ability to covalently bond the hydrogel to the substrate without prior surface
modification. I also incorporated a PEG-functionalized monolith in the EFGF channel
to reduce analyte band dispersion.

5.2

Experimental Section

5.2.1 Materials and Sample Preparation
Methyl methacrylate (MMA, 99%), 2-hydroxyethyl methacylate (HEMA,
99%+), poly(ethylene glycol) methyl ether methacrylate (PEGMEMA 1100,
MW~1100), poly(ethylene glycol) diacrylate (PEGDA 258, MW ~258),
3-(trimethoxysilyl)propyl methacrylate (98%), 2,2’-dimethoxy-2-phenylacetophenone
(DMPA), and poly(vinyl alcohol) (PVA, 99%+ hydrolyzed, MW ~89,000 – 98,000)
were purchased from Aldrich (Milwaukee, WI). Ethoxylated trimethylolpropane
triacrylate (SR 9035) was obtained from Sartomer (Warrington, PA). Anhydrous
methyl alcohol (MeOH) and hydrochloric acid (HCl, 37%) were purchased from
Mallinckrodt Chemicals (Phillipsburg, NJ). Anhydrous ethyl ether was purchased
from Fisher Scientific (Fair Lawn, NJ). Sodium hydroxide (NaOH) was purchased
from Columbus Chemical Industries (Columbus, WI). Fluorescein isothiocyanate
(FITC), tris(hydroxymethyl)-aminomethane (Trizma, Tris), -lactoglobulin A, and
myoglobin were ordered from Sigma (St. Louis, MO). R-phycoerythrin (R-PE) was
obtained from Polysciences (Warrington, PA). Recombinant, enhanced green
fluorescent protein was purchased from Clontech (Palo Alto, CA). All chemicals were
used as received without further purification.
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Deionized water (18.2 Mcm) was prepared using a Milli-Q UF Plus water
purification system (Millipore, Billerica, MA). Tris-HCl buffers (50 mM and 100 mM,
pH 8.5) were filtered using 0.2-m syringe filters (Pall, East Hills, NY) before
experiments. Precleaned microscope slides with dimensions of 70  50  1 mm3 and
70  25  1 mm3 were obtained from Fisher Scientific (Pittsburgh, PA) and Hardy
Diagnostics (Santa Maria, CA), respectively.
To label -lactoglobulin A and myoglobin, the protein samples were dissolved
in filtered 10 mM sodium bicarbonate buffer (pH 9.2) with a concentration of 1
mg/mL. FITC was dissolved in absolute dimethyl sulfoxide (DMSO) to make a 6 mM
solution. Then the protein solutions (600 L) were thoroughly mixed with 40 L
FITC solution and placed in the dark for at least 2 days at room temperature.24 All
protein samples were diluted with 10 mM Tris (pH 8.5) before use.
5.2.2 Capillary Treatment
Polyimide coated fused silica capillary tubing with 150-m i.d. and 365-m
o.d. was supplied by Polymicro Technologies (Phoenix, AZ). To resist protein
adsorption on the capillary wall and suppress electroosmotic flow, PVA was used to
coat the inner wall surface using an established protocol.25 Briefly, a PVA aqueous
solution (6.5%, w/w) in a vial was pushed through the capillary using pressurized
nitrogen gas for 3 h, after which the vial was removed and the PVA solution still
inside the capillary was slowly pushed out under pressure. The capillary was then
placed in an HP 5890 gas chromatograph oven and heated to 145 oC for 5 h while
being purged with nitrogen gas. Then the above procedure was repeated from the
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other capillary end. After this treatment, PVA became insoluble in water and formed a
smooth coating on the capillary inner surface.
After PVA coating, the polyimide coating outside the capillary near the ends
was removed carefully using a micro-torch or razor blade. The length of the uncoated
capillary ends was 1 cm, and the distance between the two was approximately 16 cm.
The two ends of the capillary were sealed with a rubber septum, and the coiled
capillary was immersed sequentially into acetone, water, 0.2 M NaOH, water, 0.2 M
HCl, water and acetone for 30 min each to clean and activate the uncoated ends. After
being dried in an oven at 120 oC for 1 h, the capillary was placed in a 30%
3-(trimethoxysilyl)propyl methacrylate/acetone solution and put in the dark for 24 h.26
Thus, double bonds were introduced on the uncoated sections so that the hydrogel
could be covalently bonded to the outside surface of the capillary. After reaction, the
capillary was washed with acetone and dried using a stream of nitrogen. Finally, the
treated capillary was cut at the middle of the uncoated and coated parts to make 8 cm
long capillaries, each with one 5 mm end that was covered with bonded acrylic
groups.
5.2.3

Fabrication of EFGF Devices
Based on the changing cross-sectional area design,8 new EFGF devices were

fabricated with PEG-functionalized materials using a casting method.27 The
fabrication procedure is outlined in Figure 5.1. In step A1, a glass form was
assembled from two glass slides and two PDMS spacers. Two small PDMS sheets of
the same height as the PDMS spacers, which would become the reservoir molds, were
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placed at their proper positions and also sandwiched in the form. Then the
PEG-functionalized monomer solution for device synthesis, with the formulation
shown in Table 5.1, was introduced into the form. The assembly was then placed 60
cm below a UV lamp (8 mW/cm2) to initiate polymerization. After UV exposure of 16
s, the assembly was cooled to room temperature immediately. The glass slides were
carefully removed using a razor blade yielding a cover plate with two reservoirs
(Figure 5.1 B1). Because the reaction time was short, the cover plate was only
semi-cured and a thin film of unreacted monomer solution remained on the plate
surface. To fabricate the bottom plate with shaped channel, a glass form was built as
shown in Figure 5.1 A2, which contained a PDMS mold with changing cross-sectional
area in the center of the form. However, the thickness of the spacers was larger than
the shaped mold, which resulted in a space between the top glass slide and the shaped
mold. After introducing the monomer solution into the form, the assembly was
exposed to UV light for 16 s to partially polymerize the solution. A diagram of the
semi-cured bottom plate with shaped channel is shown in Figure 5.1 B2. Following
this synthesis, two PVA coated capillaries threaded together with a Nichrome wire
(120-m i.d.) were placed on the bottom plate at the ends of the shaped channel. The
wire was pulled taut, and the two capillaries were centered at the ends of the shaped
channel with the treated ends positioned in contact with the plastic device (Figure 5.1
A3). The semi-cured cover plate was then placed on top of the shaped plate (Figure
5.1 B3). Any bubbles generated between the two plates were removed with silicon
wafer-handling tweezers. Then the temporarily bonded device was placed 15 cm
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below a UV lamp (50 mW/cm2) and exposed to UV radiation for 5 s. During exposure,
the methacryl and acryl residues on the contacting plate surfaces formed covalent
bonds, which permanently linked them together (Figure 5.1 A4). Because the reaction
was very fast, a stress force usually developed in the bonded copolymer substrate,
which made it deform slightly. To avoid this, the device was sandwiched between two
glass slides immediately after UV exposure and placed under a weight (2.4 kg) for 8
min.
After removing the weight from the top, a hydrogel solution containing 85
wt % SR 9035, 15 wt % 100 mM Tris-HCl buffer (pH 8.5) and DMPA (0.5 wt % of
SR 9035) was carefully introduced into the shaped channel from one reservoir. Care
was taken to avoid bubble generation and to leave the reservoirs empty. Then the
device was exposed to UV light for 1 min to polymerize the PEG-functionalized
hydrogel. After reaction, the wire was withdrawn from the device to form a separation
channel that was surrounded by hydrogel (Figure 5.1 B4). The capillaries were
attached to the separation channel and covalently bonded with hydrogel. The channel
between the two capillaries was 4 cm long.
If no monolith was incorporated in the channel, the device was flushed with 50
mM Tris-HCl buffer (pH 8.5) until focusing experiments were performed. The two
reservoirs were filled with buffer and sealed with flat pieces of PDMS to avoid drying
of the hydrogel.
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Figure 5.1. Fabrication of the PEG-functionalized EFGF device. A1: glass-PDMS
form for fabrication of top plate; B2: pre-polymerized top plate with two reservoirs;
A2: glass-PDMS form for fabrication of bottom plate; B2: pre-polymerized bottom
plate with shaped-channel; A3: assembly of wire-capillary on top of the bottom plate;
B3: assembly of the top plate with the bottom plate; A4: bonding the two plates; B4:
incorporation of hydrogel in the shaped-channel and formation of EFGF channel by
withdrawing the wire.
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5.2.4 Synthesis of a Monolith in the EFGF Channel
A monomer mixture with formulation given in Table 5.1 was prepared by
introducing the photoinitiator, monomer, crosslinker and porogens into a glass vial,
shaking by hand to dissolve the initiator and ultrasonicating for 10 s. Because the
ethyl ether porogen is easy to evaporate, the ultrasonication time was short and the
mixture was prepared before each use. After the EFGF channel was formed, fresh
monolith solution was introduced into the channel using a syringe. After the solution
filled the channel and no bubbles were seen under a microscope, the device was
placed for 8 min perpendicular to a UV dichroic mirror (Navitar, Newport Beach, CA),
which was positioned at 45o directly under the UV curing lamp. The device was then
connected to an HPLC micro pump (Eksigent, Dublin, CA) and flushed with
methanol for 5 h at 0.4 L/min to remove unreacted monomers and porogens,
followed by flushing with 50 mM Tris buffer (pH 8.5) until focusing experiments
were performed.
5.2.5 Scanning Electron Microscopy (SEM) and Pore Size Measurement
The morphologies of the EFGF channels and monoliths were studied using
SEM. Samples were prepared using a CO2 laser (Universal Laser Systems, Scottsdale,
AZ). To avoid melting and deforming the channel and monolith, the device was cut by
the laser from both sides up to the channel, followed by breaking the channel by hand
to make samples that were 5  5 mm2 in size. SEM images were taken using an FEI
Philips XL30 ESEM FEG (Hillsboro, OR).
The pore size distribution of the monolith was investigated using a PMI
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Table 5.1. Ingredients of the PEG-functionalized EFGF substrate, hydrogel and
monolith.
PEGDA 258

PEGMEMA 1100

MMA

DMPA a

Substrate

-(85 wt %)

(12 wt %)

(3 wt %)

SR9035

100 mM Tris, pH 8.5

DMPA a

Hydrogel

(0.1 wt %)

--

--

(85 wt %)

(15 wt %)

(0.5 wt %)

PEGDA 258

HEMA

Methanol

Ethyl ether DMPA a

(22.5 wt %)

(7.5 wt %)

(25 wt %)

(45 wt %)

Monolith

a

(1 wt %)

The content of photoinitiator, DMPA, is given as a weight percentage of the total

amount of monomers.
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capillary flow porometer (Porous Materials, Ithaca, NY). In order for the sample to fit
in the porometer sample chamber, it was prepared in a UV transparent capillary
(75-m i.d., 360-m o.d., Polymicro Technologies, Phoenix, AZ) after the inner
surface was modified with 3-(trimethoxysilyl)propyl methacrylate to immobilize
double bonds for covalently bonding the monolith to the inner wall.26 The
polymerization conditions were the same as in the EFGF channel. After reaction, the
monolith was washed with methanol for 4 h at 1 L/min. Then a wetting liquid,
Galwick, with a surface tension of 15.9 dynes/cm was introduced to fill the monolith
void volume. The sample was placed in the chamber and nitrogen pressure was used
to remove the liquid from the monolith pores. The maximum test pressure was 200
psi.
5.2.6 Operation of the EFGF Devices
Figure 5.2 shows a schematic of the EFGF setup. The buffer used in the
focusing and separation experiments was 50 mM Tris-HCl (pH 8.5), and the test
protein samples were either fluorescently labeled or natively fluorescent when excited
at 488 nm. The sample was introduced into the EFGF separation channel using an
electrokinetic injection method.8 At the beginning of an analysis, the cathode was
placed in a buffer reservoir. During injection, this buffer reservoir was replaced with a
reservoir containing the sample, followed by applying 800 V for 5-30 s. After
injection, the sample reservoir was replaced with the buffer reservoir and voltage was
applied to electrophoretic migration of the analytes. Once the sample was observed
entering the separation channel, the syringe pump was activated to create a
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Figure 5.2. Operational set-up of the EFGF device.

180

hydrodynamic counter flow.
When the proper counter flow and voltage were applied to the device, proteins
could be focused in the separation channel. Changing the counter flow rate or the
applied voltage caused the sample bands to move to new equilibrium positions.
5.2.7 Detection System
The microscope system used for detection and imaging was described
elsewhere.10 In brief, the 488 nm line generated from an Ar ion laser source (Melles
Griot, Carlsbad, CA) was introduced into a TE 2000-U inverted microscope (Nikon,
Tokyo, Japan) through an optical path, which consisted of different optical parts for
imaging or detection. The imaging fluorescence passed through a Z488LP long-pass
filter set (Chroma) and was recorded with a digital camera (Nikon). To carry out point
detection, a beam expander (Special Optics, Wharton, NJ) was used to expand the
laser beam, which was finally focused into a beam spot. Laser-induced fluorescence
was detected using a photomultiplier tube (Bridgewater, NJ) after passing through the
long-pass filter. The signals were amplified and recorded using LabView (National
Instruments, Austin, TX) software. To scan the separation channel, a servomotor was
installed to drive the microscope stage, and the movement was controlled by a
home-built microstepping controller.

5.3

Results and Discussion

5.3.1 EFGF Device Fabrication
Among the previously reported EFGF devices, the capillary-based device with

181

changing cross-sectional area has several advantages, such as ease of fabrication and
operation, and good reproducibility.8 In this work, I still used the wire template
casting method to form the separation channel, and the shaped channel design to
produce a linear electric field gradient. However, different materials were used to
fabricate the EFGF device, including the hydrogel. In addition, devices with
reservoirs and shaped channel were prepared using the casting method (shown in
Figure 5.1).
The body of the device was made from a PEG-functionalized copolymer. PEG
and its derivatives are now widely used as biomaterials because of their hydrophilicity,
biocompatibility, low toxicity and resistance to protein adsorption. The formulation of
the body of the device is listed in Table 5.1 and the structures of the monomers used
in the synthesis are shown in Figure 5.3. The main monomers were
PEG-functionalized acrylate or methacrylate. PEGDA was the crosslinker and
PEGMEMA enhanced the resistance to protein adsorption. A small amount of MMA
was used to increase the mechanical strength. This copolymer was successfully
applied in the fabrication of microchips, which were used for micro capillary
electrophoresis separations of peptides and proteins without further surface
modification due to their natural resistance to protein adsorption.27
Photopolymerization of the copolymer was very fast, usually requiring only
approximately 16 s to prepare the semicured copolymer, which was soft, but solidified.
A thin liquid film remained on the surface, which contained unreacted monomers that
allowed the top and bottom plates to covalently bond together when exposed to UV
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radiation. After bonding, the copolymer was hard, and possessed a variety of
attractive characteristics, including transparency to UV light above 300 nm and
resistance to various organic solvents.27 An advantage of the fabrication method is
that various channel shapes can be made to generate different electric field gradients.
A major fabrication challenge was how to make an ideal conductive
membrane, which was permeable to small buffer ions, but able to retain large
biomolecules. Simultaneously, the membrane should be resistant to protein adsorption
and have no electroosmotic flow (EOF). In a previous device, a considerable amount
of MMA (23 wt %) was used for synthesis of the conductive membrane to increase its
strength and bond it well to the PMMA substrate.8 However, the use of MMA affects
the channel surface characteristics, making it possible to adsorb proteins and induce
unwanted EOF, which disturbs the operation. In this work, I utilized only one
monomer (SR 9035) to prepare the conductive hydrogel. The ingredients listed in
Table 5.1 are fewer compared with those used to synthesize the acrylic copolymer.8
The molecular structure of SR 9035 is shown in Figure 5.3, which indicates that it has
three acrylic groups and a total of 15 ethylene glycol (EG) units. As a result, the
polymerized hydrogel is highly crosslinked, hydrophilic, and resistant to protein
adsorption. During the focusing experiments, no protein adsorption on the channel
surface was observed even when the protein was retained in the channel for more than
8 h. Tris buffer (100 mM, pH 8.5) was added to render the hydrogel conductive. Its
conductivity was measured using a method reported elsewhere.10 Briefly, the hydrogel
monomer solution was introduced into a channel with dimensions of 45 (length) × 5
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(width) × 1.5 (thickness) mm3, which was prepared from the PEG-functionalized
copolymer using the method described above, and then photopolymerized in situ. A
50 mM Tris buffer (pH 8.5) was added to the reservoirs at both ends of the channel. A
voltage of 1000 V was applied along the channel via two electrodes in contact with
the electrolyte solution. The current was recorded using LabView software. The
conductivity of the hydrogel was calculated using the equation

C  LI AV

(5.1)

where C is the conductivity, I is the current, V is the applied voltage, L is the
channel length, and A is the cross-sectional area of the channel. The hydrogel
conductivity was 2.1 × 10-4 S/m. Because the buffer was more dilute than the buffer in
the hydrogel, the current initially decreased with time. When equilibrium was reached,
the conductivity was approximately 5.3 × 10-5 S/m, which was close to the hydrogel
conductivity made from 50 mM Tris buffer (4.1 × 10-5 S/m).
Similar to the bonding of the microfluidic device pieces, the hydrogel was also
covalently bonded to the surface of the cavity. Detachment of hydrogel from the
device was never observed during operation. The hydrogel slab assumed the same
shape as the shaped channel with changing cross-sectional area normal to the
separation channel. The hydrogel was 1.5 mm thick, 18 mm wide at the low field end,
and 1.8 mm wide at the high field end. The separation channel was centered in the
hydrogel from high field side to low field side. Figure 5.4 shows an SEM image of the
open EFGF channel. Its diameter was approximately 120 m, which is consistent with
the diameter of the Ni wire. The inner surface of the channel appeared smooth. These
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Figure 5.4. SEM image of the EFGF open channel.
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observations indicated that no damage occurred to the inner surface of the separation
channel when withdrawing the wire out of the hydrogel. Due to treatment of the
outside capillary surface, the hydrogel also covalently bonded with the capillary. No
gaps or fluid leaks at this location were observed during operation.
5.3.2

Protein Focusing in the Open EFGF Channel
The concentration of all protein samples was 10 g/mL. I used electrokinetic

injection to introduce the sample into the EFGF channel. Before focusing, a broad
band was observed entering the channel. When the counter flow was applied to
balance the electrophoretic force, the broad band moved to its equilibrium point and
gradually became narrow. Panels A and B in Figure 5.5 show focused R-PE and GFP
bands, respectively, in the open EFGF channel.
In the experiments, I found that the focused band position and bandwidth
changed when altering the applied counter flow rate or voltage. Usually, it required
approximately 30 min to reach equilibrium after changing the focusing conditions.
Figure 5.6 A shows focused R-PE peaks for different counter flow rates and constant
voltage (500 V), which were recorded by scanning along the open separation channel.
With an increase in counter flow rate, the focused band moved toward the high
electric field end, and the band broadened significantly. Table 5.2 lists the peak widths
at half height for different conditions. When the counter flow rate increased 5-fold,
from 6 nL/min (0.53 mm/min linear velocity) to 30 nL/min (2.65 mm/min), the peak
width at half height changed more than 10-fold, from 0.53 mm to 5.99 mm. It is
evident that the bulk flow had significant impact on the focused bandwidth. Peaks for
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Figure 5.5. Fluorescence images of focused proteins in an EFGF open channel. (A)
R-PE focused at 500 V and 20 nL/min; (B) GFP focused at 500 V and 10 nL/min; (C)
and (D) R-PE and GFP focused at 500 V, 5 nL/min and 8 nL/min, respectively.
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A

B

Figure 5.6. Focusing of R-PE in an EFGF open channel for (A) different counter flow
rates and constant applied voltage of 500 V, and (B) different applied voltages and
constant counter flow rate of 10 nL/min.
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Table 5.2. Peak width (mm) at half height of peaks in Figures 5.6 and 5.8.
Figure No.

Peak number
1

2

3

4

5

6

5.6 A

0.53

0.82

1.32

1.96

5.99

--

5.6 B

0.53

0.75

1.05

1.42

2.27

3.09

5.8 A

0.28

0.45

0.68

0.80

1.08

--

5.8 B

0.31

0.39

0.54

0.70

0.82

--
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R-PE focused at different voltages and constant counter flow rate (10 nL/min) are
shown in Figure 5.6 B. With an increase in applied voltage, the focused band moved
toward the low electric field region, and the band became narrower (Table 5.2). When
the voltage increased from 100 V to 800 V, the peak width at half height decreased
from 3.09 mm to 0.53 mm.
These results are consistent with the EFGF theory developed by Tolley et al.4
When an analyte is in its focused equilibrium state, the standard deviation (  ) of the
bandwidth can be described by the equation

  DT /  q( x0 )

(5.2)

where  is the analyte electrophoretic mobility, q ( xo ) is the electric field gradient
at point xo , and DT is the dispersion coefficient that represents the sum of the
molecular diffusion ( DM ) and dispersion induced by the counter laminar flow ( Du ) in
the channel
DT  DM  Du

(5.3)

In my device, the PEG-functionalized hydrogel was assumed to have negligible
protein adsorption. With this assumption, the dispersion coefficient in the open
channel can be represented by

u 2d 2
DT  DM 
192 DM

(5.4)

where u is the laminar flow rate and d is the diameter of the separation channel.
The electric field gradient at any point, q ( xo ) , was assumed to be invariable when a
constant voltage was applied since our device was designed to provide a linear
electric field gradient. Therefore, when u increases, DT increases significantly,
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which results in an increase in  .
The device was designed to create a linear electric field gradient. With high
field and low field cross-sectional areas given by Ah and Al , the gradient can be
expressed by the equation

q

I  1 1
  
CL  Ah Al 

(5.5)

where I is the current, C is the conductivity, and L is the length of the
separation channel. Equation 5.5 was derived from the equations
I
CA  x 

(5.6)

E  x   qx  E0

(5.7)

E  x 

where E0 is the electric field strength at the low field end ( x  0 ). When increasing
the applied voltage, the current through the device increases, which leads to an
increase in the electric field gradient. Therefore, the bandwidth decreases because the
standard deviation of the focused band is inversely proportional to the square root of
the electric field gradient.
Panels C and D in Figure 5.5 show images of R-PE and GFP, which were
focused and separated in the open EFGF channel at different counter flow rates. When
the flow rate was low, the two protein bands were located next to each other (Figure
5.5 C). When the flow rate increased, the two protein bands separated (Figure 5.5 D).
Based on the theory,5 the resolution Rs of two analytes can be expressed as

12

  1 
x u 


Rs 
  




4
4  q  x0  DT   2 4 
 DM
d2
 q  x0    2 
192 DM
 u


1

 2

  
 2
 


(5.8)

192

where  is the average electrophoretic mobility, and  is the electrophoretic
mobility difference of two analytes. When the applied voltage is fixed (i.e., the
electric field gradient q ( xo ) remains constant), the resolution increases when
increasing the counter flow rate. On the other hand, if the counter flow rate is kept
constant, an increase in the applied voltage leads to a reduction in resolution because
the resolution is inversely proportional to the square root of the electric field gradient.
Figure 5.7 shows the results of scanning along the separation channel, which was in
qualitative agreement with the theoretical predictions. For example, the resolution
increased from 0.76 to 3.23 when the counter flow rate changed from 5 nL/min to 10
nL/min at constant applied voltage (500V). The resolution decreased from 3.23 to
1.64 when the applied voltage increased from 500 V to 800 V at constant counter flow
rate (10 nL/min).
5.3.3 Monolith Synthesis
The focused bands in the EFGF experiments described above were broad,
which is a result of the large dispersion coefficient for laminar flow. A narrower
focused band could be obtained by increasing q ( xo ) or decreasing DT based on
equation 5.2. For a fixed applied voltage and linear gradient, q ( xo ) does not change.
Therefore, the dispersion coefficient must be reduced to achieve narrower bands. This
can be done by packing the channel with particles11 or incorporating a monolith in the
channel.17 In an open channel, the parabolic laminar flow profile broadens the sample
zone. In a packed or monolithic column, the laminar flow profile is disrupted into a
large number of much smaller laminar flow profiles formed in the interparticle spaces
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B

A

Rs = 0.76

Rs = 1.72

D

C

Rs = 3.23

Rs = 1.64

Figure 5.7. Focusing and separation of (1) R-PE and (2) GFP in an EFGF open
channel under different conditions: (A) 5 nL/min flow rate, 500 V; (B) 8 nL/min flow
rate, 500 V; (C) 10 nL/min flow rate, 500 V; (D) 10 nL/min flow rate, 800 V.

194

or throughpores. These individual profiles overlap to generate an overall pluglike flow
profile, which reduces the dispersion considerably.
Koegler2,7 and Greenlee11 successfully packed a size exclusion resin in a
dialysis tube to improve the performance of their preparative scale EFGF devices.
However, in our device, the separation channel is very small, which makes it difficult
to obtain uniform packing with small particles. Also, it is necessary to make a frit to
prevent the particles from moving out of the channel during packing and operation.
Incorporation of a monolith in the channel is the most reasonable approach to
reducing laminar flow in the channel. Polymer monoliths were developed as
chromatographic stationary phases over 15 years ago.28,29 Recently, they have
received increased attention due to advantages compared to packed columns,
including ease of fabrication and low back pressure. Polymer monoliths have been
applied in various chromatographic modes, such as reversed phase chromatography,30
affinity chromatography,31 and ion exchange chromatography.32 Recently, Gu et al.
developed a novel polymer monolith, which was prepared with PEG-functionalized
methacrylate/acrylate monomers.33 PEGDA 258 functioned as a biocompatible
crosslinker. Negligible interaction was observed between the monolith and proteins.
In my work, a similar PEG-functionalized monolith was introduced into the
EFGF channel. The ingredients are listed in Table 5.1; HEMA is the monomer,
PEGDA 258 is the crosslinker, and methanol and ethyl ether are porogens. The
monolith was formed using photopolymerization. SEM images of the monolith in the
EFGF channel are shown in Figures 5.8 A and B. The monolith was bonded well to
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Figure 5.8. SEM images of the PEGDA/HEMA monolith incorporated in an EFGF
channel. (A) 500× and (B) 2000× magnification of the monolith-filled EFGF channel.
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the channel surface and had a typical monolith structure. The back pressure was
approximately 200 psi when methanol was pumped through a 4 cm long monolith
filled channel at 0.4 L/min flow rate. The mean flow pore diameter (constricted pore
diameter) was approximately 64 nm as measured using a capillary flow porometer.
5.3.4

Focusing of Proteins in Monolith Filled EFGF Channels
Figure 5.9 A shows focusing of R-PE in a monolith filled channel at different

counter flow rates. The shifting and broadening of peaks followed the same trend as
for the open channel. With an increase in flow rate, the peak moved to a higher
electric field region and increased in width. However, the increase in peak width in
the monolith filled channel was less than in an open channel. In the monolith filled
channel, when the bulk flow rate changed 20-fold, from 2 nL/min (0.25 mm/min
linear velocity) to 40 nL/min (5.05 mm/min), the peak width at half height increased
less than 4-fold, from 0.28 mm to 1.08 mm (Table 5.2). This result indicates that the
incorporated monolith reduced the flow dispersion and narrowed the protein bands.
Compared with focusing in an open channel, the monolith filled channel produced
significantly narrower peaks, even at high counter flow rate. However, when the
counter flow rate was low, the peak focused in the open channel was as narrow as that
in the monolith filled channel. From equation 5.2, the standard deviation of the
focused band only depends on the dispersion coefficient when the electric field
gradient is constant. When the counter flow rate is low, the total dispersion ( DT ) is
dominated by molecular diffusivity ( DM ), which should be minimally affected by
adding a monolith to the channel. Therefore, the peak widths should be similar. When
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A

B

Figure 5.9. Focusing of R-PE in a monolith-filled EFGF channel for (A) different
counter flow rates and constant applied voltage of 800 V, and (B) different applied
voltages and constant counter flow rate of 5 nL/min.
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the counter flow rate is high, Du dominates in the total dispersion, which can be
reduced by incorporation of a monolith in the channel to change the flow profile. In
this case, the effect of the monolith is significant.
Figure 5.9 B shows focusing of R-PE in the monolith filled channel at
different applied voltages and constant counter flow rate. With a decrease in the
voltage from 100 V to 800 V, the protein band moved to the low electric field end of
the channel. However, the peak width at half height decreased from 0.82 mm to 0.31
mm (Table 5.2). This change was less than that measured for an open channel, which
again shows that the monolith helps to reduce the bandwidth in the EFGF channel.
Figure 5.10 shows the separation and focusing of three proteins in a
monolith-filled EFGF channel. Even though the three proteins were not separated
completely, their peak widths were narrower. In this case, the peak capacity of this
channel increased. In EFGF, the resolution depends not only on the individual protein
characteristics, such as electrophoretic mobility and size, but also on the hydrogel
shape and focusing conditions. The hydrogel shape can be designed to provide
shallow electric field gradient, which can improve the resolution. From the results
described above for an open EFGF channel, resolution increases with an increase in
counter flow rate or decrease in applied voltage.
The performance of the EFGF device described in this work, compared with
the device described by Humble et al.,8 was superior in several ways: the focused
bands were more symmetrical due to less protein adsorption, focusing was easier to
control because disturbances from electroosmotic flow were eliminated, and
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Figure 5.10 Focusing and separation of three proteins in a monolith-filled EFGF
channel. The counter flow rate was 10 nL/min and the applied voltage was 800 V.
Peaks: (1) FITC--lactoglobulin A, (2) FITC-myoglobin, and (3) GFP.
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incorporation of a monolith in the focusing channel eliminated the dispersion
resulting from laminar flow in an open channel. Since the focused bands were
narrower, the peak capacity increased. Attempts to immobilize a stable monolith in
the separation channel of the previous Humble et al. device were unsuccessful.

5.4

Conclusions
EFGF devices were cast out of a PEG-functionalized copolymer. The

separation channel was formed in the hydrogel portion of the device using a wire. An
electric field gradient was obtained by changing the cross-sectional dimension of the
PEG-functionalized hydrogel normal to the separation channel. This type of device
was successfully used to focus and separate proteins. The position of the focused band
in the channel and the bandwidth depend on the electric field and the opposing
hydrodynamic flow. High counter flow rate caused broad bands, but high resolution.
High voltage led to narrow bands and low resolution. Incorporation of a
PEG-functionalized monolith in the EFGF channel reduced dispersion induced by the
laminar flow and narrowed the focused band. Both open channel and monolith-filled
devices showed negligible EOF because the device body, hydrogel and monolith were
all PEG functionalized materials, and the end capillaries were coated with PVA.
Another approach to obtain narrow bands is to change the hydrogel shape to produce
a nonlinear electric field gradient.4 For example, a bilinear electric field gradient,
which contains a steep gradient region and a shallow gradient region, should produce
sharp peaks in the steep region and high resolution in the shallow region, leading to
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high peak capacity.
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6

PERFORMANCE OPTIMIZATION IN ELECTRIC FIELD
GRADIENT FOCUSING *

6.1

Introduction
As described in Chapter 5, I fabricated an EFGF device completely from

PEG-functionalized copolymers, including the substrate, buffer ion-permeable but
protein-excluding conductive hydrogel, and flow dispersion-minimizing monolith,
which all contributed to the high resistance to adsorption of proteins.1 The electric
field gradient was generated by applying a voltage across the changing cross-sectional
area filled with the conductive hydrogel. However, I observed that the actual electric
field gradient along the channel was not the predicted linear gradient from the shaped
region design and the current was not stable over time.
In this work, I replaced the hydrogel containing Tris buffer with hydrogel
containing phosphate buffer and a salt (KCl) to improve the performance. In addition,
I investigated the influence of separation channel diameter on the focused sample
bandwidth and the concentrating ability of the new device.

6.2

Experimental Section

6.2.1 Materials and Sample Preparation
Methyl methacrylate (MMA, 99%), poly(ethylene glycol) methyl ether
methacrylate (PEGMEMA 1100, MW~1100), poly(ethylene glycol) diacrylate
(PEGDA 258, MW ~258), and 2,2’-dimethoxy-2-phenylacetophenone (DMPA) were
*

This chapter is reproduced with permission from J. Chromatogr. A 2009, 1216, 159-164. Copyright 2009 Elsevier

B.V.
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purchased from Aldrich (Milwaukee, WI). Ethoxylated trimethylolpropane triacrylate
(SR 9035) was obtained from Sartomer (Warrington, PA). Potassium chloride (KCl)
and potassium phosphate monobasic (KH2PO4) were purchased from EM Science
(Gibbstown, NJ). Potassium phosphate dibasic (anhydrous) (K2HPO4) was purchased
from Mallinckrodt Specialty Chemicals (Paris, KY). Fluorescein isothiocyanate
(FITC) was purchased from Invitrogen (Carlsbad, CA). -Lactoglobulin A and
dimethyl sulfoxide (DMSO) were ordered from Sigma (St. Louis, MO).
R-Phycoerythrin (R-PE) was obtained from Polysciences (Warrington, PA).
Recombinant, enhanced green fluorescent protein (GFP) was purchased from
Clontech (Palo Alto, CA). All chemicals were used as received without further
purification.
Deionized water (18.2 Mcm) was prepared using a Milli-Q UF Plus water
purification system (Millipore, Billerica, MA). Phosphate buffer (5 mM, pH 8.0)
containing KCl (5 mM) was filtered using 0.2-m syringe filters (Pall, East Hills, NY)
before use.
To label -lactoglobulin A, the protein was dissolved in filtered 10 mM
sodium bicarbonate buffer (pH 9.2) with a concentration of 1 mg/mL. FITC was
dissolved in absolute DMSO to make a 6 mM solution. Then, 600 L protein solution
was thoroughly mixed with 40 L FITC solution and placed in the dark for at least 2
days at room temperature. Before use, the FITC-labeled protein sample was diluted to
20 g/ mL with the running buffer.
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6.2.2

Fabrication of EFGF Devices
All EFGF devices were fabricated using the previously reported casting

method.1 In brief, two small prepolymerized slab plates (65 × 25 × 1.5 mm3 and 65 ×
25 × 2.5 mm3), one containing two reservoirs and the other containing a conical
shaped cavity, were first fabricated using a monomer solution containing PEGDA
(85%), PEGMEMA (12%), MMA (3%) and DMPA (0.1% of the total monomer
weight). The concave cone shape of the cavity was designed to generate a linear
electric field gradient. Two PVA inner-coated fused silica capillaries (150 m i.d.)
were threaded with a metal wire and mounted as inlet and outlet capillaries on top of
the bottom plate containing the cavity, followed by placing the cover plate containing
the two reservoirs over the bottom plate. The assembly was chemically bonded
together by exposure to UV radiation. After bonding, a hydrogel monomer solution
containing SR9035 (85%), buffer solution (15%) and DMPA (0.5% of the monomer
weight) was introduced into the conical shaped cavity through the reservoir at the
wide end of the cavity and photo-polymerized under a UV light. The previously used
Tris buffer (100 mM, pH 8.5) in the hydrogel was replaced with phosphate buffer (5
mM, pH 8.0) containing KCl (5 mM). Finally the metal wire was pulled out of the
fused silica capillaries, leaving a small channel through the hydrogel. Three different
metal wires were used to form channels, including two nickel wires (50 and 120 m
diameter, MWS Wire Industries, Westlake Village, CA) and nitinol wire (70 m
diameter, Fort Wayne Metals, Fort Wayne, IN). The schematic of the final EFGF
device is shown in Figure 5.2. The separation channel was 40 mm long, and the
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widths of the hydrogel at the low and high field ends and the thickness of the hydrogel
were 18 mm, 1.8 mm, and 1.5 mm, respectively.
6.2.3 EFGF Operation
The general operating procedure for EFGF using these changing
cross-sectional devices was reported previously.1 As shown in Figure 5.2, the sample
was introduced into the EFGF separation channel through the high field end capillary
using electrokinetic injection. A hydrodynamic counter flow was created by a syringe
pump (Harvard Apparatus, Holliston, MA, USA) from the low field end as soon as the
sample was observed to enter the separation channel. A voltage was applied along the
channel from the reservoir at the low field end of the device (+) to a buffer-filled vial
connected to the capillary at the high field end of the device (-). The detection system
was a laser induced fluorescence (LIF) inverted microscope (488 nm) described
previously.1 The focused protein bands were detected by scanning along the channel.
The fluorescence signal was detected using a photomultiplier (Hamamatsu,
Bridgewater, NJ) and recorded using LabView (National Instruments, Austin, TX)
software.

6.3

Results and Discussion
When an analyte is focused in an EFGF channel, the magnitude of the

electrophoretic velocity of the analyte equals the hydrodynamic counter flow velocity,

u

F
 E
S

(6.1)

but their directions are opposite.2 Where u is the linear velocity of the counter flow,
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F is the bulk counter flow rate, S is the cross-sectional area of the EFGF

separation channel,  is the analyte electrophoretic mobility, and E is the electric
field strength. By differentiating both sides of equation 6.1, assuming that the
electrophoretic mobility and channel cross-sectional area are constant, I obtain

dF
dE
 S
  Sq( x)
dx
dx

(6.2)

where q( x) is the electric field gradient at the equilibrium position, x , which is
defined as the distance along the channel from the start of the low field end of the
channel to the position of the focused peak maximum. Therefore, I can determine the
electric field gradient, q( x) , in an EFGF channel by measuring the focusing positions
of an analyte of known mobility for different hydrodynamic flow velocities. For a
linear electric field gradient under a constant applied voltage, q( x) and dF dx are
constant along the channel, which means that there is a linear relationship between the
bulk counter flow rate and the corresponding analyte equilibrium position, with a
slope that is proportional to the analyte electrophoretic mobility and the channel
cross-sectional area.
I plotted the counter flow rate versus equilibrium position using data measured
from Figure 5.6 A, which was obtained using an earlier device containing a hydrogel
with 100 mM Tris-HCl buffer. When the counter flow rate was low, the sample was
focused close to the low field end of the channel, and the relationship between F
and x was approximately linear. However, when the counter flow rate was increased,
the relationship between F and x deviated more from linearity, which meant that
the electric field gradient along the whole channel length was not linear. The variation
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in current with time for devices prepared with hydrogels containing Tris-HCl buffer
and phosphate buffer (plus KCl) were measured and plotted as shown in Figure 6.1.
The applied potential was 500 V. For the hydrogel containing Tris-HCl (upper curve),
the current decreased with time and became stable in approximately 3 h. Similar
current decrease was also observed for the EFGF device reported by Humble.3
However, the explanation that buffer solution evaporation was the cause is not
appropriate here because the hydrogel was enclosed in the channel with a top plate.
The most reasonable cause is ion transport in the hydrogel. The hydrogel was
designed to have nano-scale pores for small ion permeability, but not for larger
molecules such as proteins. Proteins remained in the separation channel. Tris ion
(Tris+) is larger than other ions, such as K+, Cl-, OH- and H+, and its migration in the
hydrogel was hindered. Because the buffer in the anode reservoir was frequently
refilled to offset evaporation and the buffer in the channel was refreshed by the
continuous counter-flow, it is clear that slow transport of Tris+ ions resulted in
build-up or depletion of buffer ions in the hydrogel, which impacted the electrical
current and electric field distribution along the channel.
To eliminate this undesirable phenomenon, a phosphate buffer containing a
strong electrolyte (KCl) comprised of small ions was doped in the hydrogel in place
of the Tris-HCl buffer. The variation in current with time for a device containing this
new hydrogel formulation is shown in Figure 6.1 (lower curve). The current was
much more stable than the previous device over the 3-h period. In addition, even
though the Tris-HCl buffer concentration was much higher, the current through the
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Figure 6.1. Current variation as a function of time for EFGF devices made from
different hydrogels. The applied voltage was 500 V; (●) hydrogel containing 100 mM
Tris-HCl (pH 8.5) buffer; (■) hydrogel containing 5 mM KCl and 5 mM phosphate
buffer (pH 8.0). Error bar breadth was taken from the typical current display accuracy
of the power supply (Stanford Research Systems, Sunnyvale, CA), ±1 A.
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new device was close to that observed with the previous one. These observations
indicate that the large ions (Tris+) migrate in the hydrogel much more slowly than
smaller inorganic ions (such as K+), which results in a decrease in conductivity and,
therefore, less disturbance of the electric field distribution. This new hydrogel
conductivity is approximately 2.2 × 10-5 S/m, which was measured as previously
reported.1 Although the new buffer concentration (~10 mM) was one fifth that in the
former hydrogel containing 50 mM Tris-HCl buffer, its conductivity was
approximately half that of the former (4.1 × 10-5 S/m).1
EFGF with the improved hydrogel was utilized to focus R-PE at different
hydrodynamic flow rates and constant voltage (500 V) to determine the electric field
distribution. Figure 6.2 A shows the focused R-PE peaks for the flow rates tested.
With an increase in hydrodynamic flow rate, the focused sample band moved toward
the high field end of the channel and broadened gradually. Compared with results
obtained using previous devices, the band broadening was not as pronounced for this
new device, even for high flow rates. The equilibrium position was plotted versus
flow rate as shown in Figure 6.2 B. A good linear relationship was obtained,
indicating that a linear electric field gradient was established in this new EFGF device.
I also repeated these experiments using GFP as a test solute, and the same linear
relationship was observed (Figure 6.2 C). The slopes were measured to be 0.90 and
0.50 for R-PE and GFP, respectively. The electrophoretic mobilities of R-PE and GFP
in pH 9 buffer were 2.4 × 10-4 cm2 V-1 s-1 and 1.9 × 10-4 cm2 V-1 s-1, respectively.4
Although analyte mobility depends on pH and other buffer conditions, in this study, I

212

A

B

C

Figure 6.2. (A) Focusing of R-PE along an EFGF channel for different hydrodynamic
flow rates using a hydrogel containing KCl. The channel i.d. was 120 m and the
applied voltage was 500 V. (B) Flow rate versus focused peak position for R-PE as
shown in A. (C) Flow rate versus focused peak position for GFP at an applied voltage
of 500 V.
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used literature values for approximate mobilities of R-PE and GFP to calculate the
electric field gradient in my EFGF device. The values of 5.55 V/cm2 and 3.86 V/cm2
for R-PE and GFP, respectively, were calculated using equation 6.2. Theoretically, the
gradients calculated for different proteins should be identical at constant applied
voltage; the lack of agreement here is a result of the approximate mobilities used in
the calculations.
Figure 6.3 compares focusing experiments using three different EFGF devices
under the same conditions. The peak positions and peak widths at half height are
listed in Table 6.1. The GFP bands were focused at approximately 10 mm from the
low field end of the channels. The relative standard deviation (RSD) for peak position
was 1.4%. The peak widths at half height were approximately 1 mm and the RSD for
peak width was 6.2%. The standard deviations were calculated based on equation

 exp  W1 2 2.354 , and are similar (see Table 6.2) to the theoretical value (0.43 mm)
obtained based on the known diffusion coefficient of GFP (~8.5 × 10-7 cm2/s).4 These
results demonstrate the best device-to-device reproducibility produced by me to date.
From equation 6.2, the slopes of the lines in Figures 6.3 B and 6.3 C should be
directly proportional to the separation channel cross-sectional area as well as to the
analyte mobility. Therefore, I investigated the focusing performance in EFGF
channels of different diameters. For example, the slope of the linear fit line is 0.331
for focusing of R-PE in a 70 m i.d. separation channel for an applied voltage of 500
V. According to equation 6.2, the electric field gradient was calculated to be 5.97
V/cm2, which is close to the value obtained for a 120 m i.d. EFGF channel with
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A

B

C

Figure 6.3. Comparison of GFP focusing experiments under the same conditions using
three different EFGF devices containing hydrogel with 5 mM KCl. The channel i.d.
was 120 m, the counter flow rate was 5 nL/min, the applied voltage was 500 V, and
the current was 6~7 A.
215

Table 6.1. Reproducibility measurements from the focusing of GFP in three different
EFGF devices containing KCl in the hydrogel (see Figure 6.3).
A

B

C

Mean (CL=95%)

RSD

Peak position (mm)

9.90

9.83

10.10

9.94 ± 0.35

1.4%

W1/2 (mm)

1.03

0.96

0.91

0.97 ± 0.15

6.2%
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Table 6.2. Calculated and experimental values of standard deviations in Figures 6.3
and 6.4.

1

2

Figure

6.3 A

6.3 B

6.3 C

6.4 A

6.4 B

6.4 C

theory (mm) 1

0.43

0.43

0.43

0.31 2

0.40

0.69

exp (mm) 3

0.44

0.41

0.38

0.21

0.27

0.53

2 2
 theory  DM  q  u d 192D  q
M

For the calculation, q = 5.76, which was the average of the two gradients obtained

for the 70 m and 120 m i.d. channels.
3

 exp  W1 2 2.354
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R-PE as analyte (5.55 V/cm2). This indicates that the field gradient is not affected by
the separation channel and only depends on the shaped hydrogel.
Figure 6.4 shows the focusing of R-PE in three different diameter EFGF
channels. The channel diameters (d) were 50, 70 and 120 m, respectively. For
comparison, the voltage (500 V) was applied over the two reservoirs molded in the
top plate instead of from the inlet reservoir to the exit vial. The counter flow rates for
each are listed in Table 6.3. Although the bulk flow rates were different, the linear
flow velocities were adjusted to be similar (~1 mm/min). Therefore, the peaks were
focused at similar positions in the channels. As can be seen, the peak widths at half
height broadened with an increase in channel diameter. This is because the Taylor
dispersion is less in smaller channels.2 Standard deviations () including theoretical
and experimental values are listed in Table 6.2. The diffusion coefficient of R-PE is 4
× 10-7 cm2/s.4 For the 50 m i.d. channel, the gradient (5.76 V/cm2) was taken as the
average of the values obtained for the 70 m and 120 m i.d. channels. The two sets
of values are close, and the experimental values are slightly smaller than the
theoretical values because the actual gradients are larger due to the fact that the
voltage was applied over the two reservoirs on top of the device instead of using the
end vial. According to EFGF theory,1 2 is linearly related to d 2 for the same analyte
and field gradient when the counter flow velocity is similar. A linear relationship does
exist between exp2 and d 2 based on the experimental results shown in Figure 6.4.
Figure 6.5 shows a separation of three proteins in a 120 m i.d. EFGF channel.
When the applied voltage was higher or the counter flow was slower, the peaks were
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A

B

C

Figure 6.4. Focusing of R-PE in three EFGF channels of different diameter. (A) 50
m i.d., (B) 70 m i.d., and (C) 120 m i.d. Voltage (500 V) was applied across the
two reservoirs of each device. The counter flow rates are listed in Table 6.2.
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Table 6.3. Measurements from the focusing of R-PE in three EFGF channels with
different diameters (see Figure 6.4).
Channel i.d.

Bulk flow rate

Linear velocity

Peak position

W1/2

(m)

(nL/min)

(mm/min)

(mm)

(mm)

6.4 A

50

2

1.02

9.77

0.49

6.4 B

70

4

1.04

11.32

0.64

6.4 C

120

12

1.06

10.94

1.25

Figure
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narrow but stacked together. When the voltage was lower or the counter flow was
faster, the peaks were resolved, but broad. Therefore, the operating conditions were
optimized to provide narrow, resolved peaks in a reasonably short time. In Figure 6.5,
the three peaks are almost completely resolved, although the FITC--lactoglobulin A
peak is quite broad and a shoulder is observed, which is likely due to FITC labeling.
Currently, the most useful application of a linear gradient EFGF device is to
preconcentrate target analytes and order them according to electrophoretic mobility.
The EFGF device reported by Humble et al. and the micro EFGF device reported by
Liu et al. were shown to concentrate GFP by 10,000- and 4,000-fold, respectively.5, 6
To determine the concentrating ability of this new EFGF device, a calibration curve
was first constructed based on five R-PE solutions of known concentrations ranging
from 10 g/mL to 100 g/mL. To measure the fluorescence intensity of each of these
standard R-PE solutions, the EFGF channel was first filled with the solution. Then the
laser was focused on the channel and the corresponding fluorescence intensity was
recorded. Three values were measured at different positions along the channel for
each standard solution, and the average fluorescence intensity was used to construct
the calibration curve (Figure 6.6). A sample solution containing 2 ng/mL R-PE was
injected into the EFGF channel electrokinetically with a voltage of 500 V for 60 min.
Then a counter flow (5 nL/min) was applied to focus the analyte in the channel. The
fluorescence intensity of the focused R-PE band was compared to the calibration
curve, and the concentration of the focused R-PE band was found to be 27 g/mL,
corresponding to a concentration factor of approximately 14,000.
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Figure 6.5. Separation of three proteins in a 120 m i.d. EFGF channel. The counter
flow rate was 10 nL/min and the applied voltage was 800 V. Peak identifications: (1)
FITC--lactoglobulin A, (2) R-PE, and (3) GFP.
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Figure 6.6. Calibration curve used to determine the concentration factor for R-PE.
Each data point used to construct the curve was averaged from three measurements
(CL% = 95%). The star (★) denotes the fluorescence intensity of the concentrated
R-PE band in the channel.
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6.4

Conclusions
A phosphate buffer containing an electrolyte with small ions (i.e., KCl) was

employed in place of the previously used Tris-HCl buffer to improve ion transport
through the hydrogel surrounding the separation channel in EFGF. The current
through the new hydrogel was stable. The electric field distribution was indirectly
determined by measuring the focused band positions of standard proteins at constant
voltage for different hydrodynamic flow rates. The expected linear electric field
gradient was achieved, in good agreement with theoretical prediction based on device
design. When the applied voltage was 500 V, the field gradients generated in a 120
m i.d. EFGF channel for R-PE and GFP were 5.55 V/cm2 and 3.86 V/cm2,
respectively. The performance of separation channels of different diameters was also
investigated. Narrower bands were obtained in smaller diameter channels due to
reduced Taylor dispersion. The gradient established in a 70 m i.d. channel for R-PE
was 5.97 V/cm2 when the applied voltage was 500 V. Three proteins were
successfully separated in the EFGF channel. The EFGF device was able to
concentrate a 2 ng/mL R-PE sample by 14,000 fold.
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7

NON-LINEAR ELECTRIC FIELD GRADIENT FOCUSING

7.1

Introduction
So far, only a linear gradient (line 1 in Figure 7.1) has been reported in EFGF

devices based on changing cross-sectional area. According to the fundamental theory
of EFGF, resolution and peak capacity in EFGF with a linear gradient cannot be
improved simultaneously, because bandwidth and resolution are inversely
proportional to the square root of the field gradient. However, some theoretical work
indicates that the peak capacity could be improved using an EFGF device with
nonlinear (convex) gradient (curve 2 in Figure 7.1), such as can be approximated with
bilinear EFGF.1,2 All analytes would first be focused in the steeper gradient section to
form narrow stacked bands. Then they would be sequentially moved into the
shallower gradient section and be resolved by manipulating the counter flow rate or
applied voltage. This dynamic improvement of peak capacity is important for further
development of the EFGF technique. An ineffective EFGF device with a nonlinear
gradient was constructed using a buffer conductivity gradient.3 This device provided a
very steep gradient section followed by a very shallow section. Unfortunately, the first
steep segment was too short to significantly improve peak capacity.
In this work, two types of nonlinear EFGF devices, bilinear (convex, curve 2
in Figure 7.1) and concave (curve 3 in Figure 7.1), were fabricated from
PEG-functionalized copolymers. A monolith was synthesized in the EFGF channels,
and the separation and focusing of proteins in these channels were investigated.
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Figure 7.1. Three types of electric field gradient profiles studied for EFGF. (1) Linear,
(2) convex, and (3) concave.
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7.2

Experimental Section

7.2.1 Materials
Poly(ethylene glycol) diacrylate (PEGDA, MW ~258), poly(ethylene glycol)
methyl ether methacrylate (PEGMEMA, MW~1100), methyl methacrylate (MMA,
99%), 2-hydroxyethyl methacylate (HEMA, 99%+), and
2,2’-dimethoxy-2-phenylacetophenone (DMPA) were purchased from Aldrich
(Milwaukee, WI). Ethoxylated trimethylolpropane triacrylate (SR 9035) was obtained
from Sartomer (Warrington, PA). Anhydrous methanol was purchased from
Mallinckrodt Chemicals (Phillipsburg, NJ). Anhydrous ethyl ether was purchased
from Fisher Scientific (Fair Lawn, NJ). Fluorescein isothiocyanate (FITC) was
purchased from Invitrogen (Carlsbad, CA). Potassium chloride (KCl) and potassium
phosphate monobasic (KH2PO4) were purchased from EM Science (Gibbstown, NJ).
Potassium phosphate dibasic (anhydrous) (K2HPO4) was purchased from
Mallinckrodt Specialty Chemicals (Paris, KY). Dimethyl sulfoxide (DMSO) and
-lactoglobulin A were ordered from Sigma (St. Louis, MO). R-phycoerythrin (R-PE)
was obtained from Polysciences (Warrington, PA). Recombinant, enhanced green
fluorescent protein was purchased from Clontech (Palo Alto, CA). All chemicals were
used as received without further purification. Deionized water (18.2 Mcm) was
prepared using a Milli-Q UF Plus water purification system (Millipore, Billerica, MA).
Carbonate buffer (10 mM, pH 9.2) and phosphate buffer (5 mM, pH 8.0) containing
KCl (5 mM) were filtered using 0.2-m syringe filters (Pall, East Hills, NY) before
being used. Precleaned microscope slides with dimensions of 70  50  1 mm3 and 70
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 25  1 mm3 were obtained from Fisher Scientific (Pittsburgh, PA) and Hardy
Diagnostics (Santa Maria, CA), respectively.
7.2.2

Preparation of FITC-Labeled -Lactoglobulin A
The procedure of labeling -lactogloblin A was reported previously.4 In brief,

1 mg/mL-lactoglobulin A solution was prepared in filtered 10 mM carbonate buffer
(pH 9.2). FITC was dissolved in absolute DMSO to form a concentration of 6 mM.
Then 600 L protein solution was thoroughly mixed with 40 L FITC solution and
placed in the dark for 2 days at room temperature. After completion of labeling, the
protein solution was stored at 4 oC. Before use, the FITC-labeled protein sample was
diluted with the running buffer.
7.2.3

Fabrication of EFGF Devices
All EFGF devices were fabricated using a previously reported casting method

(Figure 5.1).4 A prepolymerized top slab plate (65  25/50  1.5 mm3) containing two
reservoirs, and a bottom plate (65  25/50  2.5 mm3) containing a planar
horn-shaped cavity were first fabricated using a monomer solution containing PEGDA
(85%), PEGMEMA (12%), MMA (3%) and DMPA (0.1% of the total monomer
weight). The concave planar horn shape of the cavity could be easily designed to
generate the desired electric field gradient, such as linear, convex or concave. Two
fused-silica capillaries (150 m i.d.) were threaded with a nickel wire (120 m
diameter, MWS Wire Industries, Westlake Village, CA) and mounted as inlet and
outlet capillaries on the top of the bottom plate containing the cavity, followed by
placing the cover plate with two reservoirs on top. The assembly was chemically

229

bonded together by exposure to UV radiation. After bonding, a hydrogel monomer
solution containing SR 9035 (85%), DMPA (0.5% of the monomer weight) and
phosphate buffer (5 mM, pH 8.0) containing KCl (5 mM) (15%) was introduced into
the planar horn-shaped cavity through the reservoir at the wide end of the cavity and
photopolymerized under UV light. Finally, the nickel wire was pulled out of the fused
silica capillaries, leaving a small channel through the hydrogel.
7.2.4 Synthesis of a Monolith in the EFGF Channel
A protein compatible (i.e., nonadsorptive) monolith was incorporated into the
EFGF channel using a previously reported method.4 Briefly, a degassed mixture
containing PEGDA (crosslinker, 22.5 wt %), HEMA (monomer, 7.5 wt %), methanol
(porogen, 25 wt %), ethyl ether (porogen, 45 wt %) and DMPA (photoinitiator, 1% of
the total monomer weight) was carefully introduced into the channel to avoid bubble
generation. The device was then exposed to UV light for 8 min under a UV dichroic
mirror (Navitar, Newport Beach, CA). After polymerization, the device was then
connected to an HPLC micro pump (Eksigent, Dublin, CA) and washed with
methanol for 5 h at 0.4 L/min to remove unreacted monomers and porogens,
followed by flushing with operating buffer until focusing experiments were
performed.
7.2.5 Operation of EFGF and Detection
The general EFGF operating procedure was reported previously.4 First, the
sample was electrokinetically injected into the EFGF separation channel by applying
a voltage across the reservoir at the low field end of the device (+) and a sample
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solution-filled vial at the high field end of the device (-). The amount of injected
sample was controlled by the applied voltage and injection time. After injection, the
sample vial was replaced by a buffer-filled vial, and a hydrodynamic flow was created
using a syringe pump (Harvard Apparatus) from the low field end to oppose the
direction of electrophoretic migration. After focusing, the protein bands were detected
using a laser induced fluorescence (LIF) inverted microscope by scanning along the
separation channel.4 The fluorescence signal was detected using a photomultiplier
(Hamamatsu, Bridgewater, NJ) and recorded using LabView software (National
Instruments, Austin, TX).

7.3

Results and Discussion

7.3.1 EFGF with Bilinear (Convex) Electric Field Gradient
Figure 7.2 A shows the design and dimensions of a bilinear EFGF device that
was fabricated and evaluated. The left segment provided a steep gradient, while the
right segment gave a shallow gradient. The device was fabricated using a casting
method as described in Chapter 5.4 Both the substrate and conductive hydrogel were
PEG-functionalized acrylic copolymers. During photopolymerization of the substrates,
the UV exposure time was crucial for controlling the reaction. If the substrates were
too soft, they were difficult to handle and the device became deformed during
photo-induced bonding of the cover plate to the shaped cavity plate. If the
prepolymerized substrates were too hard, the bonding was not robust. To improve ion
transport in the hydrogel and obtain stable current and electric field, a phosphate
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buffer (5 mM) containing a strong electrolyte (5 mM KCl) was incorporated in the
hydrogel as described in Chapter 6. If a higher concentration buffer was mixed with
the monomer, the mixture became cloudy, and the device turned opaque after
polymerization.
According to Chapter 6, the gradient profile can be predicted by measuring the
focused band positions in the channel for different counter flow rates at constant
voltage.5 Figure 7.2 B shows the relationship between the focused R-PE band
positions in the bilinear EFGF channel and the corresponding counter flow rates when
the applied voltage was 500 V. When the counter flow rate was low, the protein was
focused near the end at low electric field. With an increase in counter flow rate, the
focused protein band moved toward the high electric field end. As shown in Figure
7.2 B, there was a linear relationship between the band positions and the counter flow
rates in the flow rate range of 2 nL/min to 22 nL/min. The slope of the line was
approximately 1.2. When the counter flow rate was higher than 22 nL/min, another
linear relationship was observed between the same two parameters, with a slope of
approximately 0.38. The presence of two linear relationships with different slopes
indicates that the fabricated EFGF device provided a bilinear field gradient profile. In
addition, the low field segment had steeper gradient than the high field segment. The
intersection point was approximately at the midpoint (20 mm) of the channel, which
was in agreement with the initial design. Figure 7.2 C shows the movement of the
focused R-PE peak along the EFGF channel when changing the applied voltage at
constant flow rate (20 nL/min). Movement of the band from the steep to shallow
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A

B

C

Figure 7.2. (A) Design and dimensions of a bilinear EFGF device (solid line). (B) Plot
of counter flow rate versus R-PE peak position in an open bilinear EFGF channel at
constant voltage (500 V). (C) Focusing positions of R-PE in an open bilinear EFGF
channel for different applied voltages at a constant counter flow rate (20 nL/min).
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segments was clearly seen by abrupt peak broadening (i.e., peaks 6-8).
As reported before, dynamic improvement of peak capacity should be realized
by increasing the counter flow rate or decreasing the applied voltage to move focused
peaks from the steep segment to the shallow segment.1 The movement of three protein
peaks in a monolith-filled bilinear EFGF channel is shown in Figure 7.3. A monolith
was incorporated in the EFGF channel to reduce flow dispersion, which narrowed the
focused bands. During an experiment, the counter flow rate was increased from 5
nL/min to 20 nL/min while the voltage was kept constant (800 V). When the counter
flow rate was low, all proteins were stacked together with narrow bands in the steep
segment (Figure 7.3 A). When the counter flow rate was increased, all proteins moved
toward the high field end, and the resolution increased gradually (Figure 7.3 B). When
samples moved into the shallow segment, they were even better resolved, and minor
components in the sample appeared (Figure 7.3 C). When the counter flow rate was
increased further, the protein with the smallest electrophoretic mobility (GFP) was
eluted (Figure 7.3 D).
7.3.2 EFGF with Concave Electric Field Gradient
EFGF devices with concave electric field gradients were fabricated using a
simple design shown in Figure 7.4 A, which looks like an isoceles triangle. Figure 7.4
B shows the movement of the R-PE peak along the EFGF channel as a function of
counter flow rate at constant voltage (500 V) using two EFGF devices with different
dimensions. When the width of the hydrogel (W1) at the low field end was larger (i.e.,
device 1), the field gradient along the channel was greater. For both, the gradient

234

A

B

C

D

Figure 7.3. Separations of three proteins in a monolith filled bilinear EFGF channel
for different counter flow rates at constant voltage (800 V). Peaks: (1)
FITC--lactoglobulin A, (2) R-PE, and (3) GFP.
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A

B

Figure 7.4. (A) Design of an EFGF device with concave gradient profile. (B) Plots of
counter flow rate versus peak position for two different EFGF devices with concave
gradient profiles. Device 1: W1 = 20 mm, W2 = 2 mm, and L = 40 mm. Device 2: W1
= 15 mm, W2 = 2 mm, and L = 40 mm.
236

gradually increased from the low field end to the high field end along the channel.
Compared with a linear EFGF device of the same dimensions (W1, W2, and L), the
gradient was shallower near the low field end and steeper near the high field end.
When the counter flow was low, sample bands focused in the low field region were
broad but well resolved compared with linear EFGF. When the counter flow was
increased to move samples into the high field region, the bandwidths and resolution
changed less than for a linear EFGF channel because of the increase in the electric
field gradient.
For example, R-PE and GFP were separated in an open-channel EFGF with a
concave electric field gradient (device 1) for different counter flow rates at constant
voltage (500 V). When the flow rate was 5 nL/min, the resolution was 1.30, which is
higher than that obtained in a linear EFGF device (0.76).4 However, when the flow
rate was increased to 10 nL/min, the resolution was 1.74, which is smaller than that
measured for a linear EFGF device (3.23).4 As the flow rate was raised to 15 nL/min
and 20 nL/min, the resolution gradually increased to 2.30 and 2.39, respectively.
Figure 7.5 shows the focusing and separation of three proteins in an open
EFGF channel with concave field gradient profile. Although the bands are broad, the
three peaks are almost completely resolved. Figure 7.6 demonstrates improved
focusing with a monolith-filled EFGF channel containing a concave gradient profile.
When the counter flow rate was low (5 nL/min), two proteins (R-PE and GFP) were
focused in the low field region, and the resolution was 1.12. The bandwidths of these
proteins at half height were approximately 0.5 mm. When the flow rate was 15
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Figure 7.5. Separation of three proteins in an open EFGF channel with concave
gradient profile for 5 nL/min counter flow rate and 500 V applied voltage. Peaks: (1)
FITC--lactoglobulin A, (2) R-PE, and (3) GFP.
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A

B

Figure 7.6. Separations of (1) R-PE and (2) GFP in a monolith filled EFGF channel
with concave gradient profile at constant voltage (500 V) and different counter flow
rates. (A) 5 nL/min and (B) 15 nL/min.
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nL/min, the samples were focused in the steeper gradient region. The resolution
increased to 1.18 and the bandwidth at half height was approximately 0.8 mm.
Compared with the results obtained using an open-channel EFGF device, the bands
became narrower.

7.4

Conclusions
I fabricated bilinear EFGF devices using the changing cross-sectional area

approach. The presence of two segments with different linear gradients was
experimentally confirmed. The steep field segment was near the low field end and the
shallow field segment was near the high field end. When samples were focused in the
steep field segment, the peaks were narrow and unresolved. After moving them into
the shallow field segment by increasing the counter flow rate or decreasing the
voltage, the peaks became broader, but better resolved. With a further increase in flow
rate, analytes with lower mobilities were sequentially eluted while others were
retained. I also fabricated a nonlinear EFGF device with a concave electric field
gradient profile, for which the gradient increased along the channel. When the counter
flow was increased to move analytes from the low field end to high field end, both
bandwidth and resolution changed less than observed for a linear gradient EFGF
channel because of an increase in the gradient along the channel.
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8

FUTURE DIRECTIONS

8.1

PEG-Functionalized Microchips
In Chapter 4, a PEG-functionalized microchip was described. The fabrication

was not only easy, but the bonding was strong, which depended on partially
polymerized liquid layers remaining on the surfaces. Actually, an unreacted monomer
layer on the microchannel wall could facilitate covalent immobilization of a monolith
or gel in the channel after quick photo-induced bonding.
Microchip capillary electrochromatography (CEC) can be performed by
incorporating a monolith with charges on the surface in the microchannel. For
example, a poly(glycidyl methacrylate-co-polyethylene glycol diacrylate) monolith
could be prepared in the channel, in which PEGDA is used as a crosslinker to reduce
analyte adsorption. Epoxy groups in GMA could be used to attach various functional
groups, such as positively charged amine groups or negatively charged acidic groups.
Another method would be to directly use functionalized monomers, such as sulfoethyl
methacrylate (SEMA), to copolymerize with PEGDA to synthesize monoliths
containing the desired functional groups without further treatment.1,2 A new size
exclusion chromatographic monolith could also be integrated in the microchannel
which resists protein adsorption and has mesopores for protein separation according
to size. In this type of monolith filled microchip, CE separation of proteins would
depend on a combination of charge and size, which is similar to gel electrophoresis. It
would also be convenient to incorporate a photo curable polyacrylamide gel or
PEG-functionalized acrylate gel in a microchannel for gel electrophoresis of proteins.

242

Microchips with more complicated designs could be fabricated using this
material and fabrication method. Various functions could be integrated into one
microdevice. As reported previously, a hydrogel with permeation to only small ions
could be used to concentrate analytes.3 An affinity monolith could be used to extract
specific target proteins from a complicated sample.4 Monolith filled microchips could
be used for microchip liquid chromatography. This biocompatible material could also
be used to fabricate droplet-based microchips to handle single cells in a microchannel.
Proteins could be released from the trapped individual cells after lysis, and then
digested. The resultant peptides would be separated by CE and analyzed by ESI-MS.
This method would be useful for proteomics analysis. For such applications, the major
issue would be to use proper solvents, which should not swell, dissolve, or destroy the
substrates.
Currently, I can fabricate very thin plates (< 400 m) using the described
microchip fabrication method and material. The thickness of the final microchip was
typically less than 1 mm, and it retained sufficient mechanical strength for operation.
It is possible that a thin microchip could offer higher efficiency due to good Joule heat
dispersion. Furthermore, I could fabricate multiple-layer microdevices for
complicated analysis.

8.2

Multi-Electrode EFGF
I fabricated linear, bilinear and concave profile gradient EFGF devices using

the changing cross sectional area approach. However, complex changing cross
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sectional channels are required to achieve complicated field gradients. Furthermore,
the field gradient cannot be easily modified once the device is fabricated. Fortunately,
multi-electrode EFGF offers a solution to this problem.
A bottom plate with a rectangular cavity would first be fabricated. A top plate
with many small reservoirs would then be bonded to the bottom plate after
photopolymerization. Hydrogel monomer solution would be introduced into the cavity
and polymerized, and the channel would be formed using a metal wire embedded in
the hydrogel. Multiple electrodes would be placed in the buffer filled reservoirs and
voltages between adjacent electrodes would be controlled by a computer. Any
complicated gradient profile could be obtained by adjusting the voltages to reach the
best separation performance. In addition to proteins, cells and viruses could be
focused and studied using this technique.
Even though significant progress has been made in EFGF performance as
described in this dissertation, it has not reached its expected performance. This is due
to current technical difficulties. For example, the hydrodynamic flow rate for focusing
is extremely low, and it is difficult to keep it constant during operation. Any slight
fluctuation in the flow rate destroys the equilibrium and, thus, affects focusing.
Furthermore, I have not been able to precisely control the desired electric field in the
channel. When these issues are adequately solved, EFGF could become a powerful
analytical technique.
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